
<html lang="en"     class="pb-page"  data-request-id="5914cdce-9d2b-4d04-974a-8fc40436d578"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm502018y;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-5;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Optimization of a Series of 1-Sulfonylpyrazolo[4,3-b]pyridines as Selective c-Met Inhibitors" /></meta><meta name="dc.Creator" content="Yuchi  Ma" /></meta><meta name="dc.Creator" content="Guangqiang  Sun" /></meta><meta name="dc.Creator" content="Danqi  Chen" /></meta><meta name="dc.Creator" content="Xia  Peng" /></meta><meta name="dc.Creator" content="Yue-Lei  Chen" /></meta><meta name="dc.Creator" content="Yi  Su" /></meta><meta name="dc.Creator" content="Yinchun  Ji" /></meta><meta name="dc.Creator" content="Jin  Liang" /></meta><meta name="dc.Creator" content="Xin  Wang" /></meta><meta name="dc.Creator" content="Lin  Chen" /></meta><meta name="dc.Creator" content="Jian  Ding" /></meta><meta name="dc.Creator" content="Bing  Xiong" /></meta><meta name="dc.Creator" content="Jing  Ai" /></meta><meta name="dc.Creator" content="Meiyu  Geng" /></meta><meta name="dc.Creator" content="Jingkang  Shen" /></meta><meta name="dc.Description" content="c-Met has emerged as an attractive target for targeted cancer therapy because of its abnormal activation in many cancer cells. To identify high potent and selective c-Met inhibitors, we started wit..." /></meta><meta name="Description" content="c-Met has emerged as an attractive target for targeted cancer therapy because of its abnormal activation in many cancer cells. To identify high potent and selective c-Met inhibitors, we started wit..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 25, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm502018y" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm502018y" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm502018y" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm502018y" /></link>
        
    
    

<title>Design and Optimization of a Series of 1-Sulfonylpyrazolo[4,3-b]pyridines as Selective c-Met Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm502018y" /></meta><meta property="og:title" content="Design and Optimization of a Series of 1-Sulfonylpyrazolo[4,3-b]pyridines as Selective c-Met Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0018.jpeg" /></meta><meta property="og:description" content="c-Met has emerged as an attractive target for targeted cancer therapy because of its abnormal activation in many cancer cells. To identify high potent and selective c-Met inhibitors, we started with profiling the potency and in vitro metabolic stability of a reported hit 7. By rational design, a novel sulfonylpyrazolo[4,3-b]pyridine 9 with improved DMPK properties was discovered. Further elaboration of π–π stacking interactions and solvent accessible polar moieties led to a series of highly potent and selective type I c-Met inhibitors. On the basis of in vitro and in vivo pharmacological and pharmacokinetics studies, compound 46 was selected as a preclinical candidate for further anticancer drug development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm502018y"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm502018y">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm502018y&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm502018y&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm502018y&amp;href=/doi/10.1021/jm502018y" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2513-2529</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501997q" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00079" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Optimization of a Series of 1-Sulfonylpyrazolo[4,3-<i>b</i>]pyridines as Selective c-Met Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuchi++Ma">Yuchi Ma</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guangqiang++Sun">Guangqiang Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Danqi++Chen">Danqi Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xia++Peng">Xia Peng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yue-Lei++Chen">Yue-Lei Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi++Su">Yi Su</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yinchun++Ji">Yinchun Ji</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jin++Liang">Jin Liang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Wang">Xin Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lin++Chen">Lin Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Ding">Jian Ding</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bing++Xiong">Bing Xiong</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Ai">Jing Ai</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Meiyu++Geng">Meiyu Geng</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jingkang++Shen">Jingkang Shen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div><div class="corresp-info"><strong>*</strong>.B.X.: phone, +86 21 50806600, extension 5412; fax, +86 21 50807088; e-mail, <a href="/cdn-cgi/l/email-protection#fa98829395949dba89939797d49b99d49994"><span class="__cf_email__" data-cfemail="ed8f958482838aad9e848080c38c8ec38e83">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>J.A.: phone, +86 21 50806600, extension 2413; e-mail, <a href="/cdn-cgi/l/email-protection#743119151d184e1e151d34071d19195a15175a171a">Email:<span class="__cf_email__" data-cfemail="610b00082112080c0c4f00024f020f">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>M.G.: phone, +86 21 50806072; e-mail, <a href="/cdn-cgi/l/email-protection#c8a5b1afada6af88bba1a5a5e6a9abe6aba6"><span class="__cf_email__" data-cfemail="432e3a24262d2403302a2e2e6d22206d202d">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>J.S.: phone, +86 21 50806600, extension 5410; e-mail, <a href="/cdn-cgi/l/email-protection#701a1b0318151e3003191d1d5e11135e131e"><span class="__cf_email__" data-cfemail="b2d8d9c1dad7dcf2c1dbdfdf9cd3d19cd1dc">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm502018y&amp;href=/doi/10.1021%2Fjm502018y" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2513–2529</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 10, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 December 2014</li><li><span class="item_label"><b>Published</b> online</span>25 February 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm502018y" title="DOI URL">https://doi.org/10.1021/jm502018y</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2513%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYuchi%2BMa%252C%2BGuangqiang%2BSun%252C%2BDanqi%2BChen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D5%26contentID%3Djm502018y%26title%3DDesign%2Band%2BOptimization%2Bof%2Ba%2BSeries%2Bof%2B1-Sulfonylpyrazolo%255B4%252C3-b%255Dpyridines%2Bas%2BSelective%2Bc-Met%2BInhibitors%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2529%26publicationDate%3DMarch%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm502018y"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2179</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">31</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm502018y" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Optimization of a Series of 1-Sulfonylpyrazolo[4,3-b]pyridines as Selective c-Met Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yuchi&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Guangqiang&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Danqi&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Xia&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Yue-Lei&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;Su&quot;},{&quot;first_name&quot;:&quot;Yinchun&quot;,&quot;last_name&quot;:&quot;Ji&quot;},{&quot;first_name&quot;:&quot;Jin&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Lin&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Bing&quot;,&quot;last_name&quot;:&quot;Xiong&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Ai&quot;},{&quot;first_name&quot;:&quot;Meiyu&quot;,&quot;last_name&quot;:&quot;Geng&quot;},{&quot;first_name&quot;:&quot;Jingkang&quot;,&quot;last_name&quot;:&quot;Shen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;2513-2529&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm502018y&quot;},&quot;abstract&quot;:&quot;c-Met has emerged as an attractive target for targeted cancer therapy because of its abnormal activation in many cancer cells. To identify high potent and selective c-Met inhibitors, we started with profiling the potency and in vitro metabolic stability of a reported hit 7. By rational design, a novel sulfonylpyrazolo[4,3-b]pyridine 9 with improved DMPK properties was discovered. Further elaboration of π–π stacking interactions and solvent accessible polar moieties led to a series of highly potent and selective type I c-Met inhibitors. On the basis of in vitro and in vivo pharmacological and pharmacokinetics studies, compound 46 was selected as a preclinical candidate for further anticancer drug development.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm502018y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm502018y" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm502018y&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm502018y" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm502018y&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm502018y" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm502018y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm502018y&amp;href=/doi/10.1021/jm502018y" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm502018y" /></input><a href="/doi/pdf/10.1021/jm502018y" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm502018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm502018y%26sid%3Dliteratum%253Aachs%26pmid%3D25668160%26genre%3Darticle%26aulast%3DMa%26date%3D2015%26atitle%3DDesign%2Band%2BOptimization%2Bof%2Ba%2BSeries%2Bof%2B1-Sulfonylpyrazolo%255B4%252C3-b%255Dpyridines%2Bas%2BSelective%2Bc-Met%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D5%26spage%3D2513%26epage%3D2529%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jmcmar.2015.58.issue-5/20150312/jmcmar.2015.58.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">c-Met has emerged as an attractive target for targeted cancer therapy because of its abnormal activation in many cancer cells. To identify high potent and selective c-Met inhibitors, we started with profiling the potency and in vitro metabolic stability of a reported hit <b>7</b>. By rational design, a novel sulfonylpyrazolo[4,3-<i>b</i>]pyridine <b>9</b> with improved DMPK properties was discovered. Further elaboration of π–π stacking interactions and solvent accessible polar moieties led to a series of highly potent and selective type I c-Met inhibitors. On the basis of in vitro and in vivo pharmacological and pharmacokinetics studies, compound <b>46</b> was selected as a preclinical candidate for further anticancer drug development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">c-Met, also termed as hepatocyte growth factor receptor (HGFR), belongs to a unique subfamily of receptor tyrosine kinases (RTKs).<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Since its discovery in 1984 as an oncogenic fusion protein TPR-MET,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> c-Met was extensively investigated for its structure and functions. Studies revealed that c-Met forms a heterodimer by connecting a short extracellular α chain and a membrane spanning β chain through a disulfide bond.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Binding of its natural ligand—hepatocyte growth factor (HGF) to c-Met initiates its kinase phosphorylation activity and then triggers a series of downstream signaling pathways including PI3K-AKT-mTOR, Ras-MEK-ERK.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7-10)</a> Physiologically, the HGF/c-Met axis plays important roles in mammalian development and tissue homeostasis.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Abnormal activation of c-Met has been reported in many types of cancers, occurring as a consequence of gene amplification or rearrangement, transcriptional regulation, as well as autocrine or paracrine ligand stimulation.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13-16)</a> Importantly, overexpression of HGF and/or c-Met has been associated with poor prognosis or metastatic progression. In addition, Met amplification is observed in 20% of acquired resistance to EGFR inhibitors.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Tumor microenvironment elicits innate resistance to BRAF inhibitors via HGF secretion.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Thus, c-Met has emerged as an attractive target for targeted cancer therapy.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0020.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative c-Met inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To disrupt the c-Met signaling, several strategies were exploited, including antibodies targeting HGF/c-Met and small molecular inhibitors binding to the kinase catalytic domain of β chain of c-Met.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> Since the activation of c-Met signaling pathway can be HGF-independent,<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> the small molecular inhibitor targeting the intracellular kinase domain was predicted to have its unique pharmacological mechanism and may cover a potentially larger patient population than that of HGF/c-Met antibody treatment, which is only responsible for HGF-dependent cases. On the basis of the analysis of binding modes, the small molecular inhibitors of c-Met can be roughly classified into three types: type I c-Met inhibitors bind to the ATP binding pocket in “U” shape, which usually interacts with the residue Met1211 at the hinge part to anchor the inhibitor and forms a typical π–π stacking interaction with residue Tyr1230. Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> lists some type I inhibitors, including a marketed drug crizotinib (<b>1</b>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and two phase II clinical trial compounds (<b>2</b>, <b>3</b>).<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Implied by the unique U-shaped binding mode, type I inhibitors all show good selectivity for c-Met, which is thought to give less side effects in cancer treatment. Type II c-Met inhibitors usually adopt an extended conformation, starting from the solvent-accessible part to hinge and further stretching to the deep hydrophobic Ile1145 subpocket near the C-helix region. As exemplified by one marketed drug (cabozantinib, <b>4</b>),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> these compounds are multikinase inhibitors and usually strongly inhibit VEGFR and other homological kinases as well. Except for above-mentioned well classified inhibitors, there are other atypical c-Met inhibitors (all classified as type III c-Met inhibitors), such as MK-2461 (<b>5</b>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and ARQ-197 (<b>6</b>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> As revealed from a cocrystal structure of an analogue of <b>5</b> bound to c-Met, the small molecule occupies the subpocket from gatekeeper Leu1157 to solvent exposed area. Although it adopted a U-turn at sulfonamide and made hydrogen bonding with Asp1222, it has no π stacking moiety as in type I inhibitors. For ARQ-197, it was initially discovered with a phenotype cell viability assay and later was identified to be a non-ATP competitive c-Met inhibitor.</div><div class="NLM_p last">In 2009 Porter et al. reported the discovery of 4-azaindoles as c-Met inhibitors through a high throughput screening campaign and structure-based optimization.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> We noticed the moderate cellular activity of this interesting scaffold and decided to investigate this structure type in detail. Toward this end, we assessed the scaffold utility from the perspective of enzymatic activity and metabolism. A novel more metabolically stable scaffold was discovered, and further optimization resulted in a series of high potent, selective c-Met inhibitors. On the basis of the extensive in vivo pharmacology and pharmacokinetics studies, compound <b>46</b> was selected as promising candidate and subjected to further development.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Inhibitor Design and Lead Identification</h3><div class="NLM_p">Sulfonyl-4-azaindoles acting as novel c-Met inhibitors were discovered by Porter et al. from a high throughput screening campaign.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The most potent compound in the series was reported to have IC<sub>50</sub> of about 9 nM in the enzymatic assay. As demonstrated by the cocrystal structure (PDB entry code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WD1">2WD1</a>) of a representative compound 1-((2-nitrophenyl)sulfonyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carboxamide with c-Met, the inhibitor binds at the ATP binding site in a typical U-shape: the pyrrolo[3,2-<i>b</i>]pyridine ring interacts with the hinge segment around residue Met1160, and the nitrophenyl group forms face to face π–π stacking with the residue Tyr1230, further enhancing the affinity by making a hydrogen bond between the nitro group and the backbone NH of Asp1222. The middle sulfonyl group makes two aromatic ring systems forming a right angle and perpendicular to each other. Although the series of pyrrolopyridine compounds is unique as c-Met inhibitors and demonstrates its utility with high potency in enzymatic assay, it only showed moderate cellular activities with GI<sub>50</sub> about 0.1 μM in MKN45 and A549 cell lines. We thought this unique binding pattern deserves to be further explored, especially for the optimization of druglike properties. Thus, compound <b>7</b> with this 1-sulfonylpyrrolo[3,2-<i>b</i>]pyridine scaffold was synthesized to reinspect the utility of the scaffold. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, compound <b>7</b> showed a good 92.8% inhibition at 1 μM concentration in enzymatic assay. To assess its druglike property, the metabolic stability of <b>7</b> was measured in the human liver microsome assay. The results indicated that it is not so stable, only with an intrinsic clearance rate of 88 μL min<sup>–1</sup> mg<sup>–1</sup>. After detailed analysis of the intermediate metabolites by incubating compound <b>7</b> in human liver microsome, it was shown that the pyrrolo[3,2-<i>b</i>]pyridine ring was easily hydroxylized. This is consistent with the works by Dalvie et al.,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> who reviewed the biotransformation of common aromatic heterocycles and showed the pyrrole group is electron rich and prone to react with metabolic enzymes especially at the C2 position. Therefore, the more metabolically stable pyrazole ring was selected to replace the pyrrole and two compounds (<b>8</b> and <b>9</b>) were designed and synthesized accordingly. After testing two compounds in enzymatic assay, the more active compound (<b>9</b>) was studied in the human liver microsome assay, and the result indicated it was much more stable than compound <b>7</b>. Hence, compound <b>9</b> was selected as a novel starting point for further modification.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of new core structures based on the reference HTS hit compound.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Initial Optimization of the π–π Stacking Part<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">The IC<sub>50</sub> or inhibition values are shown as the mean ± SD (nM) or estimated values from three separate experiments.</p></div></div><div></div></div><div class="NLM_p">After selected the scaffold structure, the initial optimization was focused on enhancing the π–π stacking interaction with the residue Tyr1230, which is confirmed to be the dominant factor for selectivity and potency of type I c-Met inhibitors. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, a variety of substituted arylsulfonylpyrazolo[4,3-<i>b</i>]pyridines were prepared and tested in c-Met enzymatic assay. Compared with compound <b>9</b>, the unsubstituted phenyl derivative (<b>10</b>) was less active, which may be caused by losing a hydrogen bond with Asp1222. To include this hydrogen bonding feature into the molecules, we prepared compounds with CF<sub>3</sub> (<b>13</b>–<b>15</b>), cyan (<b>16</b>), methoxyl (<b>17</b>), or carbonyl (<b>18</b>) substituted phenyl ring. As demonstrated by compounds <b>11</b>–<b>15</b>, the position of the substitution at benzene group was important for the inhibitory activity: the meta-substituted fluorobenzene <b>11</b> was more potent than the para-substituted one (<b>12</b>). Similarly, the compound with ortho- or meta-substituted trifluoromethylbenzene group was at least 12-fold more potent than the compound with para-substitution. This trend was also supported by the 4-acetylphenylsulfonyl derivative with reduced IC<sub>50</sub> of 4.8 μM. Interestingly, as demonstrated by compound <b>21</b> (IC<sub>50</sub> = 4.2 nM), replacing monocycle with bicycle groups improves the activity. By comparing compounds <b>20</b> and <b>21</b>, it is found that in the ring substituted with the sulfonyl group, <b>21</b> has a nitrogen atom that could form a hydrogen bond with Asp1222. It is not trivial, since this important substitution pattern pointed to a different direction. On the basis of the similarity of the 6-chloroimidazo[2,1-<i>b</i>]thiazole to other corresponding π stacking rings in various type I c-Met inhibitors, we can hybridize this series of sulfonylpyrazolo[4,3-<i>b</i>]pyridines with some well-explored type I c-Met inhibitors.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">Following this direction, we prepared three analogs (<b>22</b>–<b>24</b>) and measured their enzymatic activities. As listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, these three compounds all showed high potency, with IC<sub>50</sub> lower than 40 nM. According to the synthetic accessibility and binding affinity, compound <b>22</b> was selected to check whether it is suitable to be advanced as lead compound.</div><div class="NLM_p">Compound <b>22</b> was tested in non-small lung cancer (NSCLC) EBC-1 cells for antiproliferation effect, and we found that it showed high potency with IC<sub>50</sub> of 55.5 ± 13.6 nM. Since specificity is an important issue in current kinase drug development, a panel of other 16 diversified kinases was set up to assess the enzymatic selectivity. As indicated in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, compound <b>22</b> is a selective inhibitor toward c-Met, only showing moderate inhibition for RON, a c-Met homology kinase in the same subfamily, and weak effects on other 15 kinases with less than 50% inhibition at the concentration of 1 μM.</div><div class="NLM_p">The inhibitor was further subjected to in vitro metabolic stability assays and in vivo pharmacokinetic test. From the multispecies liver microsome stability study, compound <b>22</b> showed excellent stability with clearance rate of 9, 4, 10 μL min<sup>–1</sup> mg<sup>–1</sup> in human, rat, and dog liver microsomes, respectively. Compared to the starting point compound <b>7</b>, the metabolic stability of <b>22</b> in human liver microsome was increased considerably, which recapitulated the utility of sulfonylpyrazolo[4,3-<i>b</i>]pyridine scaffold. In addition to the liver microsome assays, five cytochrome P450 (CYP) enzymes commonly metabolizing exogenous chemicals were used to test the direct inhibition of compound <b>22</b>. As listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, the compound showed favorable metabolic properties, as the inhibition ratio for five CYPs was less than 50% even at the compound concentration of 10 μM.</div><div class="NLM_p">The selected compound <b>22</b> was further evaluated in the preliminary pharmacokinetic study in mice (see Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Oral dosing with compound <b>22</b> at the level of 10 mg/kg shows high exposure (AUC<sub>0–∞</sub> = 4098.7 ng/(mL·h)) and acceptable half-life about 1.45 h. The compound has a high <i>C</i><sub>max</sub> about 2131.4 ng/mL. These desirable PK properties strengthen our confidence of selecting compound <b>22</b> as a lead structure.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Kinase-Selectivity Profile of Compound <b>22</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RON</td><td class="colsep0 rowsep0" align="left">67.2% at 1 μM</td><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="left">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TYRO3</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">ErbB4</td><td class="colsep0 rowsep0" align="left">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Flt-1</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">c-Src</td><td class="colsep0 rowsep0" align="left">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Flt-3</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">ABL</td><td class="colsep0 rowsep0" align="left">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KDR</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">EPH-A2</td><td class="colsep0 rowsep0" align="left">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDGFR-α</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">ROS1</td><td class="colsep0 rowsep0" align="left">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDGFR-β</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">IGF1R</td><td class="colsep0 rowsep0" align="left">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RET</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">FGFR1</td><td class="colsep0 rowsep0" align="left">>1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">The IC<sub>50</sub> or inhibition values are shown as the mean ± SD (nM) or estimated values from three separate experiments.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Leadlikeness Assessment of Compound <b>22</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">property</th><th class="colsep0 rowsep0" align="center">value</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver microsome stability in rat, dog, monkey, human (μL min<sup>–1</sup> mg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">4, 10, 112, 9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP direct inhibition (10 μM; 3A4, 2D6, 2C9, 1A2, 2C19) (%)</td><td class="colsep0 rowsep0" align="left">37, 12, 26, 15, 27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">in vivo mouse PK (10 mg/kg, po,<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> <i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V<sub>Z</sub></i>/<i>F</i> (L/kg)</td><td class="colsep0 rowsep0" align="left">5.10 ± 0.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT<sub>(0–<i>t</i>)</sub> (h)</td><td class="colsep0 rowsep0" align="left">1.94 ± 0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–∞)</sub> (ng mL<sup>–1</sup> h<sup>–1</sup>))</td><td class="colsep0 rowsep0" align="left">4098.7 ± 776.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–<i>t</i>)</sub> (ng mL<sup>–1</sup> h<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">3986.5 ± 705.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub><i>Z</i></sub>/F (L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">2.49 ± 0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub><b>1/2</b></sub> (h)</td><td class="colsep0 rowsep0" align="left">1.45 ± 0.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.50 ± 0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">2131.4 ± 54.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Formulation: DMAC/0.5% methylcellulose (5:95, v:v).</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Lead Optimization</h3><div class="NLM_p">The lead compound <b>22</b> was subjected to further optimization, which focused on two ring systems connecting to the pyrazolo[4,3-<i>b</i>]pyridine scaffold. Utilizing the crystal structure, we docked the lead compound into the binding pocket of c-Met. The predicted binding conformation between <b>22</b> and c-Met revealed several expected essential interactions, including π–π stacking and two hydrogen bonding interactions: one is between N4 of pyrazolo[4,3-<i>b</i>]pyridine and the hinge part (Met1160), and another is between N1 of imidazo[1,2-<i>a</i>]pyridine and Asp1222. An obvious direction for further optimizing the π–π stacking part is substituting various groups at the 6-position of imidazo[1,2-<i>a</i>]pyridine ring, where a large room exists and connects to the solvent accessible range through a short channel.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of π–π Stacking Part<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">The IC<sub>50</sub> or inhibition values are shown as the mean ± SD (nM) or estimated values from three separate experiments.</p></div></div><div></div></div><div class="NLM_p">Incorporation of various groups to the imidazo[1,2-<i>a</i>]pyridine ring led to compounds <b>25</b>–<b>31</b> with diversified activities. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, adding a bromine atom at the C6 position of the ring (<b>25</b>) decreases the activity more than 10-fold and substituted with acetamide (<b>29</b>) or alkylamine (<b>30</b>) attenuated the affinity considerably, with IC<sub>50</sub> larger than 1 μM. Interestingly, introducing alkoxyl group (<b>26</b>) or ester groups (<b>27</b>, <b>28</b>) at this position improves the binding activity. The most potent compound in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> is <b>31</b>, which was prepared by coupling a benzene moiety at C6 position of imidazo[1,2-<i>a</i>]pyridine and showed an intriguing enzymatic activity (IC<sub>50</sub> = 0.1 nM). This instructed us to further explore the SAR around this position by decorating it with various aromatic functional groups.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR of π–π Stacking Part<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0014.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0015.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">The IC<sub>50</sub> or inhibition values are shown as the mean ± SD (nM) or estimated values from three separate experiments.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Not determined.</p></div></div><div></div></div><div class="NLM_p">As listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, various substituted benzene groups and aromatic heterocycles were selected to attach at C6 position of imidazopyridine ring. Compared to the inhibitor <b>31</b>, additional monosubstitution at the para-position of the benzene moiety reduced the binding affinity toward c-Met, as exemplified by compound <b>36</b> with IC<sub>50</sub> larger than 100 nM, as well as compounds <b>39</b> and <b>42</b> with IC<sub>50</sub> larger than 1000 nM. Compound with two methoxyl groups substituted at meta- and para-position of the benzene (<b>37</b>) showed much higher potency to c-Met, compared with compound <b>36</b>. This indicated that the meta-position is critical to the activity. This was verified by compound <b>35</b> (IC<sub>50</sub> = 1.4 nM), a bioisosteric inhibitor of <b>37</b>, and compound <b>38</b> with a meta-cyanophenyl fragment (IC<sub>50</sub> = 1.5 nM). Adding difluoro group to the phenyl ring (<b>40</b>) results in a more than 10-fold loss of binding activity in the enzymatic assay. Surprisingly, meta-substitution with trifluoromethyl group decreased the activity. Changing the phenyl ring to other aromatic hetorocyles is tolerable, as indicated from the activities of compounds <b>32</b>–<b>34</b>. Coupling the thiazole group to imidazopyridine results in the most potent compound <b>32</b> in this series, with the IC<sub>50</sub> value of about 0.04 nM. When being compared to <b>31</b>, the activity of methylpyrazole compound (<b>33</b>) slightly reduced to 0.5 nM, while the activity of fluoropyridine derivative (<b>34</b>) decreased about 100-fold. Comparing compound <b>43</b> to <b>33</b>, it was shown that the large and polar piperidine substituted at pyrazole ring is not favorable for the binding. The compounds with enzymatic activity better than 100 nM of IC<sub>50</sub> value were further assessed in cellular antiproliferation assay, and the results (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) indicated only <b>33</b>, <b>34</b>, and <b>38</b> have good cellular activities, especially compound <b>33</b> with more than 50% inhibition ratio even at concentration of 1 nM. Therefore, the methylpyrazole group was fixed for late optimization.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. SAR of Solvent Exposure Part<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0016.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0017.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">The IC<sub>50</sub> or inhibition values are shown as the mean ± SD (nM) or estimated values from three separate experiments.</p></div></div><div></div></div><div class="NLM_p">As revealed from the crystal structure and our docking study, the methylpyrazole in compound <b>22</b> pointed to the solvent exposure area in kinase domain of c-Met. This hydrophilic site is relevant to the optimization of druglike properties of kinase inhibitors as indicated in many cases of kinase drug development. Further modification was carried out at this portion to gain further insight on the potential of improvement of potency and solubility of the series. Listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, 10 compounds with varied polar fragment attaching the C6 of the pyrazolo[4,3-<i>b</i>]pyridine were prepared and tested in both enzymatic and EBC-1 cell antiproliferation assay. All of these inhibitors showed very high potency toward c-Met, with the IC<sub>50</sub> ranging from 3 to 0.3 nM. Compared to compound <b>33</b>, removing the methyl group on the 6-pyrazolepyrazolo[4,3-<i>b</i>]pyridine (<b>44</b>) resulted in about 4-fold loss of c-Met enzymatic activity, while changing to piperidine (<b>45</b>) or isopropylpiperidine (<b>46</b>) or cyclopentylpiperidine (<b>47</b>) retains the enzymatic activity. Exposing NH of pyrazole or NH of piperidine (<b>44</b> or <b>45</b>) at this part is harmful for the cellular antiproliferation activity. Substituted phenyl group at 6-position of pyrazolo[4,3-<i>b</i>]pyridine (<b>48</b>) is tolerable but with a 13-fold loss in the cellular activity assay if comparing to compound <b>33</b>. Further modification of the phenyl group by adding methylmorpholine (<b>49</b>) or acylmethylpiperazine (<b>50</b>) enhanced the potency to at least 0.4 nM in cellular assay. The nonaromatic tetrahydropyrdine or substituted compounds were also tested (<b>51</b>–<b>53</b>), showing a dramatic loss in cellular activity.</div><div class="NLM_p">In vitro metabolism studies were applied to four inhibitors with high potency in cellular assay. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, four compounds showed relatively weak inhibition in five CYP enzymes at a compound concentration of 10 μM. Compounds <b>47</b> and <b>49</b> exhibited high clearance ratio in human/rat liver microsome, indicating that they may have unfavorable issues associated with metabolic stability. The time dependent inhibition assays of five CYPs were also performed on these compounds, showing no covalent binding except for compound <b>49</b>. Taking together, compound <b>46</b> with clean DMPK properties was selected as candidate for detailed pharmacological and pharmacokinetic investigations.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vitro DMPK Profile</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">CYP direct inhibition<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a> (%)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">HLM<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> Cl<sub>int,app</sub> [μL min<sup>–1</sup> mg<sup>–1</sup>]</th><th class="colsep0 rowsep0" align="center" char=".">RLM<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> Cl<sub>int,app</sub> [μL min<sup>–1</sup> mg<sup>–1</sup>]</th><th class="colsep0 rowsep0" align="center" char=".">3A4</th><th class="colsep0 rowsep0" align="center" char=".">2D6</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center" char=".">1A2</th><th class="colsep0 rowsep0" align="center" char=".">2C19</th><th class="colsep0 rowsep0" align="center">TDI<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">172</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="char" char=".">148</td><td class="colsep0 rowsep0" align="char" char=".">232</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="left">3A4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="char" char=".">116</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Human liver microsomal intrinsic clearance.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Rat liver microsomal intrinsic clearance.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">CYP direct inhibition, sometimes referred to reversible inhibition, is assessed by measurement of an enzyme (CYP) activity in the presence of increasing concentration of inhibitor without a preincubation step.</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">TDI stands for time-dependent inhibition, which is referring to a change in enzyme inhibition during an in vitro incubation and means an irreversible inactivation of CYPs.</p></div></div></div></div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Profiling the Candidate Compound <b>46</b>. Compound <b>46</b> Is a Selective c-Met Kinase Inhibitor</h3><div class="NLM_p">By use of an ELISA-based enzymatic assay, compound <b>46</b> was distinguished for its high potency against c-Met kinase activity with an average IC<sub>50</sub> value of 0.6 ± 0.1 nM. Then we were prompted to investigate whether this potency was specifically against c-Met. Compound <b>46</b> was evaluated against a panel of 19 diversified kinases. In contrast to its high potency against c-Met, compound <b>46</b> barely inhibited the kinase activity of other tested tyrosine kinases, including c-Met family member RON and highly homologous kinase Axl, Tyro-3 (IC<sub>50</sub> > 1 μM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>), indicating that it is a selective c-Met inhibitor.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Kinase-Selectivity Profile of Compound <b>46</b><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">c-Met</td><td class="colsep0 rowsep0" align="left">0.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">RET</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RON</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Axl</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">ErbB2</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tyro-3</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">ErbB4</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALK</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">c-Src</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Flt-1</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">ABL</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KDR</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">EPH-A2</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">c-Kit</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">EPH-B2</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDGFRα</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">FGFR1</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDGFRβ</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">The IC<sub>50</sub> or inhibition values are shown as the mean ± SD (nM) or estimated values from three separate experiments.</p></div></div></div></div><div id="sec2_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cellular effects of Compound <b>46</b>. Compound <b>46</b> Effectively Inhibits c-Met Phosphorylation and Downstream Signaling</h3><div class="NLM_p">To further evaluate the cellular activity of compound <b>46</b> targeting c-Met kinase, we analyzed its effects on the phosphorylation of c-Met and its downstream signaling components Akt and Erk by using gastric cancer cell MKN45 and non-small lung cancer (NSCLC) cell EBC-1 harboring <i>MET</i> gene amplification. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A and Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B, compound <b>46</b> inhibited the phosphorylation level of c-Met, Akt, and Erk in a dose-dependent manner. Extending the study to NSCLC cell A549 that responds well to HGF stimulation, and model cell line BaF3/TPR-Met containing <i>MET</i> chromosomal rearrangement (<i>TPR-MET</i>), we found that a similar trend was followed (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D). These results suggested that compound <b>46</b> exhibits an effective inhibition of c-Met activation and its downstream signaling, regardless of the mechanistic complexity in c-Met activation across different cellular contexts.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>46</b> inhibits c-Met phosphorylation and downstream signaling in cancer cell lines. (A, B) Compound <b>46</b> effectively inhibits the phosphorylation of c-Met and the c-Met pathway downstream effectors Erk1/2 and Akt in MKN45 (A), EBC-1 (B), and BaF3/TPR-Met cells (C). Cells treated for 1 h with compound <b>46</b> at the indicated concentrations were lysed and subjected to Western blot analysis. (D) Compound <b>46</b> inhibited HGF-induced c-Met phosphorylation and its downstream signaling in A549 cells. Cells treated with compound <b>46</b> for 1 h following HGF stimulation for 15 min were then lysed and subjected to Western blot analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Compound <b>46</b> Selectively Inhibits c-Met-Driven Cancer Cells Proliferation via G1/S Arrest</h3><div class="NLM_p">To elucidate the impact of compound <b>46</b> on c-Met mediated cancer cell proliferation, a broad panel of human cancer cell lines harboring different backgrounds of c-Met expression/activation was used. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A, compound <b>46</b> significantly inhibited the cell proliferation of c-Met constitutively activated EBC-1, MKN45, SUN5, BaF3/TPR-MET cells, with the IC<sub>50</sub> values of 0.27 ± 0.03 nM, 1.10 ± 0.12 nM, 1.15 ± 0.22 nM, 0.32 ± 0.04 nM, respectively. Otherwise, the compound showed much less potency in cancer cell lines with low c-Met expression or activation (IC<sub>50</sub> > 10 μM). These results indicated that compound <b>46</b> specifically inhibits c-Met-dependent cancer cell growth, also implying it is not a cytotoxic agent.</div><div class="NLM_p">Blocking c-Met activation inhibits the cell proliferation via arresting cells in G1/S phase.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> Therefore, the cell-cycle distribution was analyzed by flow cytometry to assess the association. We observed that treatment with compound <b>46</b> induced a G1/S phase arrest in EBC-1 cell, with 90% of the cell population in G<sub>1</sub> phase at the 20 nM concentration of the inhibitor (versus 50% in the vehicle control group) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C). No obvious sub-G<sub>1</sub> cell population was observed upon compound <b>46</b> treatment (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B), largely excluding the occurrence of induced apoptosis.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>46</b> possesses potent and selective antiproliferation activity in cell lines with c-Met activation by G1/S phase arresting. (A) The antiproliferation activity of compound <b>46</b> against a panel of tumor cell lines originating from different tissue types was determined by a sulforhodamine B (SRB) or an MTT assay. The IC<sub>50</sub> values were plotted as the mean ± SD (μmol/L) from three separate experiments or estimated values from two separate experiments. (B) Induction of G<sub>1</sub> phase arrest by compound <b>46</b>. EBC-1 cells were treated with increasing concentrations of compound <b>46</b> or vehicle for 24 h. The DNA content was measured by FACS analysis. (C) Percentage of EBC-1 cells in different cell cycle phases determined by FACS and analyzed with FCS expression software. The data shown are the mean ± SD from three independent experiments, and representative images are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Compound <b>46</b> Inhibits c-Met-Dependent Cell Migration, Invasion, Scattering, and Invasive Growth</h3><div class="NLM_p">In addition to the effect of promoting cell proliferation, c-Met activation by HGF also enhances cell motility and invasion, which is associated with increased tumor aggressive and extensive metastatic phenotype.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Thus, the impact of compound <b>46</b> was evaluated in this regard. NCI-H441 cells were treated with HGF in the presence of compound <b>46</b>, and the migratory and invasive abilities were determined using Transwell-based assays. Compared to vehicle group, compound <b>46</b> dose-dependently suppresses HGF-induced cell migration and invasion and at the concentration of 20 nM could almost block the movement of NCI-H441 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A–D).</div><div class="NLM_p">Activation of HGF/c-Met axis could also induce cell scattering, a phenomenon contributing to the invasiveness and metastasis of cancer cell.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> It has been well documented that MDCK cells, which normally grow in clusters, undergo colony dispersal and become migratory, fibroblast-like cells upon HGF stimulation. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>E, we observed that treatment with compound <b>46</b> dose-dependently inhibited HGF-induced MDCK cell scattering, even reversing the scattering phenotype at a concentration of 4 nM.</div><div class="NLM_p">Activating c-Met triggers a complex genetic program termed invasive growth, which constitutes multiple biological processes including migration, matrix degradation, cell multiplication, and survival.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> In vitro, this morphogenetic program is recapitulated by stimulating cultured MDCK epithelial cells in suspension in a three-dimensional extracellular matrix (collagen) with HGF. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>F, in the absence of HGF, MDCK cell only showed round cysts, while upon HGF stimulation, a multicellular branched growth phenotype was observed. Compound <b>46</b> significantly inhibited this branching morphogenesis of the MDCK cells in a dose-dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>F), demonstrating its suppression effect on HGF-stimulated c-Met-mediated invasive growth phenotype.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>46</b> inhibits HGF-induced cell migration, invasion, scattering, and invasive growth. (A) The migratory ability and (B) invasive ability of NCI-H441 cells induced by 100 ng/mL HGF were impaired by compound <b>46</b>. Representative pictures are shown (scale bar, 100 μm). The relative migration (C) and invasion (D) were plotted. The data shown are the mean ± SD from three independent experiments, assuming 100% migration or invasion of cells stimulated with HGF. (E) Cell scattering by MDCK cells induced by HGF were dose-dependently inhibited by compound <b>46</b>. Representative images from three separate experiments are shown (scale bars, 100 μm). (F) Compound <b>46</b> significantly inhibited HGF-stimulated invasive cell growth. The MDCK branching morphogenesis on collagen induced by HGF was inhibited by compound <b>46</b>. Images were obtained 5 days after treatment. Representative images from three separate experiments are shown (scale bars, 100 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vivo Antitumor Activity of Compound <b>46</b></h3><div class="NLM_p">To assess the in vivo antitumor efficacy of compound <b>46</b>, an EBC-1 xenograft mouse model, which is specifically driven by constitutive activation of c-Met, was used. Compound <b>46</b> was administered orally at doses of 50 or 10 mg/kg once daily for 21 consecutive days. The results showed that, compared with the vehicle group, compound <b>46</b> could suppress tumor growth in a dose-dependent manner, with tumor growth inhibitory rate of 104.67% and 69.71% at the doses of 50 mg/kg and 10 mg/kg, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A). Consistent with the suppressed tumor growth, a marked reduction in the intratumoral phosphorylation of c-Met and downstream Akt and Erk was observed at 1 h after oral administration of 10 mg/kg compound <b>46</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). Taken together, compound <b>46</b> showed a robust antitumor efficacy that was correlated with the inhibition of c-Met-mediated signaling in a c-Met-dependent tumor model. Therefore, compound <b>46</b> was selected as a promising c-Met inhibitor advanced into further drug development.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo antitumor efficacy of compound <b>46</b> in EBC-1 xenograft model. (A) Compound <b>46</b> was administered orally once daily for 21 days after the tumor volume reached 100–150 mm<sup>3</sup>. Results are expressed as the mean ± SEM (<i>n</i> = 6 per group). The percentage of tumor volume inhibition values (TGI) was measured on the final day of the study for the drug-treated mice compared with the control mice: (∗∗∗) <i>P</i> < 0.001 versus vehicle group, using Student’s <i>t</i> test. Compound <b>46</b> significantly prevented tumor growth. (b) Inhibition of c-Met phosphorylation and downstream signaling pathways in EBC-1 xenografts by compound <b>46</b>. Mice were humanely euthanized on final day at 1 h postadministration of compound <b>46</b>, and the tumors were resected, snap-frozen, and pulverized. The protein lysates were subjected to Western blot analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>7</b> and <b>9</b> were prepared according to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Commercially available 4-azaindole <b>55a</b> and 4-azaindazole <b>55b</b> were sulfonylated to afford <b>56a</b> and <b>56b</b>. Conventional Suzuki coupling of <b>56a</b> and <b>56b</b> with the boronate ester of the pyrazole afforded compounds <b>7</b> and <b>9</b> directly.</div><div class="NLM_p">Compound <b>8</b> was prepared according the procedure in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Iodination of 5-bromo-7-azaindazole (<b>57</b>) produced 5-bromo- 3-iodo-7-azaindazole <b>58</b>. Treatment of compound <b>58</b> with thiophenol via copper-catalyzed reaction afforded compound <b>59</b>. Compound <b>60</b> was synthesized by oxidation of <b>59</b>, and Suzuki coupling conditions were used to generate <b>8</b>.</div><div class="NLM_p">Compounds <b>10</b>–<b>44</b> were prepared according to the procedure in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Suzuki coupling of <b>55b</b> with 1-methylpyrazole-4-boronic acid pinacol ester provided <b>63</b>. Compounds <b>10</b>–<b>26</b> were prepared by deprotonation of compound <b>63</b> followed by addition of the appropriate sulfonyl chlorides. Compound <b>68</b> was synthesized via demethylation of <b>26</b>. Compounds <b>27</b> and <b>28</b> were prepared by esterification. Compounds <b>31</b>–<b>43</b> were generated by Suzuki coupling reaction from compound <b>25</b>. Compound <b>69</b> was reduced with iron powder in toluene and water to <b>70</b>. Compound <b>29</b> was prepared with the conventional amide coupling of <b>70</b>. Compound <b>30</b> was synthesized via reductive amination of <b>70</b>.</div><div class="NLM_p">Compounds <b>44</b>–<b>53</b> were synthesized according to the procedures outlined in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Compound <b>72</b> was generated by Suzuki coupling reaction and treated with phosphorus oxychloride to generate compound <b>73</b>. A variety of aryl groups were introduced at the 5-position of <b>74</b> via a Suzuki coupling reaction to provide <b>44</b>–<b>53</b>.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-nitrobenzene-1-sulfonyl chloride, NaH, THF, rt, 4h, 64% (<b>56a</b>), 61% (<b>56b</b>); (b) 1-methylpyrazole-4-boronic acid pinacol ester, PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 30 min, 76% (<b>7</b>), 74% (<b>9</b>).</p></p></figure><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) I<sub>2</sub>, KOH, DMF, rt, 3.5 h, 96%; (b) 2-nitrothiophenol, CuI, ethylene glycol, K<sub>2</sub>CO<sub>3</sub>, isopropanol, 130 °C, 24 h, 57%; (c) mCPBA, CHCl<sub>3</sub>, 50 °C, 3 h, 75%; (d) 1-methylpyrazole-4-boronic acid pinacol ester, PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 20 min, 76%.</p></p></figure><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-methylpyrazole-4-boronic acid pinacol ester, PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 30 min, 82%; (b) NaH, DMF, rt, 4h, 46–81%; (c) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h, 68%; (d) R<sup>2</sup>-C(O)-Cl, 4-dimethylaminopyridine, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, 92–97%; (e) iron powder, ammonium chloride, acetic acid, toluene, 70 °C, 5 h, 56%; (f) butyraldehyde, NaBH<sub>3</sub>(CN), acetic acid, MeOH, rt, 14 h, 83%; (g) boronic acid or R<sup>1</sup>-boronic acid pinacol ester, PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 30 min, 37–78%.</p></p></figure><figure id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-methylpyrazole-4-boronic acid pinacol ester, PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 120 °C, 30 min, 87%; (b) phosphorus oxychloride, reflux, 24 h, 25%; (c) <b>55b</b>, NaH, DMF, rt, 4 h, 63%; (d) R-boronic acid or R-boronic acid pinacol ester, PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 30 min, 31–81%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">On the basis of a reported HTS hit, we synthesized compound <b>7</b> to recheck the utility of its core scaffold. The results demonstrated that compound <b>7</b> indeed had high potency but was relatively unstable in human liver microsome metabolic stability test. Following the rational design, we identified a novel compound <b>9</b> with improved metabolic stability. By extensive optimization of π–π stacking and solvent accessible parts, we obtained a series of type I c-Met inhibitors with high potency and exquisite selectivity. Among them, compound <b>46</b> showed excellent c-Met enzymatic activity (IC<sub>50</sub> of about 0.6 nM) and very selective toward Met sensitive cell lines (GI<sub>50</sub> < 2 nM). We assessed the antitumor efficacy of compound <b>46</b>, a novel selective c-Met inhibitor, both in vitro and in vivo. Compound <b>46</b> showed strong potency against c-Met kinase, inhibiting c-Met phosphorylation and the downstream signaling across different oncogenic forms in c-Met overactivated cancer cells and model cells. In turn, compound <b>46</b> inhibited c-Met-driven cellular phenotype. Furthermore, compound <b>46</b> treatment resulted in significant antitumor activity in c-Met-driven EBC-1 xenografts. Taken together with its good in vitro DMPK properties, compound <b>46</b> was advanced into further drug development.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Materials and Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Methods for Chemistry</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz) spectra were recorded by using a Varian Mercury-400 high performance digital FT-NMR spectrometer with tetramethylsilane (TMS) as an internal standard. <sup>13</sup>C NMR (100 or 125 MHz) spectra were recorded by using a Varian Mercury-400 high performance digital FT-NMR spectrometer or Varian Mercury-500 high performance digital FT-NMR spectrometer. Abbreviations for peak patterns in NMR spectra are the following: br = broad, s = singlet, d = doublet, and m = multiplet. Low-resolution mass spectra were obtained with a Finnigan LCQ Deca XP mass spectrometer using a CAPCELL PAK C18 (50 mm × 2.0 mm, 5 μm) or an Agilent ZORBAX Eclipse XDB C18 (50 mm × 2.1 mm, 5 μm) in positive or negative electrospray mode. Low-resolution mass spectra and high-resolution mass spectra were recorded at an ionizing voltage of 70 eV on a Finnigan/MAT95 spectrometer. High-resolution mass spectra were recorded by using a Finnigan MAT-95 mass spectrometer or an Agilent technologies 6224 TOF mass spectrometer. Purity of all compounds was determined by analytical Gilson high-performance liquid chromatography (HPLC) using an YMC ODS3 column (50 mm × 4.6 mm, 5 μm). Conditions were as follows: CH<sub>3</sub>CN/H<sub>2</sub>O eluent at 2.5 mL min<sup>–1</sup> flow [containing 0.1% trifluoroacetic acid (TFA)] at 35 °C, 8 min, gradient 5% CH<sub>3</sub>CN to 95% CH<sub>3</sub>CN, monitored by UV absorption at 214 and 254 nm. TLC analysis was carried out with glass precoated silica gel GF254 plates. TLC spots were visualized under UV light. Flash column chromatography was performed with a Teledyne ISCO CombiFlash Rf system. All solvents and reagents were used directly as obtained commercially unless otherwise noted. Anhydrous dimethylformamide was purchased from Acros and was used without further drying. All air and moisture sensitive reactions were carried out under an atmosphere of dry argon with heat-dried glassware and standard syringe techniques. Microwave reactions were performed with Biotage initiator focused beam microwave reactor (400 W).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 6-Bromo-1-((2-nitrophenyl)sulfonyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine (<b>56a</b>)</h4><div class="NLM_p last">Sodium hydride (43.8 mg, 1.83 mmol) was suspended in 30 mL of anhydrous tetrahydrofuran. 6-Bromo-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine (180 mg, 0.91 mmol) dissolved in 10 mL of anhydrous tetrahydrofuran was slowly added dropwise, and the mixture was stirred for 30 min. 2-Nitrobenzene-1-sulfonyl chloride (213 mg, 0.96 mmol) dissolved in 10 mL of anhydrous tetrahydrofuran was slowly added in drops, and the mixture was stirred for 4 h at room temperature. The reaction solution was poured into 0.1 N hydrochloric acid, which was then brought to basic using aqueous sodium bicarbonate solution and extracted with ethyl acetate. The organic layer was collected and distilled under reduced pressure. The remaining substance was purified by flash column chromatography to give <b>56a</b> (223 mg, 64% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 382, 384 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.64 (d, <i>J</i> = 2.0 Hz, 1H), 8.34 (d, <i>J</i> = 1.3 Hz, 1H), 7.92 (d, <i>J</i> = 7.4 Hz, 1H), 7.86–7.79 (m, 3H), 7.79–7.73 (m, 1H), 6.93 (d, <i>J</i> = 3.9 Hz, 1H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 6-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-1-((2-nitrophenyl)sulfonyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine (<b>7</b>)</h4><div class="NLM_p">A solution of <b>56a</b> (110 mg, 0.29 mmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (65.9 mg, 0.32 mmol), PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> (7.05 mg, 8.63 μmol), and K<sub>2</sub>CO<sub>3</sub> (119 mg, 0.86 mmol) in 1,4-dioxane/water (6 mL, 2:1, v/v) in a microwave tube was flushed with N<sub>2</sub> for 5 min and then sealed. The tube was placed in the microwave cavity and heated at 90 °C for 30 min. Then the reaction mixture was evaporated to dryness. The residue was purified by flash chromatography to give <b>7</b> (84 mg, 76% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 384 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.87 (d, <i>J</i> = 1.5 Hz, 1H), 8.38 (s, 1H), 8.27 (d, <i>J</i> = 8.4 Hz, 1H), 8.21 (d, <i>J</i> = 1.8 Hz, 1H), 8.13 (d, <i>J</i> = 7.8 Hz, 1H), 8.05 (s, 1H), 8.00 (d, <i>J</i> = 3.7 Hz, 2H), 7.92 (t, <i>J</i> = 7.9 Hz, 1H), 7.06 (d, <i>J</i> = 3.5 Hz, 1H), 3.91 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 147.92, 146.76, 144.79, 136.90, 135.31, 132.58, 131.55, 129.91, 129.50, 128.95, 127.49, 125.11, 125.09, 119.95, 117.26, 110.45, 39.28. HRMS <i>m</i>/<i>z</i> (ESI) found 384.0758 (M + H)<sup>+</sup>, C<sub>17</sub>H<sub>14</sub>N<sub>5</sub>O<sub>4</sub>S<sup>+</sup> calcd for 384.0761; retention time 2.83 min, >98% pure.</div><div class="NLM_p last">Compound <b>9</b> was prepared with a similar procedure as that used for <b>7</b> (see Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 5-Bromo-3-iodo-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine (<b>58</b>)</h4><div class="NLM_p last">To a stirred solution of the 5-bromo-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine (1.0 g, 5.05 mmol) in DMF (14 mL) was added crushed KOH pellets (1.13 g, 20.20 mmol) in one portion. After 10 min, I<sub>2</sub> (1.41 g, 5.55 mmol) was added and the mixture stirred vigorously for 3.5 h. The mixture was then partially concentrated in vacuo, diluted with EtOAc (40 mL)/saturated NaHCO<sub>3</sub> solution (20 mL), and partitioned. The aqueous layer was extracted with EtOAc (2 × 20 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to afford <b>58</b> (1.57 g, 96% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 324, 326 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 10.85 (brs,NH), 8.57 (d, <i>J</i> = 2.1 Hz, 1H), 7.93 (d, <i>J</i> = 2.1 Hz, 1H).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 5-Bromo-3-((2-nitrophenyl)thio)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine (<b>59</b>)</h4><div class="NLM_p last"><b>58</b> (500 mg, 1.54 mmol), potassium carbonate (427 mg, 3.09 mmol), and copper(I) iodide (44.1 mg, 0.23 mmol) are mixed with 40 mL of isopropanol, ethylene glycol (172 μL, 3.09 mmol), and 2-nitrobenzenethiol (479 mg, 3.09 mmol) under an argon atmosphere, and the mixture is stirred at 130 °C for 24 h. The mixture is cooled to room temperature, mixed with silica gel, evaporated in vacuum. The residue was purified by flash chromatography to give <b>59</b> (309 mg, 57% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 351, 353 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.69 (d, <i>J</i> = 2.2 Hz, 1H), 8.30 (d, <i>J</i> = 9.7 Hz, 1H), 8.14 (d, <i>J</i> = 2.2 Hz, 1H), 7.32 (t, <i>J</i> = 8.6 Hz, 2H), 6.82 (d, <i>J</i> = 7.9 Hz, 1H), NH on indazole is missing.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5-Bromo-3-((2-nitrophenyl)sulfonyl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine (<b>60</b>)</h4><div class="NLM_p last">mCPBA (1.97 g, 11.39 mmol) was added to a solution of <b>59</b> (500 mg, 1.42 mmol) in CHCl<sub>3</sub> (15 mL), and the reaction mixture was stirred at 50 °C for 3 h. After the mixture was cooled, saturated NaHCO<sub>3</sub> solution (20 mL) and saturated Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution (20 mL) were added, and the resulting mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL). The organic phases were combined, washed with brine (100 mL), and dried over Na<sub>2</sub>SO<sub>4</sub>. After filtration, the organic phase was concentrated under reduced pressure. The residue was purified by flash chromatography to afford <b>60</b> (409 mg, 75% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 383, 385 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.82 (d, <i>J</i> = 2.2 Hz, 1H), 8.53 (d, <i>J</i> = 2.2 Hz, 1H), 8.46–8.42 (m, 1H), 8.10–8.06 (m, 1H), 8.05–7.99 (m, 2H), NH on indazole is missing.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 5-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-3-((2-nitrophenyl)sulfonyl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine (<b>8</b>)</h4><div class="NLM_p last">A solution of <b>60</b> (150 mg, 0.39 mmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (98 mg, 0.47 mmol), PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> (15.98 mg, 0.02 mmol), and K<sub>2</sub>CO<sub>3</sub> (162 mg, 1.17 mmol) in 1,4-dioxane/water (3 mL, 2:1, v/v) in a microwave tube was flushed with N<sub>2</sub> for 5 min and then sealed. The tube was placed in the microwave cavity and heated at 90 °C for 20 min. Then the reaction mixture was evaporated to dryness. The residue was purified by flash chromatography to give <b>8</b> (114 mg, 76% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 385 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.03 (d, <i>J</i> = 2.0 Hz, 1H), 8.47–8.44 (m, 1H), 8.41 (s, 1H), 8.40 (d, <i>J</i> = 2.1 Hz, 1H), 8.08 (s, 1H), 8.07–8.05 (m, 1H), 8.01 (m, 2H), 3.92 (s, 3H), NH on indazole is missing. <sup>13</sup>C NMR (126 MHz, DMSO) δ 150.88, 149.68, 148.04, 142.03, 136.90, 136.70, 133.90, 132.76, 131.77, 129.15, 125.76, 125.57, 123.57, 118.80, 113.19, 31.17. HRMS <i>m</i>/<i>z</i> (ESI) found 385.0713 (M + H)<sup>+</sup>, C<sub>16</sub>H<sub>13</sub>N<sub>6</sub>O<sub>4</sub>S<sup>+</sup> calcd for 385.0719; retention time 2.77 min, >98% pure.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> General Procedure A for the Preparation of Sulfonyl Chloride Compounds. 6-Methoxyimidazo[1,2-<i>a</i>]pyridine-3-sulfonyl Chloride (<b>64</b>)</h4><div id="sec4_2_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Step 1</h5><div class="NLM_p last">Chlorosulfonic acid (1.36 mL, 20.25 mmol) was dissolved in chloroform (10 mL), and this solution was added dropwise to 6-methoxyimidazo[1,2-<i>a</i>]pyridine (1.00 g, 6.75 mmol) in chloroform (15 mL) over 20 min. The reaction mixture was heated to reflux for 24 h, then allowed to cool to rt and concentrated to dryness under vacuum. The crude oily product was treated with diethyl ether (20 mL) and ethanol (10 mL), resulting in a white precipitate. The solid was collected by filtration, washed with EtOH, and dried to give 6-methoxyimidazo[1,2-<i>a</i>]pyridine-3-sulfonic acid (1.51 g, 98% yield). MS <i>m</i>/<i>z</i> (EI) found 228 (M)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (s, 1H), 8.21 (dd, <i>J</i> = 2.4, 0.8 Hz, 1H), 7.74 (dd, <i>J</i> = 9.7, 0.8 Hz, 1H), 7.39 (dd, <i>J</i> = 9.7, 2.4 Hz, 1H), 3.95 (s, 3H); OH on sulfonic acid is missing.</div></div><div id="sec4_2_7_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Step 2</h5><div class="NLM_p">The product from step 1 (800 mg, 3.51 mmol) was treated with phosphorus oxychloride (5 mL) and heated to reflux overnight. The reaction mixture was cooled to rt and treated with DCM (50 mL), poured into ice–water (100 mL), and then extracted with DCM (4 × 100 mL). The organic layers were combined and dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to dryness under vacuum to give <b>64</b> (389 mg, 45% yield). MS <i>m</i>/<i>z</i> (EI) found 246 (M)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.30 (s, 1H), 8.20 (dd, <i>J</i> = 2.4, 0.8 Hz, 1H), 7.75 (dd, <i>J</i> = 9.7, 0.8 Hz, 1H), 7.40 (dd, <i>J</i> = 9.8, 2.4 Hz, 1H), 3.95 (s, 3H).</div><div class="NLM_p last">Compounds <b>65</b> and <b>66</b> were prepared according to the general procedure A (see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>).</div></div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> General Procedure B for the Preparation of Sulfonamide Compounds. 6-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-1-(phenylsulfonyl)-1<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridine (<b>10</b>)</h4><div id="sec4_2_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Step 1</h5><div class="NLM_p last">A solution of <b>55b</b> (450 mg, 2.27 mmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (520 mg, 2.50 mmol), PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub> (55.7 mg, 0.07 mmol), and K<sub>2</sub>CO<sub>3</sub> (942 mg, 6.82 mmol) in 1,4-dioxane/water (6 mL, 2:1, v/v) in a microwave tube was flushed with N<sub>2</sub> for 5 min and then sealed. The tube was placed in the microwave cavity and heated at 90 °C for 30 min. Then the reaction mixture was evaporated to dryness. The residue was purified by flash chromatography to give <b>63</b> (371 mg, 82% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 200 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.29 (s, 1H), 8.80 (s, 1H), 8.36 (s, 1H), 8.24 (s, 1H), 8.07 (s, 2H), 3.90 (s, 3H).</div></div><div id="sec4_2_8_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> Step 2</h5><div class="NLM_p">NaH (21.68 mg, 0.91 mmol) was dissolved in 5 mL of anhydrous DMF. <b>63</b> (90 mg, 0.45 mmol) dissolved in 5 mL of anhydrous DMF was slowly added in drops, and the mixture was stirred for 30 min. Benzenesulfonyl chloride (120 mg, 0.68 mmol) dissolved in 5 mL of anhydrous DMF was slowly added in drops, and the mixture was stirred for 4 h at room temperature. The reaction solution was poured into 0.1 N hydrochloric acid, which was then controlled to basic using aqueous sodium bicarbonate solution and extracted with ethyl acetate. The organic layer was collected and distilled under reduced pressure. The residue was purified by flash chromatography to give <b>10</b> (103 mg, 67% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 340 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.84 (d, <i>J</i> = 1.7 Hz, 1H), 8.49 (s, 1H), 8.38 (s, 1H), 8.02 (d, <i>J</i> = 7.4 Hz, 2H), 7.94 (s, 1H), 7.86 (s, 1H), 7.62 (t, <i>J</i> = 7.4 Hz, 1H), 7.51 (t, <i>J</i> = 7.8 Hz, 2H), 4.03 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 146.74, 142.03, 141.55, 137.28, 137.11, 134.65, 134.39, 129.45 × 2, 128.85, 128.08, 127.70 × 2, 119.26, 115.99, 39.40. HRMS <i>m</i>/<i>z</i> (ESI) found 340.0878 (M + H)<sup>+</sup>, C<sub>16</sub>H<sub>14</sub>N<sub>5</sub>O<sub>2</sub>S<sup>+</sup> calcd for 340.0868; retention time 2.95 min, >98% pure.</div><div class="NLM_p last">Compounds <b>11</b>–<b>26</b> and <b>69</b> were prepared according to general procedure B (see Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>).</div></div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-((6-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-1-yl)sulfonyl)imidazo[1,2-<i>a</i>]pyridin-6-ol (<b>68</b>)</h4><div class="NLM_p last">To a solution of <b>26</b> (90 mg, 0.22 mmol) in dichloromethane (5 mL), borontribromide in dichloromethane (66 μL, 0.66 mmol) was added dropwise at 0 °C. After being warmed to room temperature, it was stirred for 3 h before quenching with ice–water. The resulted emulsion was stirred for a further 30 min before it was extracted with EtOAc 3 times. The combined organic layers were subsequently washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The remaining substance was purified by flash chromatography to give <b>68</b> (59.1 mg, 68% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 396 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.85 (d, <i>J</i> = 1.8 Hz, 1H), 8.64 (d, <i>J</i> = 2.4 Hz, 1H), 8.48–8.42 (m, 1H), 8.33 (s, 1H), 8.23 (s, 1H), 7.93 (s, 1H), 7.85 (s, 1H), 7.59 (d, <i>J</i> = 9.7 Hz, 1H), 7.25 (d, <i>J</i> = 2.4 Hz, 2H), 3.95 (s, 3H).</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-((6-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-1-yl)sulfonyl)imidazo[1,2-<i>a</i>]pyridin-6-yl Isobutyrate (<b>27</b>)</h4><div class="NLM_p">To a solution of <b>68</b> (150 mg, 0.379 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) in the presence of DMAP (55.6 mg, 0.455 mmol) was added dropwise a solution of isobutyryl chloride (81 mg, 0.759 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) at 0 °C, under argon atmosphere. The reaction medium was stirred for 2 h at room temperature. The organic layers were washed with brine, subsequently dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The remaining substance was purified by flash chromatography to give <b>27</b> (171 mg, 97% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 466 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.15–9.05 (m, 1H), 8.87 (d, <i>J</i> = 1.9 Hz, 1H), 8.46 (dd, <i>J</i> = 2.1, 1.1 Hz, 1H), 8.40–8.35 (m, 1H), 8.32 (s, 1H), 7.95 (d, <i>J</i> = 5.7 Hz, 1H), 7.88 (d, <i>J</i> = 6.2 Hz, 1H), 7.72 (d, <i>J</i> = 9.7 Hz, 1H), 7.41–7.32 (m, 1H), 4.04 (s, 3H), 2.90 (p, <i>J</i> = 6.9 Hz, 1H), 1.37 (dd, <i>J</i> = 7.1, 0.9 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 174.87, 146.96, 142.18, 142.13, 141.64, 141.51, 137.30, 137.24, 133.75, 129.10, 128.12, 128.06, 126.32, 120.26, 119.13, 117.95, 115.84, 39.36, 34.07, 18.78 × 2. HRMS <i>m</i>/<i>z</i> (ESI) found 466.1301 (M + H)<sup>+</sup>, C<sub>21</sub>H<sub>20</sub>N<sub>7</sub>O<sub>4</sub>S<sup>+</sup> calcd for 466.1297; retention time 3.18 min, >95% pure.</div><div class="NLM_p last">Compounds <b>28</b> and <b>29</b> were prepared with a similar procedure as that used for <b>27</b> (see Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="secz" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-((6-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-1-yl)sulfonyl)imidazo[1,2-<i>a</i>]pyridin-6-amine (<b>70</b>)</h4><div class="NLM_p last">The <b>69</b> (0.83 g, 1.96 mmol) was dissolved in toluene (20 mL) and treated with saturated ammonium chloride (3 mL), water (3 mL), acetic acid (0.2 mL), and iron powder (0.22 g, 3.91 mmol). The reaction mixture was heated to 70 °C for 5 h. After cooling, the mixture was filtered through a pad of Celite. The filtrate was evaporated to dryness under reduced pressure, and the crude material was resuspended in ethyl acetate (100 mL) before washing with 1 N NaOH (20 mL) and water (60 mL). The organic layer was dried with MgSO<sub>4</sub> and evaporated to dryness under reduced pressure. The crude material was purified by flashchromatography to give <b>70</b> (0.43 g, 56% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 395 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.14 (s, 2H), 9.33 (d, <i>J</i> = 1.9 Hz, 1H), 9.04 (d, <i>J</i> = 1.9 Hz, 1H), 9.02 (s, 1H), 8.72 (s, 1H), 8.54 (s, 1H), 8.48 (d, <i>J</i> = 1.4 Hz, 1H), 8.17 (s, 1H), 7.75 (d, <i>J</i> = 9.8 Hz, 1H), 7.58 (dd, <i>J</i> = 9.9, 2.0 Hz, 1H), 3.93 (s, 3H).</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-Butyl-3-((6-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-1-yl)sulfonyl)imidazo[1,2-<i>a</i>]pyridin-6-amine (<b>30</b>)</h4><div class="NLM_p last">To a solution of <b>70</b> (230 mg, 0.58 mmol) in methanol (15 mL), cooled to 0 °C, was added acetic acid (0.4 mL, 11 mmol) followed by butyraldehyde (50.5 mg, 0.70 mmol). The reaction mixture was stirred at 0 °C for 1 h, and then sodium cyanoborohydride (92 mg, 1.46 mmol) was added. The mixture was left stirring for 14 h at rt. Methanol (30 mL) was added, and the mixture was washed with water and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to dryness. The crude material was purified by flashchromatography to give <b>30</b> (218 mg, 83% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 451 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, chloroform) δ 8.86 (d, <i>J</i> = 1.9 Hz, 1H), 8.63 (dd, <i>J</i> = 2.0, 1.0 Hz, 1H), 8.38 (d, <i>J</i> = 1.0 Hz, 1H), 8.20 (s, 1H), 7.96 (d, <i>J</i> = 0.9 Hz, 1H), 7.88 (s, 1H), 7.33 (d, <i>J</i> = 9.7 Hz, 1H), 7.20 (d, <i>J</i> = 2.1 Hz, 1H), 6.81 (dd, <i>J</i> = 9.7, 2.2 Hz, 1H), 4.03 (s, 3H), 3.01 (t, <i>J</i> = 7.0 Hz, 2H), 1.66 (p, <i>J</i> = 7.2 Hz, 2H), 1.46 (h, <i>J</i> = 7.4 Hz, 2H), 0.99 (t, <i>J</i> = 7.3 Hz, 3H); NH is missing. <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 146.54, 142.16, 141.60, 141.32, 139.05, 138.26, 137.33, 134.84, 128.73, 128.17, 123.67, 119.46, 118.72, 116.79, 116.75, 103.48, 43.83, 39.34, 30.91, 20.27, 13.82. HRMS <i>m</i>/<i>z</i> (ESI) found 451.1655 (M + H)<sup>+</sup>, C<sub>21</sub>H<sub>23</sub>N<sub>8</sub>O<sub>2</sub>S<sup>+</sup> calcd for 451.1665; retention time 2.55 min, >93% pure.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 6-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-1-((6-phenylimidazo[1,2-<i>a</i>]pyridin-3-yl)sulfonyl)-1<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridine (<b>31</b>)</h4><div class="NLM_p">A solution of <b>25</b> (125 mg, 0.27 mmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (62.4 mg, 0.30 mmol), PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub> (6.68 mg, 8.18 μmol), and K<sub>2</sub>CO<sub>3</sub> (113 mg, 0.82 mmol) in 1,4-dioxane/water (12 mL, 2:1, v/v) in a microwave tube was flushed with N<sub>2</sub> for 5 min and then sealed. The tube was placed in the microwave cavity and heated at 90 °C for 30 min. Then the reaction mixture was evaporated to dryness. The residue was purified by flash chromatography to give <b>31</b> (86 mg, 69% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 456 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.27 (t, <i>J</i> = 1.3 Hz, 1H), 8.86 (d, <i>J</i> = 1.9 Hz, 1H), 8.48 (dd, <i>J</i> = 1.8, 0.8 Hz, 1H), 8.35 (m, 2H), 7.95 (d, <i>J</i> = 0.7 Hz, 1H), 7.85 (s, 1H), 7.78 (m, 2H), 7.61 (m, 2H), 7.50 (m, 3H), 4.04 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 148.32, 146.96, 142.12, 142.02, 141.65, 137.31, 135.90, 133.77, 129.93, 129.86, 129.42 × 2, 129.08, 128.78, 128.13, 127.23 × 2, 124.50, 119.16, 118.39, 118.09, 115.85, 39.43. HRMS <i>m</i>/<i>z</i> (ESI) found 456.1245 (M + H)<sup>+</sup>, C<sub>23</sub>H<sub>18</sub>N<sub>7</sub>O<sub>2</sub>S<sup>+</sup> calcd for 456.1243; retention time 3.36 min, >98% pure.</div><div class="NLM_p last">Compounds <b>32</b>–<b>43</b> was prepared with a similar procedure as that used for <b>31</b> (see Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 6-(1-Methyl-1<i>H</i>-pyrazol-4-yl)imidazo[1,2-<i>a</i>]pyridine-3-sulfonic Acid (<b>72</b>)</h4><div class="NLM_p last">A solution of <b>71</b> (339 mg, 1.22 mmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (280 mg, 1.35 mmol), PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub> (28.8 mg, 0.04 mmol), and K<sub>2</sub>CO<sub>3</sub> (507 mg, 3.67 mmol) in 1,4-dioxane/water (12 mL, 2:1, v/v) in a microwave tube was flushed with N<sub>2</sub> for 5 min and then sealed. The tube was placed in the microwave cavity and heated at 120 °C for 30 min. Then the reaction mixture was evaporated to dryness. The residue was purified by flash chromatography to give <b>72</b> (296 mg, 87% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 279 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.71 (s, 1H), 8.19 (s, 1H), 7.81 (s, 1H), 7.63 (d, <i>J</i> = 9.3 Hz, 1H), 7.60–7.50 (m, 2H), 3.89 (s, 3H); OH on sulfonic acid is missing.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 6-(1-Methyl-1<i>H</i>-pyrazol-4-yl)imidazo[1,2-<i>a</i>]pyridine-3-sulfonyl Chloride (<b>73</b>)</h4><div class="NLM_p last"><b>72</b> (210 mg, 0.76 mmol) was treated with phosphorus oxychloride (5 mL) and heated to reflux for 24 h. The reaction mixture was cooled to rt and treated with DCM (50 mL), poured ice–water (100 mL), and then extracted with DCM (4 × 100 mL). The organic layers were combined and dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to dryness under vacuum to give <b>73</b> (56.0 mg, 25% yield). MS <i>m</i>/<i>z</i> (EI) found 296 (M)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (s, 1H), 8.18 (s, 1H), 7.79 (s, 1H), 7.61 (d, <i>J</i> = 9.3 Hz, 1H), 7.61–7.53 (m, 2H), 3.90 (s, 3H).</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 6-Bromo-1-((6-(1-methyl-1<i>H</i>-pyrazol-4-yl)imidazo[1,2-<i>a</i>]pyridin-3-yl)sulfonyl)-1<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridine (<b>74</b>)</h4><div class="NLM_p last">NaH (29.9 mg, 1.25 mmol) was dissolved in 5 mL of anhydrous DMF. The <b>55b</b> (149 mg, 0.75 mmol) dissolved in 5 mL of anhydrous DMF was slowly added in drops, and the mixture was stirred for 30 min. <b>73</b> (185 mg, 0.62 mmol) dissolved in 5 mL of anhydrous DMF was slowly added in drops, and the mixture was stirred for 4 h at room temperature. The reaction solution was poured into 0.1 N hydrochloric acid, which was then controlled to basic using aqueous sodium bicarbonate solution, and extracted with ethyl acetate. The organic layer was collected and distilled under reduced pressure. The remaining substance was purified by column chromatography to give <b>74</b> (180 mg, 63% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 458, 460 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.17 (s, 1H), 8.76 (d, <i>J</i> = 1.7 Hz, 1H), 8.69 (d, <i>J</i> = 1.9 Hz, 1H), 8.34 (d, <i>J</i> = 6.0 Hz, 2H), 7.84 (d, <i>J</i> = 5.8 Hz, 2H), 7.78 (s, 1H), 7.72 (d, <i>J</i> = 8.2 Hz, 1H), 4.03 (s, 3H).</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-((6-(1-Methyl-1<i>H</i>-pyrazol-4-yl)imidazo[1,2-<i>a</i>]pyridin-3-yl)sulfonyl)-6-(1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridine (<b>44</b>)</h4><div class="NLM_p">A solution of <b>74</b> (730 mg, 1.59 mmol), 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (340 mg, 1.75 mmol), PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub> (35 mg, 0.05 mmol), and K<sub>2</sub>CO<sub>3</sub> (660 mg, 4.78 mmol) in 1,4-dioxane/water (15 mL, 2:1, v/v) in a microwave tube was flushed with N<sub>2</sub> for 5 min and then sealed. The tube was placed in the microwave cavity and heated at 90 °C for 30 min. Then the reaction mixture was evaporated to dryness. The residue was purified by flash chromatography to give <b>44</b> (488 mg, 81% yield). LC–MS <i>m</i>/<i>z</i> (ESI) found 446 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.26 (s, 1H), 10.36 (s, 2H), 9.04 (s, 1H), 8.97 (s, 1H), 8.76 (s, 1H), 8.63 (s, 1H), 8.59 (s, 1H), 8.57 (s, 1H), 8.23 (s, 1H), 7.96 (d, <i>J</i> = 9.3 Hz, 1H), 7.88 (d, <i>J</i> = 9.4 Hz, 1H), 3.94 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 148.01, 147.29, 142.99, 142.88, 141.58, 137.61, 133.86, 133.82, 130.17, 130.01, 129.59, 129.42, 122.59, 121.07, 118.74, 118.47, 117.38, 116.75, 114.95, 45.78. HRMS <i>m</i>/<i>z</i> (ESI) found 446.1139 (M + H)<sup>+</sup>, C<sub>20</sub>H<sub>16</sub>N<sub>9</sub>O<sub>2</sub>S<sup>+</sup> calcd for 446.1142; retention time 2.52 min, >98% pure.</div><div class="NLM_p last">Compounds <b>45</b>–<b>53</b> were prepared with a similar procedure as that used for <b>44</b> (see Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> and <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> ELISA Kinase Assay</h3><div class="NLM_p last">The effects of compound <b>46</b> on the activities of various tyrosine kinases were determined using enzyme-linked immunosorbent assays (ELISAs) with purified recombinant proteins. Briefly, 20 μg/mL poly(Glu, Tyr)<sub>4:1</sub> (Sigma, St. Louis, MO, USA) was precoated in 96-well plates as a substrate. A 50 μL aliquot of 10 μmol/L ATP solution diluted in kinase reaction buffer (50 mmol/L HEPES [pH 7.4], 50 mmol/L MgCl<sub>2</sub>, 0.5 mmol/L MnCl<sub>2</sub>, 0.2 mmol/L Na<sub>3</sub>VO<sub>4</sub>, and 1 mmol/L DTT) was added to each well; 1 μL of various concentrations of compound <b>46</b> diluted in 1% DMSO (v/v) (Sigma, St. Louis, MO, USA) was then added to each reaction well. DMSO (1%, v/v) was used as the negative control. The kinase reaction was initiated by the addition of purified tyrosine kinase proteins diluted in 49 μL of kinase reaction buffer. After incubation for 60 min at 37 °C, the plate was washed three times with phosphate-buffered saline (PBS) containing 0.1% Tween 20 (T-PBS). Anti-phosphotyrosine (PY99) antibody (100 μL; 1:500, diluted in 5 mg/mL BSA T-PBS) was then added. After a 30 min incubation at 37 °C, the plate was washed three times, and 100 μL of horseradish peroxidase-conjugated goat anti-mouse IgG (1:2000, diluted in 5 mg/mL BSA T-PBS) was added. The plate was then incubated at 37 °C for 30 min and washed 3 times. A 100 μL aliquot of a solution containing 0.03% H<sub>2</sub>O<sub>2</sub> and 2 mg/mL <i>o</i>-phenylenediamine in 0.1 mol/L citrate buffer (pH 5.5) was added. The reaction was terminated by the addition of 50 μL of 2 mol/L H<sub>2</sub>SO<sub>4</sub> as the color changed, and the plate was analyzed using a multiwell spectrophotometer (SpectraMAX 190, from Molecular Devices, Palo Alto, CA, USA) at 490 nm. The inhibition rate (%) was calculated using the following equation: [1 – (<i>A</i><sub>490</sub>/<i>A</i><sub>490 control</sub>)] × 100. The IC<sub>50</sub> values were calculated from the inhibition curves in two separate experiments.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Cell Culture</h3><div class="NLM_p last">The human gastric cancer cell lines SNU-5; the human prostate cancer cell line DU-145; the human lung cancer cell lines A549, NCI-H441, and NCI-H1299, H460; the human breast cancer cell lines MDA-MB-231; the human colon cancer cell lines HCT-116, SW116; the human hepatic cancer cell HepG2, BEL-7404; the human pancreatic cancer cell PANC-1; and the Madin–Daby canine kidney (MDCK) cell line were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). The hepatic carcinoma cell line SMMC- 7721 was obtained from the Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (Shanghai, China). The human gastric cell line MKN45 and the human NSCLC cell line EBC-1 were purchased from Joint Conference of Restoration Branches (JCRB). All the cell lines were routinely maintained in media according to the suppliers’ recommendations. A cell line, derived from the parental cell line BaF3, was constructed to stably express a constitutively active TPR-Met and was designated as BaF3/TPR-Met.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Western Blot Analysis</h3><div class="NLM_p last">A549 cell was serum-starved for 24 h, treated with the indicated dose of compound <b>46</b> for 1 h at 37 °C, stimulated with HGF (100 ng/mL, PeproTech, Rocky Hill, NJ, USA) for 15 min, and then lysed in 1× sodium dodecyl sulfate (SDS) sample buffer. EBC-1, MKN45, and BaF3/TPR-Met cells were treated with the indicated dose of compound <b>46</b> for 1 h at 37 °C and then lysed in 1× SDS sample buffer. The cell lysates were subsequently resolved by 10% SDS–PAGE and transferred to nitrocellulose membranes. The membranes were probed with the appropriate primary antibodies [c-Met and cyclin E (Santa Cruz, CA, USA), phospho-c-Met, phospho-ERK1/2, ERK1/2, phospho-AKT, AKT (all from Cell Signaling Technology, Beverly, MA, USA), and GAPDH (KangChen Biotech, Shanghai, China)] and then with horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG. The immunoreactive proteins were detected using an enhanced chemiluminescence detection reagent (Thermo Fisher Scientific, Rockford, IL, USA).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Cell Proliferation Assay</h3><div class="NLM_p last">Cells were seeded in 96-well tissue culture plates. On the next day, the cells were exposed to various concentrations of compounds and further cultured for 72 h. Cell proliferation was then determined using sulforhodamine B (SRB, from Sigma-Aldrich, St. Louis, MO, USA) or the thiazolyl blue tetrazolium bromide (MTT, from Sigma-Aldrich, St. Louis, MO, USA) assay. The IC<sub>50</sub> values were calculated by concentration–response curve fitting using the four-parameter method.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Cell Cycle Distribution Assay</h3><div class="NLM_p last">EBC-1 cell (2 × 10<sup>5</sup>) were seeded in six-well plates overnight and treated with different concentrations of compound <b>46</b> on the following day. After 24 h, the cells were collected by EDTA-free trypsinization, centrifuged at 900 rpm for 5 min, and fixed in 70% ethanol at −20 °C for 1 h. The cells were then centrifuged at 5000 rpm for 5 min, resuspended in 500 μL of PBS containing 20 ng/mL RNase and 10 ng/mL propidium iodide, incubated in the dark for 30 min at room temperature, and analyzed using flow cytometry (FACsCalibur, from BD Biosciences, San Jose, CA, USA). The data were analyzed using Flowjo software.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Migration Assay and Invasion Assay</h3><div class="NLM_p">For the migration assay, NCI-H441 cells suspended in serum- free medium (1.5 × 10<sup>5</sup> cells per well) were seeded in 24-well Transwell plates (pore size, 8 μm; Corning). The bottom chambers were filled with serum-free medium supplemented with HGF (100 ng/mL), and 0.8, 4.0, and 20 nmol/L compound <b>46</b> was added to both sides of the membrane. The cultures were maintained for 24 h. The migrating cells were fixed in precold alcohol (95%) at 4 °C and stained with crystal violet (0.1%) for 15 min at room temperature, followed by the removal of nonmotile cells at the top of the filter using a cotton swab. The dye that was taken up by the cells bound to the membrane was released by the addition of 100 μL of 10% acetic acid, and the absorbance of the resulting solution was measured at 600 nm using a multiwell spectrophotometer (Spetra-MAX 190, from Molecular Devices, Palo Alto, CA, USA). The assay was performed in triplicate.</div><div class="NLM_p last">For the invasion assay, NCI-H441 cells were cultured in the top chambers containing Matrigel-coated membrane inserts (Matrigel, BD). The ensuing procedure was identical to the migration assay. The assay was performed in triplicate. Images were obtained using an Olympus BX51 microscope.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Cell-Scatter Assay</h3><div class="NLM_p last">MDCK cells (1.5 × 10<sup>3</sup> cells per well) were plated in 24-well plates and grown overnight. Different concentrations of compound <b>46</b> and HGF (100 ng/mL) were added to the appropriate wells, and the plates were incubated at 37 °C and 5% CO<sub>2</sub> for 24 h. The cells were fixed with 4% paraformaldehyde for 15 min at room temperature and then stained with 1% crystal violet, washed with water, and dried. Images were obtained using an Olympus IX51 microscope.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Cell Branching Morphogenesis Assay</h3><div class="NLM_p last">MDCK cells at a density of 2 × 10<sup>4</sup> cells/mL in DMEM medium were mixed with an equal volume of collagen I (BD, 354236) solution and plated at 0.1 mL/well in a 96-well culture plate. After incubation for 1 h at 37 °C and 5% CO<sub>2</sub> to allow the collagen to gel, HGF (100 ng/mL) with or without compound <b>46</b> at various concentrations dissolved in 100 μL of growth medium was added to each well. The medium was replaced with fresh growth medium every 2 days. Images were obtained using an Olympus IX51 microscope after 5 days.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> In Vivo Antitumor Activity Assay</h3><div class="NLM_p">Female nude mice (4–6 weeks) were housed at five or six mice per cage in a specific pathogen-free room with a 12 h light/dark schedule at 25 ± 1 °C; the animals were fed an autoclaved chow diet and water ad libitum. All the animal experiments were performed according to the institutional ethical guidelines of animal care.</div><div class="NLM_p last">EBC-1 cells at a density of (5–10) × 10<sup>6</sup> in 200 μL were first implanted sc into the right flank of each mouse and then allowed to grow to 700–800 mm<sup>3</sup>, which was defined as a well-developed tumor. The well-developed tumors were cut into 1 mm<sup>3</sup> fragments and transplanted sc into the right flank of nude mice using a tracer. When the tumor volume reached 100–150 mm<sup>3</sup>, the mice were randomly assigned into control and treatment groups (<i>n</i> = 6 per group). The control groups were given vehicle alone, and the treatment groups received compound <b>46</b> at the indicated doses via oral administration once daily for 21 weeks. Crizotinib was a positive drug.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> The sizes of the tumors were measured twice per week using microcalipers. The tumor volume (TV) was calculated as follows: TV = (length × width<sup>2</sup>)/2. The tumor volume shown was obtained on the indicated days as the median tumor volume ± SEM for indicated groups of mice. The percent (%) inhibition values were measured on the final day of the study for the drug-treated mice compared with the vehicle-treated mice and were calculated as 100 × {1 – [(treated final day – treated day 0)/(control final day – control day 0)]}. Significant differences between the treated versus the control groups (<i>P</i> ≤ 0.05) were determined using Student’s <i>t</i> test.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Statistical Analysis</h3><div class="NLM_p last">Data from the in vitro assays are presented as the mean ± SD. While in the in vivo assay, data are presented as the mean ± SEM. The statistical difference between multiple treatments and control was analyzed using Student’s <i>t</i> test. <i>P</i> < 0.05 vs control group was considered statistically significant.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> In Vitro Metabolic Stability Study</h3><div class="NLM_p">Microsomes (human microsome, Xenotech, lot H0610; rat microsome, Xenotech, lot R1000) (0.5 mg/mL) were preincubated with 1 μM test compound for 5 min at 37 °C in 0.1 M phosphate buffer (pH 7.4) with 1 mmol of EDTA and 5 mmol of MgCl<sub>2</sub>. The reactions were initiated by adding prewarmed cofactors (1 mmol NADPH). After 0, 5, 10, and 30 min incubations at 37 °C, the reactions were stopped by adding an equal volume of cold acetonitrile. The samples were vortexed for 10 min and then centrifuged at 10000<i>g</i> for 10 min. Supernatants were analyzed by LC/MS/MS for the amount of parent compound remaining, and the corresponding loss of parent compound was also determined by LC/MS/MS.</div><div class="NLM_p last">The CYP enzymatic activities were characterized based on their probe reactions: CYP3A4 (midazolam), CYP2D6 (dextromethorphan), CYP2C9 (diclofenac), CYP1A2 (phenacetin), and CYP2C19 (mephenytoin). Incubation mixtures were prepared in a total volume of 100 μL as follows: 0.2 mg/mL microsome (human microsome, Xenotech, lot H0610), 1 mmol NADPH, 100 mmol phosphate buffer (pH 7.4), probe substrates cocktail (10 μM midazolam, 100 μM testosterone, 10 μM dextromethophan, 20 μM diclofenac, 100 μM phenacetin, 100 μM mephenytoin), and 10 μM tested compound or positive control cocktail (10 μM ketoconazole, 10 μM quinidine, 100 μM sulfaphenazole, 10 μM naphthoflavone, and 1000 μM tranylcypromine) or negative control (PBS). The final concentration of organic reagent in incubation mixtures was less than 1% v/v. There was a 5 min preincubation period at 37 °C before the reaction was initiated by adding a NADPH-generating system. Reactions were conducted for 20 min for CYPs. For each probe drug, the percentage of metabolite conversion was less than 20% of substrate added. The inhibition rate was calculated as [(the formation of the metabolite of probe substrates with 10 μM tested compound)/(the formation of the metabolite of probe substrates with PBS)] × 100.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55"><a href="/doi/suppl/10.1021/jm502018y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64004" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64004" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Analytical and spectral data for compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm502018y/suppl_file/jm502018y_si_001.pdf">jm502018y_si_001.pdf (88.49 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm502018y" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51330" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51330" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bing Xiong</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#adcfd5c4c2c3caeddec4c0c083ccce83cec3"><span class="__cf_email__" data-cfemail="1e7c66777170795e6d777373307f7d307d70">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Ai</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b7f2dad6dedb8dddd6def7c4dedada99d6d499d4d9">Email:<span class="__cf_email__" data-cfemail="a8c2c9c1e8dbc1c5c586c9cb86cbc6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meiyu Geng</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7d10041a18131a3d0e141010531c1e531e13"><span class="__cf_email__" data-cfemail="6904100e0c070e291a00040447080a470a07">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jingkang Shen</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#731918001b161d33001a1e1e5d12105d101d"><span class="__cf_email__" data-cfemail="751f1e061d101b35061c18185b14165b161b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuchi Ma</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guangqiang Sun</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Danqi Chen</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xia Peng</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yue-Lei Chen</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi Su</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yinchun Ji</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin Liang</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Wang</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lin Chen</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Ding</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zuchongzhi
Road, Shanghai 201203, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.M. and G.S. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d56e3993-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27121" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27121" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Haiyan Liu, Guangxin Xia, and Xuejun Liu from Central Research Institute, Shanghai Pharmaceutical Holding Co., Ltd., for performing the in vitro PK study. We are grateful for financial support from “Interdisciplinary Cooperation Team” Program for Science and Technology Innovation of the Chinese Academy of Sciences; The National Natural Science Foundation of China (Grants 81202391, 91229205, 81473243, 81321092, and 81330076); The National Science & Technology Major Project “Key New Drug Creation and Manufacturing Program” of China (Grants 2014ZX09507002, 2012ZX09301001-007, and 2013ZX09507001), and National Program on Key Basic Research Project of China (Grant 2012CB10704).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i58" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i58"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i59" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i59"> Abbreviations Used</h2><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high throughput screening</p></td></tr><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism and pharmacokinetics</p></td></tr><tr><td class="NLM_term">HGFR</td><td class="NLM_def"><p class="first last">hepatocyte growth factor receptor</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Bottaro, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faletto, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kmiecik, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandewoude, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aaronson, S. A.</span><span> </span><span class="NLM_article-title">Identification of the hepatocyte growth-factor receptor as the c-Met protooncogene product</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1991&pages=802-804&author=D.+P.+Bottaroauthor=J.+S.+Rubinauthor=D.+L.+Falettoauthor=A.+M.+L.+Chanauthor=T.+E.+Kmiecikauthor=G.+F.+Vandewoudeauthor=S.+A.+Aaronson&title=Identification+of+the+hepatocyte+growth-factor+receptor+as+the+c-Met+protooncogene+product"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26aulast%3DRubin%26aufirst%3DJ.%2BS.%26aulast%3DFaletto%26aufirst%3DD.%2BL.%26aulast%3DChan%26aufirst%3DA.%2BM.%2BL.%26aulast%3DKmiecik%26aufirst%3DT.%2BE.%26aulast%3DVandewoude%26aufirst%3DG.%2BF.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26atitle%3DIdentification%2520of%2520the%2520hepatocyte%2520growth-factor%2520receptor%2520as%2520the%2520c-Met%2520protooncogene%2520product%26jtitle%3DScience%26date%3D1991%26volume%3D251%26spage%3D802%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebeau, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandewoude, G. F.</span><span> </span><span class="NLM_article-title">The human Met oncogene is related to the tyrosine kinase oncogenes</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=1985&pages=385-388&author=M.+Deanauthor=M.+Parkauthor=M.+M.+Lebeauauthor=T.+S.+Robinsauthor=M.+O.+Diazauthor=J.+D.+Rowleyauthor=D.+G.+Blairauthor=G.+F.+Vandewoude&title=The+human+Met+oncogene+is+related+to+the+tyrosine+kinase+oncogenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DM.%26aulast%3DLebeau%26aufirst%3DM.%2BM.%26aulast%3DRobins%26aufirst%3DT.%2BS.%26aulast%3DDiaz%26aufirst%3DM.%2BO.%26aulast%3DRowley%26aufirst%3DJ.%2BD.%26aulast%3DBlair%26aufirst%3DD.%2BG.%26aulast%3DVandewoude%26aufirst%3DG.%2BF.%26atitle%3DThe%2520human%2520Met%2520oncogene%2520is%2520related%2520to%2520the%2520tyrosine%2520kinase%2520oncogenes%26jtitle%3DNature%26date%3D1985%26volume%3D318%26spage%3D385%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0li6xZo57ziuvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Cooper, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tainsky, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huebner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croce, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandewoude, G. F.</span><span> </span><span class="NLM_article-title">Molecular-cloning of a new transforming gene from a chemically transformed human cell-line</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=1984&pages=29-33&author=C.+S.+Cooperauthor=M.+Parkauthor=D.+G.+Blairauthor=M.+A.+Tainskyauthor=K.+Huebnerauthor=C.+M.+Croceauthor=G.+F.+Vandewoude&title=Molecular-cloning+of+a+new+transforming+gene+from+a+chemically+transformed+human+cell-line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DC.%2BS.%26aulast%3DPark%26aufirst%3DM.%26aulast%3DBlair%26aufirst%3DD.%2BG.%26aulast%3DTainsky%26aufirst%3DM.%2BA.%26aulast%3DHuebner%26aufirst%3DK.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26aulast%3DVandewoude%26aufirst%3DG.%2BF.%26atitle%3DMolecular-cloning%2520of%2520a%2520new%2520transforming%2520gene%2520from%2520a%2520chemically%2520transformed%2520human%2520cell-line%26jtitle%3DNature%26date%3D1984%26volume%3D311%26spage%3D29%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hubbard, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickson, W. A.</span><span> </span><span class="NLM_article-title">Crystal-structure of the tyrosine kinase domain of the human insulin-receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1994&pages=746-754&author=S.+R.+Hubbardauthor=L.+Weiauthor=L.+Elisauthor=W.+A.+Hendrickson&title=Crystal-structure+of+the+tyrosine+kinase+domain+of+the+human+insulin-receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DElis%26aufirst%3DL.%26aulast%3DHendrickson%26aufirst%3DW.%2BA.%26atitle%3DCrystal-structure%2520of%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520the%2520human%2520insulin-receptor%26jtitle%3DNature%26date%3D1994%26volume%3D372%26spage%3D746%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Holmes, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillozzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deakin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carafoli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, P. J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, E.</span><span> </span><span class="NLM_article-title">Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2007&pages=395-408&author=O.+Holmesauthor=S.+Pillozziauthor=J.+A.+Deakinauthor=F.+Carafoliauthor=L.+Kempauthor=P.+J.+G.+Butlerauthor=M.+Lyonauthor=E.+Gherardi&title=Insights+into+the+structure%2Ffunction+of+hepatocyte+growth+factor%2Fscatter+factor+from+studies+with+individual+domains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DO.%26aulast%3DPillozzi%26aufirst%3DS.%26aulast%3DDeakin%26aufirst%3DJ.%2BA.%26aulast%3DCarafoli%26aufirst%3DF.%26aulast%3DKemp%26aufirst%3DL.%26aulast%3DButler%26aufirst%3DP.%2BJ.%2BG.%26aulast%3DLyon%26aufirst%3DM.%26aulast%3DGherardi%26aufirst%3DE.%26atitle%3DInsights%2520into%2520the%2520structure%252Ffunction%2520of%2520hepatocyte%2520growth%2520factor%252Fscatter%2520factor%2520from%2520studies%2520with%2520individual%2520domains%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D367%26spage%3D395%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ponzetto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallazonca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panayotou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">A multifunctional docking site mediates signaling and transformation by the hepatocyte growth-factor scatter factor-receptor family</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1994&pages=261-271&author=C.+Ponzettoauthor=A.+Bardelliauthor=Z.+Zhenauthor=F.+Mainaauthor=P.+Dallazoncaauthor=S.+Giordanoauthor=A.+Grazianiauthor=G.+Panayotouauthor=P.+M.+Comoglio&title=A+multifunctional+docking+site+mediates+signaling+and+transformation+by+the+hepatocyte+growth-factor+scatter+factor-receptor+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPonzetto%26aufirst%3DC.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DZhen%26aufirst%3DZ.%26aulast%3DMaina%26aufirst%3DF.%26aulast%3DDallazonca%26aufirst%3DP.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DGraziani%26aufirst%3DA.%26aulast%3DPanayotou%26aufirst%3DG.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DA%2520multifunctional%2520docking%2520site%2520mediates%2520signaling%2520and%2520transformation%2520by%2520the%2520hepatocyte%2520growth-factor%2520scatter%2520factor-receptor%2520family%26jtitle%3DCell%26date%3D1994%26volume%3D77%26spage%3D261%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span> </span><span class="NLM_article-title">Met, metastasis, motility and more</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1038%2Fnrm1261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=14685170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=915-925&author=C.+Birchmeierauthor=W.+Birchmeierauthor=E.+Gherardiauthor=G.+F.+Vande+Woude&title=Met%2C+metastasis%2C+motility+and+more"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Met, metastasis, motility and more</span></div><div class="casAuthors">Birchmeier, Carmen; Birhcmeier, Walter; Gherardi, Ermanno; Vande Woude, George F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">915-925</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocyte growth factor. scatter factor and its receptor, the tyrosine kinase Met, arose late in evolution and are unique to vertebrates.  In spite of this, Met uses mols. such as Gab1 - homologues of which are present in Caenorhabditis elegans and Drosophila melanogaster - for downstream signalling. Pivotal roles for Met in development and cancer have been established: Met controls cell migration and growth in embryogenesis; it also controls growth, invasion and metastasis in cancer cells; and activating Met mutations predispose to human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG_-6XRpZ-sLVg90H21EOLACvtfcHk0ljoirCo9W12BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D&md5=ff5a02c73415784480c628fe65299a81</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrm1261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1261%26sid%3Dliteratum%253Aachs%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DGherardi%26aufirst%3DE.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26atitle%3DMet%252C%2520metastasis%252C%2520motility%2520and%2520more%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D915%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Weidner, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiCesare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=173-176&author=K.+M.+Weidnerauthor=S.+DiCesareauthor=M.+Sachsauthor=V.+Brinkmannauthor=J.+Behrensauthor=W.+Birchmeier&title=Interaction+between+Gab1+and+the+c-Met+receptor+tyrosine+kinase+is+responsible+for+epithelial+morphogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeidner%26aufirst%3DK.%2BM.%26aulast%3DDiCesare%26aufirst%3DS.%26aulast%3DSachs%26aufirst%3DM.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBehrens%26aufirst%3DJ.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DInteraction%2520between%2520Gab1%2520and%2520the%2520c-Met%2520receptor%2520tyrosine%2520kinase%2520is%2520responsible%2520for%2520epithelial%2520morphogenesis%26jtitle%3DNature%26date%3D1996%26volume%3D384%26spage%3D173%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Trusolino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">MET signalling: principles and functions in development, organ regeneration and cancer</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1038%2Fnrm3012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=21102609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGrurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=834-848&author=L.+Trusolinoauthor=A.+Bertottiauthor=P.+M.+Comoglio&title=MET+signalling%3A+principles+and+functions+in+development%2C+organ+regeneration+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">MET signalling: principles and functions in development, organ regeneration and cancer</span></div><div class="casAuthors">Trusolino, Livio; Bertotti, Andrea; Comoglio, Paolo M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">834-848</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The MET tyrosine kinase receptor (also known as the HGF receptor) promotes tissue remodelling, which underlies developmental morphogenesis, wound repair, organ homeostasis and cancer metastasis, by integrating growth, survival and migration cues in response to environmental stimuli or cell-autonomous perturbations.  The versatility of MET-mediated biol. responses is sustained by qual. and quant. signal modulation.  Qual. mechanisms include the engagement of dedicated signal transducers and the subcellular compartmentalization of MET signalling pathways, whereas quant. regulation involves MET partnering with adaptor amplifiers or being degraded through the shedding of its extracellular domain or through intracellular ubiquitylation.  Controlled activation of MET signalling can be exploited in regenerative medicine, whereas MET inhibition might slow down tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzaWXvEKEpVrVg90H21EOLACvtfcHk0ljoirCo9W12BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGrurfI&md5=c97f7b6ff2522bc0d20d0371d07c5ea2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrm3012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3012%26sid%3Dliteratum%253Aachs%26aulast%3DTrusolino%26aufirst%3DL.%26aulast%3DBertotti%26aufirst%3DA.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DMET%2520signalling%253A%2520principles%2520and%2520functions%2520in%2520development%252C%2520organ%2520regeneration%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D834%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Chmielowiec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borowiak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stradal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">c-Met is essential for wound healing in the skin</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2007&pages=151-162&author=J.+Chmielowiecauthor=M.+Borowiakauthor=M.+Morkelauthor=T.+Stradalauthor=B.+Munzauthor=S.+Wernerauthor=J.+Wehlandauthor=C.+Birchmeierauthor=W.+Birchmeier&title=c-Met+is+essential+for+wound+healing+in+the+skin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChmielowiec%26aufirst%3DJ.%26aulast%3DBorowiak%26aufirst%3DM.%26aulast%3DMorkel%26aufirst%3DM.%26aulast%3DStradal%26aufirst%3DT.%26aulast%3DMunz%26aufirst%3DB.%26aulast%3DWerner%26aufirst%3DS.%26aulast%3DWehland%26aufirst%3DJ.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3Dc-Met%2520is%2520essential%2520for%2520wound%2520healing%2520in%2520the%2520skin%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2007%26volume%3D177%26spage%3D151%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Michalopoulos, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFrances, M. C.</span><span> </span><span class="NLM_article-title">Liver regeneration</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1126%2Fscience.276.5309.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=9082986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADyaK2sXitlyqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=60-66&author=G.+K.+Michalopoulosauthor=M.+C.+DeFrances&title=Liver+regeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Liver regeneration</span></div><div class="casAuthors">Michalopoulos, George K.; DeFrances, Marie C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">5309</span>),
    <span class="NLM_cas:pages">60-66</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 98 refs.  Liver regeneration after the loss of hepatic tissue is a fundamental parameter of liver response to injury.  Recognized as a phenomenon from mythol. times, it is now defined as an orchestrated response induced by specific external stimuli and involving sequential changes in gene expression, growth factor prodn., and morphol. structure.  Many growth factors and cytokines, most notably hepatocyte growth factor, epidermal growth factor, transforming growth factor-α, interleukin-6, tumor necrosis factor-α, insulin, and norepinephrine, appear to play important roles in this process.  This review attempts to integrate the findings of the last three decades and looks toward clues as to the nature of the causes that trigger this fascinating organ and cellular response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryWZQ48IfGpbVg90H21EOLACvtfcHk0liR5QNb-x06LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitlyqt78%253D&md5=3961787026f78ecfbd3032e6c6f8fc90</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.276.5309.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.276.5309.60%26sid%3Dliteratum%253Aachs%26aulast%3DMichalopoulos%26aufirst%3DG.%2BK.%26aulast%3DDeFrances%26aufirst%3DM.%2BC.%26atitle%3DLiver%2520regeneration%26jtitle%3DScience%26date%3D1997%26volume%3D276%26spage%3D60%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusolino, L.</span><span> </span><span class="NLM_article-title">Invasive growth: from development to metastasis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=857-862&author=P.+M.+Comoglioauthor=L.+Trusolino&title=Invasive+growth%3A+from+development+to+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DTrusolino%26aufirst%3DL.%26atitle%3DInvasive%2520growth%253A%2520from%2520development%2520to%2520metastasis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D109%26spage%3D857%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Otsuka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRochelle, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottaro, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellmore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anver, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlino, G.</span><span> </span><span class="NLM_article-title">c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5157</span><span class="NLM_x">–</span> <span class="NLM_lpage">5167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=5157-5167&author=T.+Otsukaauthor=H.+Takayamaauthor=R.+Sharpauthor=G.+Celliauthor=W.+J.+LaRochelleauthor=D.+P.+Bottaroauthor=N.+Ellmoreauthor=W.+Vieiraauthor=J.+W.+Owensauthor=M.+Anverauthor=G.+Merlino&title=c-Met+autocrine+activation+induces+development+of+malignant+melanoma+and+acquisition+of+the+metastatic+phenotype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtsuka%26aufirst%3DT.%26aulast%3DTakayama%26aufirst%3DH.%26aulast%3DSharp%26aufirst%3DR.%26aulast%3DCelli%26aufirst%3DG.%26aulast%3DLaRochelle%26aufirst%3DW.%2BJ.%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26aulast%3DEllmore%26aufirst%3DN.%26aulast%3DVieira%26aufirst%3DW.%26aulast%3DOwens%26aufirst%3DJ.%2BW.%26aulast%3DAnver%26aufirst%3DM.%26aulast%3DMerlino%26aufirst%3DG.%26atitle%3Dc-Met%2520autocrine%2520activation%2520induces%2520development%2520of%2520malignant%2520melanoma%2520and%2520acquisition%2520of%2520the%2520metastatic%2520phenotype%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D5157%26epage%3D5167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Schmidt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duh, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choyke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubensky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allikmets, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chidambaram, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergerheim, U. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltis, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamarron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernues, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lips, C. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geil, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orcutt, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stackhouse, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slife, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niehans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storkel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerman, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linehan, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zbar, B.</span><span> </span><span class="NLM_article-title">Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1038%2Fng0597-68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=9140397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADyaK2sXivFKhsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=68-73&author=L.+Schmidtauthor=F.+M.+Duhauthor=F.+Chenauthor=T.+Kishidaauthor=G.+Glennauthor=P.+Choykeauthor=S.+W.+Schererauthor=Z.+P.+Zhuangauthor=I.+Lubenskyauthor=M.+Deanauthor=R.+Allikmetsauthor=A.+Chidambaramauthor=U.+R.+Bergerheimauthor=J.+T.+Feltisauthor=C.+Casadevallauthor=A.+Zamarronauthor=M.+Bernuesauthor=S.+Richardauthor=C.+J.+M.+Lipsauthor=M.+M.+Waltherauthor=L.+C.+Tsuiauthor=L.+Geilauthor=M.+L.+Orcuttauthor=T.+Stackhouseauthor=J.+Lipanauthor=L.+Slifeauthor=H.+Brauchauthor=J.+Deckerauthor=G.+Niehansauthor=M.+D.+Hughsonauthor=H.+Mochauthor=S.+Storkelauthor=M.+I.+Lermanauthor=W.+M.+Linehanauthor=B.+Zbar&title=Germline+and+somatic+mutations+in+the+tyrosine+kinase+domain+of+the+MET+proto-oncogene+in+papillary+renal+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas</span></div><div class="casAuthors">Schmidt, Laura; Duh, Fuh-Mei; Chen, Fan; Kishida, Takeshi; Glenn, Gladys; Choyke, Peter; Scherer, Stephen W.; Zhuang, Zhenping; Lubensky, Irina; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-73</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Hereditary papillary renal carcinoma (HPRC) is a recently recognized form of inherited kidney cancer characterized by a predisposition to develop multiple, bilateral papillary renal tumors.  The pattern of inheritance of HPRC is consistent with autosomal dominant transmission with reduced penetrance.  HPRC is histol. and genetically distinct from two other causes of inherited renal carcinoma, von Hippel-Lindau disease (VHL) and the chromosome translocation (3;8).  Malignant papillary renal carcinomas are characterized by trisomy of chromosomes 7, 16 and 17, and in men, by loss of the Y chromosome.  Inherited and sporadic clear cell renal carcinomas are characterized by inactivation of both copies of the VHL gene by mutation, and/or by hypermethylation.  We found that the HPRC gene was located at chromosome 7q31.1-34 in a 27-centimorgan (cM) interval between D7S496 and D7S1837.  We identified missense mutations located in the tyrosine kinase domain of the MET gene in the germline of affected members of HPRC families and in a subset of sporadic papillary renal carcinomas.  Three mutations in the MET gene are located in codons that are homologous to those in c-kit and RET, proto-oncogenes that are targets of naturally-occurring mutations.  The results suggest that missense mutations located in the MET proto-oncogene lead to constitutive activation of the MET protein and papillary renal carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm-x_dqJPR-7Vg90H21EOLACvtfcHk0liR5QNb-x06LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFKhsbw%253D&md5=7209dbbaa538b418defad117830df3c9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fng0597-68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0597-68%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DL.%26aulast%3DDuh%26aufirst%3DF.%2BM.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DKishida%26aufirst%3DT.%26aulast%3DGlenn%26aufirst%3DG.%26aulast%3DChoyke%26aufirst%3DP.%26aulast%3DScherer%26aufirst%3DS.%2BW.%26aulast%3DZhuang%26aufirst%3DZ.%2BP.%26aulast%3DLubensky%26aufirst%3DI.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DAllikmets%26aufirst%3DR.%26aulast%3DChidambaram%26aufirst%3DA.%26aulast%3DBergerheim%26aufirst%3DU.%2BR.%26aulast%3DFeltis%26aufirst%3DJ.%2BT.%26aulast%3DCasadevall%26aufirst%3DC.%26aulast%3DZamarron%26aufirst%3DA.%26aulast%3DBernues%26aufirst%3DM.%26aulast%3DRichard%26aufirst%3DS.%26aulast%3DLips%26aufirst%3DC.%2BJ.%2BM.%26aulast%3DWalther%26aufirst%3DM.%2BM.%26aulast%3DTsui%26aufirst%3DL.%2BC.%26aulast%3DGeil%26aufirst%3DL.%26aulast%3DOrcutt%26aufirst%3DM.%2BL.%26aulast%3DStackhouse%26aufirst%3DT.%26aulast%3DLipan%26aufirst%3DJ.%26aulast%3DSlife%26aufirst%3DL.%26aulast%3DBrauch%26aufirst%3DH.%26aulast%3DDecker%26aufirst%3DJ.%26aulast%3DNiehans%26aufirst%3DG.%26aulast%3DHughson%26aufirst%3DM.%2BD.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DStorkel%26aufirst%3DS.%26aulast%3DLerman%26aufirst%3DM.%2BI.%26aulast%3DLinehan%26aufirst%3DW.%2BM.%26aulast%3DZbar%26aufirst%3DB.%26atitle%3DGermline%2520and%2520somatic%2520mutations%2520in%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520the%2520MET%2520proto-oncogene%2520in%2520papillary%2520renal%2520carcinomas%26jtitle%3DNat.%2520Genet.%26date%3D1997%26volume%3D16%26spage%3D68%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Umeki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, H.</span><span> </span><span class="NLM_article-title">Clinical significance of c-met oncogene alterations in human colorectal cancer</span> <span class="citation_source-journal">Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=314-321&author=K.+Umekiauthor=G.+Shiotaauthor=H.+Kawasaki&title=Clinical+significance+of+c-met+oncogene+alterations+in+human+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUmeki%26aufirst%3DK.%26aulast%3DShiota%26aufirst%3DG.%26aulast%3DKawasaki%26aufirst%3DH.%26atitle%3DClinical%2520significance%2520of%2520c-met%2520oncogene%2520alterations%2520in%2520human%2520colorectal%2520cancer%26jtitle%3DOncology%26date%3D1999%26volume%3D56%26spage%3D314%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zejnullahu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsudomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappuzzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span> </span><span class="NLM_article-title">MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1043</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1126%2Fscience.1141478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=17463250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlOjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=1039-1043&author=J.+A.+Engelmanauthor=K.+Zejnullahuauthor=T.+Mitsudomiauthor=Y.+Songauthor=C.+Hylandauthor=J.+O.+Parkauthor=N.+Lindemanauthor=C.-M.+Galeauthor=X.+Zhaoauthor=J.+Christensenauthor=T.+Kosakaauthor=A.+J.+Holmesauthor=A.+M.+Rogersauthor=F.+Cappuzzoauthor=T.+Mokauthor=C.+Leeauthor=B.+E.+Johnsonauthor=L.+C.+Cantleyauthor=P.+A.+Janne&title=MET+amplification+leads+to+gefitinib+resistance+in+lung+cancer+by+activating+ERBB3+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling</span></div><div class="casAuthors">Engelman, Jeffrey A.; Zejnullahu, Kreshnik; Mitsudomi, Tetsuya; Song, Youngchul; Hyland, Courtney; Park, Joon Oh; Lindeman, Neal; Gale, Christopher-Michael; Zhao, Xiaojun; Christensen, James; Kosaka, Takayuki; Holmes, Alison J.; Rogers, Andrew M.; Cappuzzo, Federico; Mok, Tony; Lee, Charles; Johnson, Bruce E.; Cantley, Lewis C.; Jaenne, Pasi A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5827</span>),
    <span class="NLM_cas:pages">1039-1043</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance.  Here, we describe a gefitinib-sensitive lung cancer cell line that developed resistance to gefitinib as a result of focal amplification of the MET proto-oncogene. inhibition of MET signaling in these cells restored their sensitivity to gefitinib.  MET amplification was detected in 4 of 18 (22%) lung cancer specimens that had developed resistance to gefitinib or erlotinib.  We find that amplification of MET causes gefitinib resistance by driving ERBB3 (HER3)-dependent activation of PI3K, a pathway thought to be specific to EGFR/ERBB family receptors.  Thus, we propose that MET amplification may promote drug resistance in other ERBB-driven cancers as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr430gbvBeIoLVg90H21EOLACvtfcHk0lj6DK1dj9R8tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlOjt7g%253D&md5=3da9383b4acb965f57529b095f8f4686</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.1141478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1141478%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DMitsudomi%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DHyland%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DJ.%2BO.%26aulast%3DLindeman%26aufirst%3DN.%26aulast%3DGale%26aufirst%3DC.-M.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DKosaka%26aufirst%3DT.%26aulast%3DHolmes%26aufirst%3DA.%2BJ.%26aulast%3DRogers%26aufirst%3DA.%2BM.%26aulast%3DCappuzzo%26aufirst%3DF.%26aulast%3DMok%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26atitle%3DMET%2520amplification%2520leads%2520to%2520gefitinib%2520resistance%2520in%2520lung%2520cancer%2520by%2520activating%2520ERBB3%2520signaling%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D1039%26epage%3D1043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Michieli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basilico, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavassa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sottile, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">Targeting the tumor and its microenvironment by a dual-function decoy Met receptor</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=61-73&author=P.+Michieliauthor=M.+Mazzoneauthor=C.+Basilicoauthor=S.+Cavassaauthor=A.+Sottileauthor=L.+Naldiniauthor=P.+M.+Comoglio&title=Targeting+the+tumor+and+its+microenvironment+by+a+dual-function+decoy+Met+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMichieli%26aufirst%3DP.%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DBasilico%26aufirst%3DC.%26aulast%3DCavassa%26aufirst%3DS.%26aulast%3DSottile%26aufirst%3DA.%26aulast%3DNaldini%26aufirst%3DL.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DTargeting%2520the%2520tumor%2520and%2520its%2520microenvironment%2520by%2520a%2520dual-function%2520decoy%2520Met%2520receptor%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D61%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusolino, L.</span><span> </span><span class="NLM_article-title">Drug development of MET inhibitors: targeting oncogene addiction and expedience</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=504-516&author=P.+M.+Comoglioauthor=S.+Giordanoauthor=L.+Trusolino&title=Drug+development+of+MET+inhibitors%3A+targeting+oncogene+addiction+and+expedience"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DTrusolino%26aufirst%3DL.%26atitle%3DDrug%2520development%2520of%2520MET%2520inhibitors%253A%2520targeting%2520oncogene%2520addiction%2520and%2520expedience%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D504%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Cui, J. J.</span><span> </span><span class="NLM_article-title">Targeting receptor tyrosine kinase MET in cancer: small molecule inhibitors and clinical progress</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4427</span><span class="NLM_x">–</span> <span class="NLM_lpage">4453</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401427c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4427-4453&author=J.+J.+Cui&title=Targeting+receptor+tyrosine+kinase+MET+in+cancer%3A+small+molecule+inhibitors+and+clinical+progress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress</span></div><div class="casAuthors">Cui, J. Jean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4427-4453</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The HGF/MET signaling pathway is crit. in mediating a wide range of normal physiol. functions including embryol. development, wound healing, and tissue regeneration.  Aberrant activation of the pathway has frequently been found in human cancers via protein overexpression, mutation, gene amplification, and also paracrine or autocrine up-regulation.  In addn., the activation of HGF/MET signaling confers resistance to the effects of cancer treatments.  Therefore, inhibition of the HGF/MET signaling pathway has great potential for therapeutic intervention in cancer.  Currently, there are three approaches toward modulating HGF/MET signaling in human clin. studies of cancer: anti-HGF monoclonal antibodies, MET monoclonal antibodies, and small mol. MET inhibitors.  Preliminary clin. benefit from inhibition of HGF or MET has been reported.  This Perspective will provide an overview of the HGF/MET signaling pathway in cancer and then will review the development of small mol. MET inhibitors and their progress in clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoARAsEnH4X5rVg90H21EOLACvtfcHk0ljpQw3ZJ7qdeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltbvE&md5=534fd1c6fd8b83be41251d0d556903d1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm401427c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401427c%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520receptor%2520tyrosine%2520kinase%2520MET%2520in%2520cancer%253A%2520small%2520molecule%2520inhibitors%2520and%2520clinical%2520progress%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4427%26epage%3D4453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ghiso, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span> </span><span class="NLM_article-title">Targeting MET: why, where and how?</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1016%2Fj.coph.2013.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=23797036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVSmurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=511-518&author=E.+Ghisoauthor=S.+Giordano&title=Targeting+MET%3A+why%2C+where+and+how%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting MET: why, where and how?</span></div><div class="casAuthors">Ghiso, Elena; Giordano, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-518</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite the initial skepticism, targeted therapies represent a new perspective in the treatment of cancer.  Tyrosine kinases, and in particular receptor tyrosine kinases (RTKs), are considered ideal targets for this type of therapy.  MET, the tyrosine kinase receptor for the Hepatocyte Growth Factor (HGF), has recently become a very interesting and studied target in oncol.  In this review we discuss firstly 'why' the MET/HGF pathway can be considered a target in human tumors; secondly 'where' MET/HGF inhibition can be useful in cancer treatment and finally 'how' MET and HGF can be inhibited using either monoclonal antibodies or tyrosine kinase inhibitors.  We also highlight some questions in the anti-MET/HGF targeted therapy field that are still waiting for an answer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq33qI6WAqWJ7Vg90H21EOLACvtfcHk0ljpQw3ZJ7qdeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSmurnL&md5=507f17d762550af451af791c1527d50d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2013.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2013.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DGhiso%26aufirst%3DE.%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DTargeting%2520MET%253A%2520why%252C%2520where%2520and%2520how%253F%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2013%26volume%3D13%26spage%3D511%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Organ, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, M. S.</span><span> </span><span class="NLM_article-title">An overview of the c-MET signaling pathway</span> <span class="citation_source-journal">Ther. Adv. Med. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">S7</span><span class="NLM_x">–</span> <span class="NLM_lpage">S19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1177%2F1758834011422556" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=22128289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=S7-S19&author=S.+L.+Organauthor=M.+S.+Tsao&title=An+overview+of+the+c-MET+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of the c-MET signaling pathway</span></div><div class="casAuthors">Organ, Shawna Leslie; Tsao, Ming-Sound</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Medical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S7-S19</span>CODEN:
                <span class="NLM_cas:coden">TAMOB8</span>;
        ISSN:<span class="NLM_cas:issn">1758-8340</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  C-MET is a receptor tyrosine kinase that, after binding with its ligand, hepatocyte growth factor, activates a wide range of different cellular signaling pathways, including those involved in proliferation, motility, migration and invasion.  Although c-MET is important in the control of tissue homeostasis under normal physiol. conditions, it has also been found to be aberrantly activated in human cancers via mutation, amplification or protein overexpression.  This paper provides an overview of the c-MET signaling pathway, including its role in the development of cancers, and provides a rationale for targeting the pathway as a possible treatment option.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp79uA73SrMTLVg90H21EOLACvtfcHk0ljpQw3ZJ7qdeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSqsg%253D%253D&md5=94f1ef8e31e21a15edc525e2c6325f52</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1177%2F1758834011422556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1758834011422556%26sid%3Dliteratum%253Aachs%26aulast%3DOrgan%26aufirst%3DS.%2BL.%26aulast%3DTsao%26aufirst%3DM.%2BS.%26atitle%3DAn%2520overview%2520of%2520the%2520c-MET%2520signaling%2520pathway%26jtitle%3DTher.%2520Adv.%2520Med.%2520Oncol.%26date%3D2011%26volume%3D3%26spage%3DS7%26epage%3DS19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusolino, L.</span><span> </span><span class="NLM_article-title">Drug development of MET inhibitors: targeting oncogene addiction and expedience</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=504-16&author=P.+M.+Comoglioauthor=S.+Giordanoauthor=L.+Trusolino&title=Drug+development+of+MET+inhibitors%3A+targeting+oncogene+addiction+and+expedience"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DTrusolino%26aufirst%3DL.%26atitle%3DDrug%2520development%2520of%2520MET%2520inhibitors%253A%2520targeting%2520oncogene%2520addiction%2520and%2520expedience%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D504%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Dube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrous, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6342</span><span class="NLM_x">–</span> <span class="NLM_lpage">6363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2007613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6342-6363&author=J.+J.+Cuiauthor=M.+Tran-Dubeauthor=H.+Shenauthor=M.+Nambuauthor=P.+P.+Kungauthor=M.+Pairishauthor=L.+Jiaauthor=J.+Mengauthor=L.+Funkauthor=I.+Botrousauthor=M.+McTigueauthor=N.+Grodskyauthor=K.+Ryanauthor=E.+Padriqueauthor=G.+Altonauthor=S.+Timofeevskiauthor=S.+Yamazakiauthor=Q.+H.+Liauthor=H.+L.+Zouauthor=J.+Christensenauthor=B.+Mroczkowskiauthor=S.+Benderauthor=R.+S.+Kaniaauthor=M.+P.+Edwards&title=Structure+based+drug+design+of+crizotinib+%28PF-02341066%29%2C+a+potent+and+selective+dual+inhibitor+of+mesenchymal-epithelial+transition+factor+%28c-MET%29+kinase+and+anaplastic+lymphoma+kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)</span></div><div class="casAuthors">Cui, J. Jean; Tran-Dube, Michelle; Shen, Hong; Nambu, Mitchell; Kung, Pei-Pei; Pairish, Mason; Jia, Lei; Meng, Jerry; Funk, Lee; Botrous, Iriny; McTigue, Michele; Grodsky, Neil; Ryan, Kevin; Padrique, Ellen; Alton, Gordon; Timofeevski, Sergei; Yamazaki, Shinji; Li, Qiuhua; Zou, Helen; Christensen, James; Mroczkowski, Barbara; Bender, Steve; Kania, Robert S.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6342-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the crit. roles of aberrant signaling in cancer, both c-MET and ALK receptor tyrosine kinases are attractive oncol. targets for therapeutic intervention.  The cocrystal structure of 3 (PHA-665752), bound to c-MET kinase domain, revealed a novel ATP site environment, which served as the target to guide parallel, multiattribute drug design.  A novel 2-amino-5-aryl-3-benzyloxypyridine series was created to more effectively make the key interactions achieved with 3.  In the novel series, the 2-aminopyridine core allowed a 3-benzyloxy group to reach into the same pocket as the 2,6-dichlorophenyl group of 3 via a more direct vector and thus with a better ligand efficiency (LE).  Further optimization of the lead series generated the clin. candidate crizotinib (PF-02341066), which demonstrated potent in vitro and in vivo c-MET kinase and ALK inhibition, effective tumor growth inhibition, and good pharmaceutical properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHs_cKJ-U3t7Vg90H21EOLACvtfcHk0ljpQw3ZJ7qdeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN&md5=dbab4c1b3e7c76180dbad04be2b6a474</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm2007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007613%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%2BH.%26aulast%3DZou%26aufirst%3DH.%2BL.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DStructure%2520based%2520drug%2520design%2520of%2520crizotinib%2520%2528PF-02341066%2529%252C%2520a%2520potent%2520and%2520selective%2520dual%2520inhibitor%2520of%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-MET%2529%2520kinase%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6342%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Boezio, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santostefano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimanovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span> </span><span class="NLM_article-title">Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6307</span><span class="NLM_x">–</span> <span class="NLM_lpage">6312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1016%2Fj.bmcl.2009.09.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=19819693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWlsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6307-6312&author=A.+A.+Boezioauthor=L.+Berryauthor=B.+K.+Albrechtauthor=D.+Bauerauthor=S.+F.+Bellonauthor=C.+Bodeauthor=A.+Chenauthor=D.+Choquetteauthor=I.+Dussaultauthor=S.+Hiraiauthor=P.+Kaplan-Lefkoauthor=J.+F.+Larrowauthor=M.+H.+J.+Linauthor=J.+Lohmanauthor=M.+H.+Potashmanauthor=K.+Rexauthor=M.+Santostefanoauthor=K.+Shahauthor=R.+Shimanovichauthor=S.+K.+Springerauthor=Y.+Tefferaauthor=Y.+J.+Yangauthor=Y.+H.+Zhangauthor=J.+C.+Harmange&title=Discovery+and+optimization+of+potent+and+selective+triazolopyridazine+series+of+c-Met+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors</span></div><div class="casAuthors">Boezio, Alessandro A.; Berry, Loren; Albrecht, Brian K.; Bauer, David; Bellon, Steven F.; Bode, Christiane; Chen, April; Choquette, Deborah; Dussault, Isabelle; Hirai, Satoko; Kaplan-Lefko, Paula; Larrow, Jay F.; Lin, Min-Hwa Jasmine; Lohman, Julia; Potashman, Michele H.; Rex, Karen; Santostefano, Michael; Shah, Kavita; Shimanovich, Roman; Springer, Stephanie K.; Teffera, Yohannes; Yang, Yajing; Zhang, Yihong; Harmange, Jean-Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6307-6312</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Deregulation of the receptor tyrosine kinase c-Met has been implicated in several human cancers and is an attractive target for small mol. drug discovery.  We previously showed that O-linked triazolopyridazines can be potent inhibitors of c-Met.  Herein, we report the discovery of a related series of N-linked triazolopyridazines which demonstrate nanomolar inhibition of c-Met kinase activity and display improved pharmacodynamic profiles.  Specifically, the potent time-dependent inhibition of cytochrome P 450 assocd. with the O-linked triazolopyridazines has been eliminated within this novel series of inhibitors.  N-linked triazolopyridazine 24 exhibited favorable pharmacokinetics and displayed potent inhibition of HGF-mediated c-Met phosphorylation in a mouse liver PD model.  Once-daily oral administration of 24 for 22 days showed significant tumor growth inhibition in an NIH-3T3/TPR-Met xenograft mouse efficacy model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiJYhob-fk_bVg90H21EOLACvtfcHk0lj8cIK-GIpUtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWlsrbF&md5=254e67e6f81b7018b75f73290505e8af</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.09.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.09.096%26sid%3Dliteratum%253Aachs%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DHirai%26aufirst%3DS.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DLarrow%26aufirst%3DJ.%2BF.%26aulast%3DLin%26aufirst%3DM.%2BH.%2BJ.%26aulast%3DLohman%26aufirst%3DJ.%26aulast%3DPotashman%26aufirst%3DM.%2BH.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSantostefano%26aufirst%3DM.%26aulast%3DShah%26aufirst%3DK.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSpringer%26aufirst%3DS.%2BK.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520potent%2520and%2520selective%2520triazolopyridazine%2520series%2520of%2520c-Met%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6307%26epage%3D6312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Liu, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marando, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behshad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span> </span><span class="NLM_article-title">A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7127</span><span class="NLM_x">–</span> <span class="NLM_lpage">7138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1158%2F1078-0432.CCR-11-1157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=21918175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKht7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=7127-7138&author=X.+D.+Liuauthor=Q.+Wangauthor=G.+J.+Yangauthor=C.+Marandoauthor=H.+K.+Koblishauthor=L.+M.+Hallauthor=J.+S.+Fridmanauthor=E.+Behshadauthor=R.+Wynnauthor=Y.+Liauthor=J.+Boerauthor=S.+Diamondauthor=C.+H.+Heauthor=M.+Z.+Xuauthor=J.+C.+Zhuoauthor=W.+Q.+Yaoauthor=R.+C.+Newtonauthor=P.+A.+Scherle&title=A+novel+kinase+inhibitor%2C+INCB28060%2C+blocks+c-MET-dependent+signaling%2C+neoplastic+activities%2C+and+cross-talk+with+EGFR+and+HER-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Kinase Inhibitor, INCB28060, Blocks c-MET-Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3</span></div><div class="casAuthors">Liu, Xiangdong; Wang, Qian; Yang, Gengjie; Marando, Cindy; Koblish, Holly K.; Hall, Leslie M.; Fridman, Jordan S.; Behshad, Elham; Wynn, Richard; Li, Yu; Boer, Jason; Diamond, Sharon; He, Chunhong; Xu, Meizhong; Zhuo, Jincong; Yao, Wenqing; Newton, Robert C.; Scherle, Peggy A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7127-7138</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The c-MET receptor tyrosine kinase plays important roles in the formation, progression, and dissemination of human cancer and presents an attractive therapeutic target.  This study describes the preclin. characterization of INCB28060, a novel inhibitor of c-MET kinase.  Exptl. Design: Studies were conducted using a series of in vitro and in vivo biochem. and biol. expts.  RESULTS: INCB28060 exhibits picomolar enzymic potency and is highly specific for c-MET with more than 10,000-fold selectivity over a large panel of human kinases.  This inhibitor potently blocks c-MET phosphorylation and activation of its key downstream effectors in c-MET-dependent tumor cell lines.  As a result, INCB28060 potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis in vitro.  Oral dosing of INCB28060 results in time- and dose-dependent inhibition of c-MET phosphorylation and tumor growth in c-MET-driven mouse tumor models, and the inhibitor is well tolerated at doses that achieve complete tumor inhibition.  In a further exploration of potential interactions between c-MET and other signaling pathways, we found that activated c-MET pos. regulates the activity of epidermal growth factor receptors (EGFR) and HER-3, as well as expression of their ligands.  These effects are reversed with INCB28060 treatment.  Finally, we confirmed that circulating hepatocyte growth factor levels are significantly elevated in patients with various cancers.  CONCLUSIONS: Activated c-MET has pleiotropic effects on multiple cancer-promoting signaling pathways and may play a crit. role in driving tumor cell growth and survival.  INCB28060 is a potent and selective c-MET kinase inhibitor that may have therapeutic potential in cancer treatment.  Clin Cancer Res; 17(22); 7127-38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqqT6dM1mGprVg90H21EOLACvtfcHk0lj8cIK-GIpUtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKht7nK&md5=c272514704702cb5cbcc9e405bea3c53</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1157%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%2BD.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DG.%2BJ.%26aulast%3DMarando%26aufirst%3DC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DHall%26aufirst%3DL.%2BM.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DBehshad%26aufirst%3DE.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DDiamond%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DC.%2BH.%26aulast%3DXu%26aufirst%3DM.%2BZ.%26aulast%3DZhuo%26aufirst%3DJ.%2BC.%26aulast%3DYao%26aufirst%3DW.%2BQ.%26aulast%3DNewton%26aufirst%3DR.%2BC.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26atitle%3DA%2520novel%2520kinase%2520inhibitor%252C%2520INCB28060%252C%2520blocks%2520c-MET-dependent%2520signaling%252C%2520neoplastic%2520activities%252C%2520and%2520cross-talk%2520with%2520EGFR%2520and%2520HER-3%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D7127%26epage%3D7138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Atreya, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messersmith, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venook, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arcaroli, J. J.</span><span> </span><span class="NLM_article-title">Potent antitumor activity of XL184 (cabozantinib), a c-MET and VEGFR2 inhibitor, in colorectal cancer patient-derived tumor explant models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=73&author=C.+E.+Atreyaauthor=E.+K.+Songauthor=W.+Messersmithauthor=A.+Purkeyauthor=S.+Bagbyauthor=K.+Quackenbushauthor=R.+K.+Kelleyauthor=E.+Kwakauthor=D.+Ryanauthor=A.+Venookauthor=J.+J.+Arcaroli&title=Potent+antitumor+activity+of+XL184+%28cabozantinib%29%2C+a+c-MET+and+VEGFR2+inhibitor%2C+in+colorectal+cancer+patient-derived+tumor+explant+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtreya%26aufirst%3DC.%2BE.%26aulast%3DSong%26aufirst%3DE.%2BK.%26aulast%3DMessersmith%26aufirst%3DW.%26aulast%3DPurkey%26aufirst%3DA.%26aulast%3DBagby%26aufirst%3DS.%26aulast%3DQuackenbush%26aufirst%3DK.%26aulast%3DKelley%26aufirst%3DR.%2BK.%26aulast%3DKwak%26aufirst%3DE.%26aulast%3DRyan%26aufirst%3DD.%26aulast%3DVenook%26aufirst%3DA.%26aulast%3DArcaroli%26aufirst%3DJ.%2BJ.%26atitle%3DPotent%2520antitumor%2520activity%2520of%2520XL184%2520%2528cabozantinib%2529%252C%2520a%2520c-MET%2520and%2520VEGFR2%2520inhibitor%252C%2520in%2520colorectal%2520cancer%2520patient-derived%2520tumor%2520explant%2520models%26jtitle%3DCancer%2520Res.%26date%3D2013%26spage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Katz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlberg, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabarda, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumb, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutterbach, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathvink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazef, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soisson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q. W.</span><span> </span><span class="NLM_article-title">Discovery of a 5<i>H</i>-benzo[4,5]cyclohepta[1,2-<i>b</i>]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4092</span><span class="NLM_x">–</span> <span class="NLM_lpage">4108</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200112k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4092-4108&author=J.+D.+Katzauthor=J.+P.+Jewellauthor=D.+J.+Guerinauthor=J.+Limauthor=C.+J.+Dinsmoreauthor=S.+V.+Deshmukhauthor=B.+S.+Panauthor=C.+G.+Marshallauthor=W.+Luauthor=M.+D.+Altmanauthor=W.+K.+Dahlbergauthor=L.+Davisauthor=D.+Falconeauthor=A.+E.+Gabardaauthor=G.+Z.+Hangauthor=H.+Hatchauthor=R.+Holmesauthor=K.+Kuniiauthor=K.+J.+Lumbauthor=B.+Lutterbachauthor=R.+Mathvinkauthor=N.+Nazefauthor=S.+B.+Patelauthor=X.+L.+Quauthor=J.+F.+Reillyauthor=K.+W.+Rickertauthor=C.+Rosensteinauthor=S.+M.+Soissonauthor=K.+B.+Spencerauthor=A.+A.+Szewczakauthor=D.+Walkerauthor=W.+X.+Wangauthor=J.+Youngauthor=Q.+W.+Zeng&title=Discovery+of+a+5H-benzo%5B4%2C5%5Dcyclohepta%5B1%2C2-b%5Dpyridin-5-one+%28MK-2461%29+inhibitor+of+c-Met+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm200112k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200112k%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%2BD.%26aulast%3DJewell%26aufirst%3DJ.%2BP.%26aulast%3DGuerin%26aufirst%3DD.%2BJ.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DPan%26aufirst%3DB.%2BS.%26aulast%3DMarshall%26aufirst%3DC.%2BG.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DDahlberg%26aufirst%3DW.%2BK.%26aulast%3DDavis%26aufirst%3DL.%26aulast%3DFalcone%26aufirst%3DD.%26aulast%3DGabarda%26aufirst%3DA.%2BE.%26aulast%3DHang%26aufirst%3DG.%2BZ.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DHolmes%26aufirst%3DR.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DLumb%26aufirst%3DK.%2BJ.%26aulast%3DLutterbach%26aufirst%3DB.%26aulast%3DMathvink%26aufirst%3DR.%26aulast%3DNazef%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DQu%26aufirst%3DX.%2BL.%26aulast%3DReilly%26aufirst%3DJ.%2BF.%26aulast%3DRickert%26aufirst%3DK.%2BW.%26aulast%3DRosenstein%26aufirst%3DC.%26aulast%3DSoisson%26aufirst%3DS.%2BM.%26aulast%3DSpencer%26aufirst%3DK.%2BB.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DW.%2BX.%26aulast%3DYoung%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DQ.%2BW.%26atitle%3DDiscovery%2520of%2520a%25205H-benzo%255B4%252C5%255Dcyclohepta%255B1%252C2-b%255Dpyridin-5-one%2520%2528MK-2461%2529%2520inhibitor%2520of%2520c-Met%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4092%26epage%3D4108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Munshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">France, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leggett, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. J.</span><span> </span><span class="NLM_article-title">ARQ 197, a novel and selective inhibitor of the human c-met receptor tyrosine kinase with antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1544</span><span class="NLM_x">–</span> <span class="NLM_lpage">1553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1158%2F1535-7163.MCT-09-1173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=20484018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFGgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1544-1553&author=N.+Munshiauthor=S.+Jeayauthor=Y.+Z.+Liauthor=C.+R.+Chenauthor=D.+S.+Franceauthor=M.+A.+Ashwellauthor=J.+Hillauthor=M.+M.+Moussaauthor=D.+S.+Leggettauthor=C.+J.+Li&title=ARQ+197%2C+a+novel+and+selective+inhibitor+of+the+human+c-met+receptor+tyrosine+kinase+with+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity</span></div><div class="casAuthors">Munshi, Neru; Jeay, Sebastien; Li, Youzhi; Chen, Chang-Rung; France, Dennis S.; Ashwell, Mark A.; Hill, Jason; Moussa, Magdi M.; Leggett, David S.; Li, Chiang J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1544-1553</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The met proto-oncogene is functionally linked with tumorigenesis and metastatic progression.  Validation of the receptor tyrosine kinase c-Met as a selective anticancer target has awaited the emergence of selective c-Met inhibitors.  Herein, we report ARQ 197 as the first non-ATP-competitive small mol. that selectively targets the c-Met receptor tyrosine kinase.  Exposure to ARQ 197 resulted in the inhibition of proliferation of c-Met-expressing cancer cell lines as well as the induction of caspase-dependent apoptosis in cell lines with constitutive c-Met activity.  These cellular responses to ARQ 197 were phenocopied by RNAi-mediated c-Met depletion and further demonstrated by the growth inhibition of human tumors following oral administration of ARQ 197 in multiple mouse xenograft efficacy studies.  Cumulatively, these data suggest that ARQ 197, currently in phase II clin. trials, is a promising agent for targeting cancers in which c-Met-driven signaling is important for their survival and proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxYa8M1T1wfLVg90H21EOLACvtfcHk0lgVTYZi8LV_mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFGgsL0%253D&md5=2fd9c4ad5be6e1a119f2aa9699bb9519</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1173%26sid%3Dliteratum%253Aachs%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DJeay%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%2BZ.%26aulast%3DChen%26aufirst%3DC.%2BR.%26aulast%3DFrance%26aufirst%3DD.%2BS.%26aulast%3DAshwell%26aufirst%3DM.%2BA.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DMoussa%26aufirst%3DM.%2BM.%26aulast%3DLeggett%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DC.%2BJ.%26atitle%3DARQ%2520197%252C%2520a%2520novel%2520and%2520selective%2520inhibitor%2520of%2520the%2520human%2520c-met%2520receptor%2520tyrosine%2520kinase%2520with%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1544%26epage%3D1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Porter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascon-Simorte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calmiano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Riche, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallemand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyaerts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecomte, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuberson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, M.</span><span> </span><span class="NLM_article-title">Discovery of 4-azaindoles as novel inhibitors of c-Met kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2780</span><span class="NLM_x">–</span> <span class="NLM_lpage">2784</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1016%2Fj.bmcl.2009.03.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=19369077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltl2rsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2780-2784&author=J.+Porterauthor=S.+Lumbauthor=R.+J.+Franklinauthor=J.+M.+Gascon-Simorteauthor=M.+Calmianoauthor=K.+Le+Richeauthor=B.+Lallemandauthor=J.+Keyaertsauthor=H.+Edwardsauthor=A.+Maloneyauthor=J.+Delgadoauthor=L.+Kingauthor=A.+Foleyauthor=F.+Lecomteauthor=J.+Reubersonauthor=C.+Meierauthor=M.+Batchelor&title=Discovery+of+4-azaindoles+as+novel+inhibitors+of+c-Met+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4-azaindoles as novel inhibitors of c-Met kinase</span></div><div class="casAuthors">Porter, John; Lumb, Simon; Franklin, Richard J.; Gascon-Simorte, Jose M.; Calmiano, Mark; Le Riche, Kelly; Lallemand, Benedicte; Keyaerts, Jean; Edwards, Helen; Maloney, Alison; Delgado, Jean; King, Lloyd; Foley, Anne; Lecomte, Fabien; Reuberson, James; Meier, Christoph; Batchelor, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2780-2784</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 4-azaindole inhibitors of c-Met kinase, e.g. I (R1 = H, NH2, CO2H, 1-piperazinyl, etc.; R2 = PhSO2, 2-O2NC6H4SO2, benzofurazan-4-ylsulfonyl, etc.), is described.  The postulated binding mode was confirmed by an X-ray crystal structure of complex of I (R1 = CONH2; R2 = 2-O2NC6H4SO2) with c-Met kinase and series optimization was performed on the basis of this structure.  Future directions for series development are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9V4U2KtkairVg90H21EOLACvtfcHk0lg-4scghL6jTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltl2rsLY%253D&md5=41dac12c5511c2ca5bb33a72704dfb78</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.110%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DJ.%26aulast%3DLumb%26aufirst%3DS.%26aulast%3DFranklin%26aufirst%3DR.%2BJ.%26aulast%3DGascon-Simorte%26aufirst%3DJ.%2BM.%26aulast%3DCalmiano%26aufirst%3DM.%26aulast%3DLe%2BRiche%26aufirst%3DK.%26aulast%3DLallemand%26aufirst%3DB.%26aulast%3DKeyaerts%26aufirst%3DJ.%26aulast%3DEdwards%26aufirst%3DH.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DDelgado%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DL.%26aulast%3DFoley%26aufirst%3DA.%26aulast%3DLecomte%26aufirst%3DF.%26aulast%3DReuberson%26aufirst%3DJ.%26aulast%3DMeier%26aufirst%3DC.%26aulast%3DBatchelor%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25204-azaindoles%2520as%2520novel%2520inhibitors%2520of%2520c-Met%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2780%26epage%3D2784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span> </span><span class="NLM_article-title">Biotransformation reactions of five-membered aromatic heterocyclic rings</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx015574b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=269-299&author=D.+K.+Dalvieauthor=A.+S.+Kalgutkarauthor=S.+C.+Khojasteh-Bakhtauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnell&title=Biotransformation+reactions+of+five-membered+aromatic+heterocyclic+rings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span></div><div class="casAuthors">Dalvie, Deepak K.; Kalgutkar, Amit S.; Khojasteh-Bakht, S. Cyrus; Obach, R. Scott; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-299</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 278 refs. is given on the biotransformation pathways of most commonly used 5-membered arom. heterocyclic rings.  The effect of physicochem. properties such as the electronic effects of heteroatoms, aromaticity, and acidity/basicity (pKa) of the rings are correlated on their biotransformation.  The generation of reactive metabolites following oxidn. or redn. of these heterocycles and the subsequent toxicol. consequences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNaEz19aehbVg90H21EOLACvtfcHk0lg-4scghL6jTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D&md5=e8e2dfd12772f9ff2289b173bdefa590</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Ftx015574b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx015574b%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBiotransformation%2520reactions%2520of%2520five-membered%2520aromatic%2520heterocyclic%2520rings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D269%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">He, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M. Y.</span><span> </span><span class="NLM_article-title">Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1038%2Faps.2013.125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=24241352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitlSktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=89-97&author=C.+X.+Heauthor=J.+Aiauthor=W.+Q.+Xingauthor=Y.+Chenauthor=H.+T.+Zhangauthor=M.+Huangauthor=Y.+H.+Huauthor=J.+Dingauthor=M.+Y.+Geng&title=Yhhu3813+is+a+novel+selective+inhibitor+of+c-Met+kinase+that+inhibits+c-Met-dependent+neoplastic+phenotypes+of+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Yhhu3813 is a novel selective inhibitor of c-Met Kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells</span></div><div class="casAuthors">He, Chang-xi; Ai, Jing; Xing, Wei-qiang; Chen, Yi; Zhang, Hao-tian; Huang, Min; Hu, You-hong; Ding, Jian; Geng, Mei-yu</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aim: c-Met kinase deregulation is strongly assocd. with the formation, progression and dissemination of human cancers.  In this study we identified Yhhu3813 as a small-mol. inhibitor of c-Met kinase and characterized its antitumor properties both in vitro and in vivo.  Methods: The activities of different kinases were measured using ELISA assays and signaling proteins in the cells were detected with Western blotting.  Cell proliferation was assessed using SRB or MTT assay in twenty human cell lines and cell cycle distribution was detd. with flow cytometry.  Transwell-based assay was used to evaluate cell migration and invasion.  Cell invasive growth was detected by a morphogenesis assay. c-Met overactivated human NSCLC cell line EBC-1 xenografts were used to evaluate the in vivo anti-tumor efficacy.  Results: Yhhu3813 potently inhibited c-Met kinase activity in vitro with an IC50 value of 2.4±0.3 nmol/L, >400-fold higher than that for a panel of 15 different tyrosine kinases, suggesting a high selectivity of Yhhu3813.  The compd. (20, 100 and 500 nmol/L) dose-dependently inhibited the phosphorylation of c-Met and its key downstream Akt and Erk signal cascades in multiple c-Met aberrant human cancer cell lines, regardless of the mechanistic complexity in c-Met activation across different cellular contexts.  In 20 human cancer cell lines harboring different backgrounds of c-Met expression/activation, Yhhu3813 potently inhibited c-Met-driven cell proliferation via arresting cells at G1/S phase.  Furthermore, Yhhu3813 substantially impaired c-Met-mediated cell migration, invasion, scattering, and invasive growth.  Oral administration of EBC-1 xenograft mice with Yhhu3813 (50 or 100 mg·kg-1·d-1, qd, for 2 wk) dose-dependently suppressed the tumor growth, which was correlated with a redn. in the intratumoral proliferation index and c-Met signaling.  Conclusion: Yhhu3813 is a potent selective inhibitor of c-Met that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlTbQCB6nXg7Vg90H21EOLACvtfcHk0lg-4scghL6jTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitlSktw%253D%253D&md5=24f843fa996cd92beb20ca8b814fcd77</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Faps.2013.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2013.125%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DC.%2BX.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DXing%26aufirst%3DW.%2BQ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DY.%2BH.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%2BY.%26atitle%3DYhhu3813%2520is%2520a%2520novel%2520selective%2520inhibitor%2520of%2520c-Met%2520kinase%2520that%2520inhibits%2520c-Met-dependent%2520neoplastic%2520phenotypes%2520of%2520human%2520cancer%2520cells%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2014%26volume%3D35%26spage%3D89%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Patil, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macias, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Puebla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Role of Ccclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=253-261&author=M.+A.+Patilauthor=S.+A.+Leeauthor=E.+Maciasauthor=E.+T.+Lamauthor=C.+R.+Xuauthor=K.+D.+Jonesauthor=C.+Hoauthor=M.+Rodriguez-Pueblaauthor=X.+Chen&title=Role+of+Ccclin+D1+as+a+mediator+of+c-Met-+and+beta-catenin-induced+hepatocarcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DM.%2BA.%26aulast%3DLee%26aufirst%3DS.%2BA.%26aulast%3DMacias%26aufirst%3DE.%26aulast%3DLam%26aufirst%3DE.%2BT.%26aulast%3DXu%26aufirst%3DC.%2BR.%26aulast%3DJones%26aufirst%3DK.%2BD.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DRodriguez-Puebla%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DRole%2520of%2520Ccclin%2520D1%2520as%2520a%2520mediator%2520of%2520c-Met-%2520and%2520beta-catenin-induced%2520hepatocarcinogenesis%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D253%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C. H.</span><span> </span><span class="NLM_article-title">Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma</span> <span class="citation_source-journal">Oral Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1114</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1016%2Fj.oraloncology.2012.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=22704061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFCitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=1114-1119&author=Y.+C.+Limauthor=J.+H.+Hanauthor=H.+J.+Kangauthor=Y.+S.+Kimauthor=B.+H.+Leeauthor=E.+C.+Choiauthor=C.+H.+Kim&title=Overexpression+of+c-Met+promotes+invasion+and+metastasis+of+small+oral+tongue+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma</span></div><div class="casAuthors">Lim, Young Chang; Han, Jae Ho; Kang, Hyun Jung; Kim, Young Sook; Lee, Bum Hei; Choi, Eun Chang; Kim, Chul-Ho</div><div class="citationInfo"><span class="NLM_cas:title">Oral Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1114-1119</span>CODEN:
                <span class="NLM_cas:coden">EJCCER</span>;
        ISSN:<span class="NLM_cas:issn">1368-8375</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">C-Met proto-oncogene, which is a receptor of ligand hepatocyte growth factor (HGF), has been assocd. with cancer cell invasion.  There have been no reports on the relationship between the expression of c-Met and tumor invasion and metastasis in small (T1-2) squamous cell carcinoma of the oral tongue (SCCOT).  We analyzed the relationship between c-Met expression and tumor invasion depth and lymph node metastasis in 71 surgically treated patients with small SCCOT using immunohistochem.  Furthermore, we investigated the assocns. between the c-Met expression status and patient survival.  In addn., we explored whether overexpression of c-Met enhances tumor growth and invasion of tongue cancer cells in vitro and in vivo.  Pos. immunohistochem. staining of c-Met was obsd. in 39 (55%) samples.  Presence of neck metastasis, and >4 mm depth of tumor invasion, strongly correlated with c-Met expression in small SCCOT both by the univariate and multivariate anal. (p < .05).  The survival rates with c-Met expression were significantly shorter than for patients without c-Met expression (p < .05).  Constitutive activation of c-Met enhanced migration and invasion of tongue cancer cells in vitro through the expressions of matrix metalloproteinase-1, -2, and -9, and promoted tongue cancer cell growth in vitro and in vivo.  The results support the assocn. of c-Met with the invasiveness and metastasis of small SCCOT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmHuJ5PG_n3LVg90H21EOLACvtfcHk0ljTN1OPIWtSNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFCitLg%253D&md5=51d0d79d6e308d6895cce0b8c41615b6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.oraloncology.2012.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.oraloncology.2012.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DY.%2BC.%26aulast%3DHan%26aufirst%3DJ.%2BH.%26aulast%3DKang%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DChoi%26aufirst%3DE.%2BC.%26aulast%3DKim%26aufirst%3DC.%2BH.%26atitle%3DOverexpression%2520of%2520c-Met%2520promotes%2520invasion%2520and%2520metastasis%2520of%2520small%2520oral%2520tongue%2520carcinoma%26jtitle%3DOral%2520Oncol.%26date%3D2012%26volume%3D48%26spage%3D1114%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M. Y.</span><span> </span><span class="NLM_article-title">SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1016%2Fj.canlet.2014.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=24880078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVejtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=143-150&author=L.+Wangauthor=J.+Aiauthor=Y.+Y.+Shenauthor=H.+T.+Zhangauthor=X.+Pengauthor=M.+Huangauthor=A.+Zhangauthor=J.+Dingauthor=M.+Y.+Geng&title=SOMCL-863%2C+a+novel%2C+selective+and+orally+bioavailable+small-molecule+c-Met+inhibitor%2C+exhibits+antitumor+activity+both+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo</span></div><div class="casAuthors">Wang, Lu; Ai, Jing; Shen, Yanyan; Zhang, Haotian; Peng, Xia; Huang, Min; Zhang, Ao; Ding, Jian; Geng, Meiyu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">143-150</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Deregulation of HGF/c-Met signaling and its driven neoplastic phenotype are assocd. with a variety of human malignancies.  We herein reported SOMCL-863 as a novel selective c-Met inhibitor which effectively abrogated c-Met signaling pathways, thereby leading to substantial impairment of c-Met-dependent cell proliferation, migration, invasion, cell scattering and invasive growth.  In EBC-1 and NCI-H1993 xenografts, SOMCL-863 exerted significant anti-tumor efficacy through anti-proliferative effects and antiangiogenic mechanisms, including redn. of tumor cell proliferation and redns. of microvessel d. and secretion of proangiogenic factor IL-8.  Together with the optimal pharmacokinetic properties, SOMCL-863 is a promising candidate worthy for further evaluation as a treatment of c-Met-driven human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSI82XfAkPNLVg90H21EOLACvtfcHk0ljTN1OPIWtSNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVejtL0%253D&md5=eb872a6784e3a2c2349feed61195d83c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DY.%2BY.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%2BY.%26atitle%3DSOMCL-863%252C%2520a%2520novel%252C%2520selective%2520and%2520orally%2520bioavailable%2520small-molecule%2520c-Met%2520inhibitor%252C%2520exhibits%2520antitumor%2520activity%2520both%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D351%26spage%3D143%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Horm, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitler, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broka, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louderbough, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, J. A.</span><span> </span><span class="NLM_article-title">MUC1 drives c-Met-dependent migration and scattering</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1544</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1158%2F1541-7786.MCR-12-0296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=23193156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyns7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=1544-1554&author=T.+M.+Hormauthor=B.+G.+Bitlerauthor=D.+M.+Brokaauthor=J.+M.+Louderboughauthor=J.+A.+Schroeder&title=MUC1+drives+c-Met-dependent+migration+and+scattering"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">MUC1 Drives c-Met-Dependent Migration and Scattering</span></div><div class="casAuthors">Horm, Teresa M.; Bitler, Benjamin G.; Broka, Derrick M.; Louderbough, Jeanne M.; Schroeder, Joyce A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1544-1554</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The transmembrane mucin MUC1 is overexpressed in most ductal carcinomas, and its overexpression is frequently assocd. with metastatic progression.  MUC1 can drive tumor initiation and progression via interactions with many oncogenic partners, including β-catenin, the EGF receptor (EGFR) and Src.  The decoy peptide protein transduction domain MUC1 inhibitory peptide (PMIP) has been shown to inhibit the tumor promoting activities of MUC1 in breast and lung cancer, including cell growth and invasion, and its usage suppresses metastatic progression in mouse models of breast cancer.  To further characterize the reduced metastasis obsd. upon PMIP treatment, we conducted motility assays and obsd. that PMIP inhibits cell motility of breast cancer cells.  To det. the mechanism by which PMIP inhibits motility, we evaluated changes in global gene transcription upon PMIP treatment, and identified a no. of genes with altered expression in response to PMIP.  Among these genes is the metastatic mediator, c-Met, a transmembrane tyrosine kinase that can promote cell scattering, migration, and invasion.  To further investigate the role of c-Met in MUC1-dependent metastatic events, we evaluated the effects of MUC1 expression and EGFR activation on breast cancer cell scattering, branching, and migration.  We found that MUC1 strongly promoted all of these events and this effect was further amplified by EGF treatment.  Importantly, the effect of MUC1 and EGF on these phenotypes was dependent upon c-Met activity.  Overall, these results indicate that PMIP can block the expression of a key metastatic mediator, further advancing its potential use as a clin. therapeutic.  Mol Cancer Res; 10(12); 1544-54. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA7km5ZMahs7Vg90H21EOLACvtfcHk0ljTN1OPIWtSNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyns7bN&md5=2d9932d3da7601556e6d5e5ae4febb3a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-12-0296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-12-0296%26sid%3Dliteratum%253Aachs%26aulast%3DHorm%26aufirst%3DT.%2BM.%26aulast%3DBitler%26aufirst%3DB.%2BG.%26aulast%3DBroka%26aufirst%3DD.%2BM.%26aulast%3DLouderbough%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DJ.%2BA.%26atitle%3DMUC1%2520drives%2520c-Met-dependent%2520migration%2520and%2520scattering%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2012%26volume%3D10%26spage%3D1544%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Boccaccio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">Invasive growth: a MET-driven genetic programme for cancer and stem cells</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1038%2Fnrc1912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=16862193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFGlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=637-645&author=C.+Boccaccioauthor=P.+M.+Comoglio&title=Invasive+growth%3A+a+MET-driven+genetic+programme+for+cancer+and+stem+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Invasive growth: a MET-driven genetic programme for cancer and stem cells</span></div><div class="casAuthors">Boccaccio, Carla; Comoglio, Paolo M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">637-645</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Metastasis follows the inappropriate activation of a genetic program termed invasive growth, which is a physiol. process that occurs during embryonic development and post-natal organ regeneration.  Burgeoning evidence indicates that invasive growth is also executed by stem and progenitor cells, and is usurped by cancer stem cells.  The MET proto-oncogene, which is expressed in both stem and cancer cells, is a key regulator of invasive growth.  Recent findings indicate that the MET tyrosine-kinase receptor is a sensor of adverse microenvironmental conditions (such as hypoxia) and drives cell invasion and metastasis through the transcriptional activation of a set of genes that control blood coagulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrNb2dfp5v27Vg90H21EOLACvtfcHk0lje9gDHU3V81w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFGlu70%253D&md5=79319c46d57d395726d389e6cd03068f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnrc1912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1912%26sid%3Dliteratum%253Aachs%26aulast%3DBoccaccio%26aufirst%3DC.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DInvasive%2520growth%253A%2520a%2520MET-driven%2520genetic%2520programme%2520for%2520cancer%2520and%2520stem%2520cells%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D637%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Direnzo, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chastre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirossay, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordlinger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plebani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gespach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">Overexpression and amplification of the Met/Hgf receptor gene during the progression of colorectal-cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=9815967" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=147-154&author=M.+F.+Direnzoauthor=M.+Oliveroauthor=A.+Giacominiauthor=H.+Porteauthor=E.+Chastreauthor=L.+Mirossayauthor=B.+Nordlingerauthor=S.+Brettiauthor=S.+Bottardiauthor=S.+Giordanoauthor=M.+Plebaniauthor=C.+Gespachauthor=P.+M.+Comoglio&title=Overexpression+and+amplification+of+the+Met%2FHgf+receptor+gene+during+the+progression+of+colorectal-cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDirenzo%26aufirst%3DM.%2BF.%26aulast%3DOlivero%26aufirst%3DM.%26aulast%3DGiacomini%26aufirst%3DA.%26aulast%3DPorte%26aufirst%3DH.%26aulast%3DChastre%26aufirst%3DE.%26aulast%3DMirossay%26aufirst%3DL.%26aulast%3DNordlinger%26aufirst%3DB.%26aulast%3DBretti%26aufirst%3DS.%26aulast%3DBottardi%26aufirst%3DS.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DPlebani%26aufirst%3DM.%26aulast%3DGespach%26aufirst%3DC.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DOverexpression%2520and%2520amplification%2520of%2520the%2520Met%252FHgf%2520receptor%2520gene%2520during%2520the%2520progression%2520of%2520colorectal-cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1995%26volume%3D1%26spage%3D147%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span> </span><span class="NLM_article-title">An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4408</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1158%2F0008-5472.CAN-06-4443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=17483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4408-17&author=H.+Y.+Zouauthor=Q.+Liauthor=J.+H.+Leeauthor=M.+E.+Arangoauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=T.+B.+Koudriakovaauthor=G.+Altonauthor=J.+J.+Cuiauthor=P.+P.+Kungauthor=M.+D.+Nambuauthor=G.+Losauthor=S.+L.+Benderauthor=B.+Mroczkowskiauthor=J.+G.+Christensen&title=An+orally+available+small-molecule+inhibitor+of+c-Met%2C+PF-2341066%2C+exhibits+cytoreductive+antitumor+efficacy+through+antiproliferative+and+antiangiogenic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms</span></div><div class="casAuthors">Zou, Helen Y.; Li, Qiuhua; Lee, Joseph H.; Arango, Maria E.; McDonnell, Scott R.; Yamazaki, Shinji; Koudriakova, Tatiana B.; Alton, Gordon; Cui, Jingrong J.; Kung, Pei-Pei; Nambu, Mitchell D.; Los, Gerrit; Bender, Steven L.; Mroczkowski, Barbara; Christensen, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4408-4417</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), have been implicated in the progression of several human cancers and are attractive therapeutic targets.  PF-2341066 was identified as a potent, orally bioavailable, ATP-competitive small-mol. inhibitor of the catalytic activity of c-Met kinase.  PF-2341066 was selective for c-Met (and anaplastic lymphoma kinase) compared with a panel of >120 diverse tyrosine and serine-threonine kinases.  PF-2341066 potently inhibited c-Met phosphorylation and c-Met-dependent proliferation, migration, or invasion of human tumor cells in vitro (IC50 values, 5-20 nmol/L).  In addn., PF-2341066 potently inhibited HGF-stimulated endothelial cell survival or invasion and serum-stimulated tubulogenesis in vitro, suggesting that this agent also exhibits antiangiogenic properties.  PF-2341066 showed efficacy at well-tolerated doses, including marked cytoreductive antitumor activity, in several tumor models that expressed activated c-Met.  The antitumor efficacy of PF-2341066 was dose dependent and showed a strong correlation to inhibition of c-Met phosphorylation in vivo.  Near-maximal inhibition of c-Met activity for the full dosing interval was necessary to maximize the efficacy of PF-2341066.  Addnl. mechanism-of-action studies showed dose-dependent inhibition of c-Met-dependent signal transduction, tumor cell proliferation (Ki67), induction of apoptosis (caspase-3), and redn. of microvessel d. (CD31).  These results indicated that the antitumor activity of PF-2341066 may be mediated by direct effects on tumor cell growth or survival as well as antiangiogenic mechanisms.  Collectively, these results show the therapeutic potential of targeting c-Met with selective small-mol. inhibitors for the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEAWtGPOBHC7Vg90H21EOLACvtfcHk0lje9gDHU3V81w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D&md5=798bf93e6cf8d5e9897e27485cba9002</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4443%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DKoudriakova%26aufirst%3DT.%2BB.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%2BL.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DAn%2520orally%2520available%2520small-molecule%2520inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520exhibits%2520cytoreductive%2520antitumor%2520efficacy%2520through%2520antiproliferative%2520and%2520antiangiogenic%2520mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4408%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Zillhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengyel, E.</span><span> </span><span class="NLM_article-title">An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1-10&author=M.+Zillhardtauthor=J.+G.+Christensenauthor=E.+Lengyel&title=An+orally+available+small-molecule+inhibitor+of+c-Met%2C+PF-2341066%2C+reduces+tumor+burden+and+metastasis+in+a+preclinical+model+of+ovarian+cancer+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZillhardt%26aufirst%3DM.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DLengyel%26aufirst%3DE.%26atitle%3DAn%2520orally%2520available%2520small-molecule%2520inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520reduces%2520tumor%2520burden%2520and%2520metastasis%2520in%2520a%2520preclinical%2520model%2520of%2520ovarian%2520cancer%2520metastasis%26jtitle%3DNeoplasia%26date%3D2010%26volume%3D12%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 31 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenzhou  Hao</span>, <span class="hlFld-ContribAuthor ">Fan  Zhao</span>, <span class="hlFld-ContribAuthor ">Hongyan  Song</span>, <span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Li</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Jiang</span>, <span class="hlFld-ContribAuthor ">Ran  Huan</span>, <span class="hlFld-ContribAuthor ">Shuai  Song</span>, <span class="hlFld-ContribAuthor ">Qiaoling  Zhang</span>, <span class="hlFld-ContribAuthor ">Ruifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Pang</span>, <span class="hlFld-ContribAuthor ">Tongchao  Liu</span>, <span class="hlFld-ContribAuthor ">Tianqi  Lu</span>, <span class="hlFld-ContribAuthor ">Wanxu  Huang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Bin  Lin</span>, <span class="hlFld-ContribAuthor ">Zhonggui  He</span>, <span class="hlFld-ContribAuthor ">Haitao  Li</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>, and <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives as Potent and Selective p21-Activated Kinase 4 (PAK4) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (1)
                                     , 265-285. <a href="https://doi.org/10.1021/acs.jmedchem.7b01342" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01342%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252B6-Chloro-4-aminoquinazoline-2-carboxamide%252BDerivatives%252Bas%252BPotent%252Band%252BSelective%252Bp21-Activated%252BKinase%252B4%252B%252528PAK4%252529%252BInhibitors%26aulast%3DHao%26aufirst%3DChenzhou%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D09092017%26date%3D30122017%26date%3D11012018%26date%3D30112017%26volume%3D61%26issue%3D1%26spage%3D265%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoki  Katsuki</span>, <span class="hlFld-ContribAuthor ">Shumpei  Isshiki</span>, <span class="hlFld-ContribAuthor ">Daisuke  Fukatsu</span>, <span class="hlFld-ContribAuthor ">Juan  Okamura</span>, <span class="hlFld-ContribAuthor ">Kouji  Kuramochi</span>, <span class="hlFld-ContribAuthor ">Takeo  Kawabata</span>, and <span class="hlFld-ContribAuthor ">Kazunori  Tsubaki</span>  . </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of Dendrochrysanene through a Frame Rearrangement. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (21)
                                     , 11573-11584. <a href="https://doi.org/10.1021/acs.joc.7b02223" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02223%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTotal%252BSynthesis%252Bof%252BDendrochrysanene%252Bthrough%252Ba%252BFrame%252BRearrangement%26aulast%3DKatsuki%26aufirst%3DNaoki%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04092017%26date%3D13102017%26date%3D03112017%26date%3D02102017%26volume%3D82%26issue%3D21%26spage%3D11573%26epage%3D11584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Micael R.  Cunha</span>, <span class="hlFld-ContribAuthor ">Maurício T.  Tavares</span>, <span class="hlFld-ContribAuthor ">Camila F.  Carvalho</span>, <span class="hlFld-ContribAuthor ">Nuno A. T.  Silva</span>, <span class="hlFld-ContribAuthor ">Alfredo D. F.  Souza</span>, <span class="hlFld-ContribAuthor ">Gustavo J. V.  Pereira</span>, <span class="hlFld-ContribAuthor ">Fábio F.  Ferreira</span>, and <span class="hlFld-ContribAuthor ">Roberto  Parise-Filho</span>  . </span><span class="cited-content_cbyCitation_article-title">Environmentally Safe Condition for the Synthesis of Aryl and Alkyl Sulfonyl Hydrazones via One-Pot Reaction. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2016,</strong> <em>4 </em>
                                    (4)
                                     , 1899-1905. <a href="https://doi.org/10.1021/acssuschemeng.6b00193" title="DOI URL">https://doi.org/10.1021/acssuschemeng.6b00193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.6b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.6b00193%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DEnvironmentally%252BSafe%252BCondition%252Bfor%252Bthe%252BSynthesis%252Bof%252BAryl%252Band%252BAlkyl%252BSulfonyl%252BHydrazones%252Bvia%252BOne-Pot%252BReaction%26aulast%3DCunha%26aufirst%3DMicael%2BR.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28012016%26date%3D29022016%26date%3D07032016%26date%3D04042016%26date%3D03032016%26volume%3D4%26issue%3D4%26spage%3D1899%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irina V.  Rassokhina</span>, <span class="hlFld-ContribAuthor ">Valerii Z.  Shirinian</span>, <span class="hlFld-ContribAuthor ">Igor V.  Zavarzin</span>, <span class="hlFld-ContribAuthor ">Vladimir  Gevorgyan</span>, and <span class="hlFld-ContribAuthor ">Yulia A.  Volkova</span>  . </span><span class="cited-content_cbyCitation_article-title">Copper(II)-Mediated Aerobic Synthesis of Imidazo[1,2-a]pyridines via Cascade Aminomethylation/Cycloisomerization of Alkynes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (21)
                                     , 11212-11218. <a href="https://doi.org/10.1021/acs.joc.5b02102" title="DOI URL">https://doi.org/10.1021/acs.joc.5b02102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b02102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b02102%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper%252528II%252529-Mediated%252BAerobic%252BSynthesis%252Bof%252BImidazo%25255B1%25252C2-a%25255Dpyridines%252Bvia%252BCascade%252BAminomethylation%25252FCycloisomerization%252Bof%252BAlkynes%26aulast%3DRassokhina%26aufirst%3DIrina%2BV.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D08092015%26date%3D21102015%26date%3D06112015%26date%3D12102015%26volume%3D80%26issue%3D21%26spage%3D11212%26epage%3D11218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiuyao  Huang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhong</span>, <span class="hlFld-ContribAuthor ">Bingbing  Li</span>, <span class="hlFld-ContribAuthor ">Shumin  Ouyang</span>, <span class="hlFld-ContribAuthor ">Lin  Deng</span>, <span class="hlFld-ContribAuthor ">Jianshan  Mo</span>, <span class="hlFld-ContribAuthor ">Shuo  Shi</span>, <span class="hlFld-ContribAuthor ">Nan  Lv</span>, <span class="hlFld-ContribAuthor ">Ruibo  Wu</span>, <span class="hlFld-ContribAuthor ">Peiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Wenhao  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuanxiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113525. <a href="https://doi.org/10.1016/j.ejmech.2021.113525" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113525%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdiscovery%252Bof%252Bpotent%252Band%252Bselective%252Bsmall-molecule%252Binhibitors%252Btargeting%252Bsignal%252Btransducer%252Band%252Bactivator%252Bof%252Btranscription%252B3%252B%252528STAT3%252529%26aulast%3DHuang%26aufirst%3DQiuyao%26date%3D2021%26volume%3D221%26spage%3D113525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lu  Yu</span>, <span class="hlFld-ContribAuthor ">Jiyan  Chi</span>, <span class="hlFld-ContribAuthor ">Lingling  Xiao</span>, <span class="hlFld-ContribAuthor ">Jie  Li</span>, <span class="hlFld-ContribAuthor ">Zhangfei  Tang</span>, <span class="hlFld-ContribAuthor ">Shuming  Tan</span>, <span class="hlFld-ContribAuthor ">Pei  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Thiochromanone Derivatives Containing a Sulfonyl Hydrazone Moiety: Design, Synthesis, and Bioactivity Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (10)
                                     , 2925. <a href="https://doi.org/10.3390/molecules26102925" title="DOI URL">https://doi.org/10.3390/molecules26102925</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26102925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26102925%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNovel%252BThiochromanone%252BDerivatives%252BContaining%252Ba%252BSulfonyl%252BHydrazone%252BMoiety%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBioactivity%252BEvaluation%26aulast%3DYu%26aufirst%3DLu%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D10%26spage%3D2925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatemeh  Moosavi</span>, <span class="hlFld-ContribAuthor ">Ahmad  Ebadi</span>, <span class="hlFld-ContribAuthor ">Maryam  Mohabbati</span>, <span class="hlFld-ContribAuthor ">Tahereh  Damghani</span>, <span class="hlFld-ContribAuthor ">Motahareh  Mortazavi</span>, <span class="hlFld-ContribAuthor ">Ramin  Miri</span>, <span class="hlFld-ContribAuthor ">Omidreza  Firuzi</span>. </span><span class="cited-content_cbyCitation_article-title">Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3,4-dihydropyrimidin-2(1H)-one C5 amide derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2021,</strong> <em>894 </em>, 173850. <a href="https://doi.org/10.1016/j.ejphar.2021.173850" title="DOI URL">https://doi.org/10.1016/j.ejphar.2021.173850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2021.173850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2021.173850%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DAntiproliferative%252Beffect%25252C%252Balteration%252Bof%252Bcancer%252Bcell%252Bcycle%252Bprogression%252Band%252Bpotential%252BMET%252Bkinase%252Binhibition%252Binduced%252Bby%252B3%25252C4-dihydropyrimidin-2%2525281H%252529-one%252BC5%252Bamide%252Bderivatives%26aulast%3DMoosavi%26aufirst%3DFatemeh%26date%3D2021%26volume%3D894%26spage%3D173850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imtiaz  Khan</span>, <span class="hlFld-ContribAuthor ">Aliya  Ibrar</span>, <span class="hlFld-ContribAuthor ">Sumera  Zaib</span>. </span><span class="cited-content_cbyCitation_article-title">Alkynoates as Versatile and Powerful Chemical Tools for the Rapid Assembly of Diverse Heterocycles under Transition-Metal Catalysis: Recent Developments and Challenges. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2021,</strong> <em>379 </em>
                                    (1)
                                     <a href="https://doi.org/10.1007/s41061-020-00316-4" title="DOI URL">https://doi.org/10.1007/s41061-020-00316-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-020-00316-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-020-00316-4%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DAlkynoates%252Bas%252BVersatile%252Band%252BPowerful%252BChemical%252BTools%252Bfor%252Bthe%252BRapid%252BAssembly%252Bof%252BDiverse%252BHeterocycles%252Bunder%252BTransition-Metal%252BCatalysis%25253A%252BRecent%252BDevelopments%252Band%252BChallenges%26aulast%3DKhan%26aufirst%3DImtiaz%26date%3D2021%26date%3D2021%26volume%3D379%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Yang</span>, <span class="hlFld-ContribAuthor ">Jian-Qiong  Yang</span>, <span class="hlFld-ContribAuthor ">Shi-He  Luo</span>, <span class="hlFld-ContribAuthor ">Wen-Jie  Mei</span>, <span class="hlFld-ContribAuthor ">Jian-Yun  Lin</span>, <span class="hlFld-ContribAuthor ">Jia-Qi  Zhan</span>, <span class="hlFld-ContribAuthor ">Zhao-Yang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of N-2(5H)-furanonyl sulfonyl hydrazone derivatives and their biological evaluation in vitro and in vivo activity against MCF-7 breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>107 </em>, 104518. <a href="https://doi.org/10.1016/j.bioorg.2020.104518" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104518%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BN-2%2525285H%252529-furanonyl%252Bsulfonyl%252Bhydrazone%252Bderivatives%252Band%252Btheir%252Bbiological%252Bevaluation%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bactivity%252Bagainst%252BMCF-7%252Bbreast%252Bcancer%252Bcells%26aulast%3DYang%26aufirst%3DKai%26date%3D2021%26volume%3D107%26spage%3D104518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janos  Sapi</span>, <span class="hlFld-ContribAuthor ">Stéphane  Gérard</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems: Three Heteroatoms 2:1. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00021-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00021-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00021-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00021-4%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%25253A%252BThree%252BHeteroatoms%252B2%25253A1%26aulast%3DSapi%26aufirst%3DJanos%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%252010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng-Tao  Liu</span>, <span class="hlFld-ContribAuthor ">Nian-Guang  Li</span>, <span class="hlFld-ContribAuthor ">Yan-Min  Zhang</span>, <span class="hlFld-ContribAuthor ">Wu-Chen  Xie</span>, <span class="hlFld-ContribAuthor ">Si-Ping  Yang</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Zhi-Hao  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advance in the development of novel, selective and potent FGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>186 </em>, 111884. <a href="https://doi.org/10.1016/j.ejmech.2019.111884" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111884</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111884%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvance%252Bin%252Bthe%252Bdevelopment%252Bof%252Bnovel%25252C%252Bselective%252Band%252Bpotent%252BFGFR%252Binhibitors%26aulast%3DLiu%26aufirst%3DFeng-Tao%26date%3D2020%26volume%3D186%26spage%3D111884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vegard Torp  Lien</span>, <span class="hlFld-ContribAuthor ">Margrethe Konstanse  Kristiansen</span>, <span class="hlFld-ContribAuthor ">Solveig  Pettersen</span>, <span class="hlFld-ContribAuthor ">Mads Haugland  Haugen</span>, <span class="hlFld-ContribAuthor ">Dag Erlend  Olberg</span>, <span class="hlFld-ContribAuthor ">Jo  Waaler</span>, <span class="hlFld-ContribAuthor ">Jo  Klaveness</span>. </span><span class="cited-content_cbyCitation_article-title">Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (63)
                                     , 37092-37100. <a href="https://doi.org/10.1039/C9RA08954C" title="DOI URL">https://doi.org/10.1039/C9RA08954C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA08954C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA08954C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DTowards%252Bdual%252Binhibitors%252Bof%252Bthe%252BMET%252Bkinase%252Band%252BWNT%252Bsignaling%252Bpathway%25253B%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DLien%26aufirst%3DVegard%2BTorp%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D63%26spage%3D37092%26epage%3D37100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyi  Jiang</span>, <span class="hlFld-ContribAuthor ">Ji  Yu</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design opportunities presented by solvent‐exposed regions of target proteins. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (6)
                                     , 2194-2238. <a href="https://doi.org/10.1002/med.21581" title="DOI URL">https://doi.org/10.1002/med.21581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21581%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMolecular%252Bdesign%252Bopportunities%252Bpresented%252Bby%252Bsolvent%2525E2%252580%252590exposed%252Bregions%252Bof%252Btarget%252Bproteins%26aulast%3DJiang%26aufirst%3DXiangyi%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D2194%26epage%3D2238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng-Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Yu-Shun  Yang</span>, <span class="hlFld-ContribAuthor ">Zhong-Chang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Development of Small Molecule c-Met Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (15)
                                     , 1276-1288. <a href="https://doi.org/10.2174/1568026619666190712205353" title="DOI URL">https://doi.org/10.2174/1568026619666190712205353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190712205353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190712205353%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BDevelopment%252Bof%252BSmall%252BMolecule%252Bc-Met%252BInhibitors%26aulast%3DLv%26aufirst%3DPeng-Cheng%26date%3D2019%26volume%3D19%26issue%3D15%26spage%3D1276%26epage%3D1288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Ning</span>, <span class="hlFld-ContribAuthor ">Xinwei  He</span>, <span class="hlFld-ContribAuthor ">Youpeng  Zuo</span>, <span class="hlFld-ContribAuthor ">Panyuan  Cai</span>, <span class="hlFld-ContribAuthor ">Mengqing  Xie</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Yongjia  Shang</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium(II) Acetate‐Catalysed Cyclization of Pyrazol‐5‐amine and 1,3‐Diketone‐2‐diazo Compounds Using
              N
              ,
              N
              ‐Dimethylformamide as a Carbon‐Hydrogen Source: Access to Pyrazolo[3,4‐
              b
              ]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (15)
                                     , 3518-3524. <a href="https://doi.org/10.1002/adsc.201900093" title="DOI URL">https://doi.org/10.1002/adsc.201900093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201900093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201900093%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DRhodium%252528II%252529%252BAcetate%2525E2%252580%252590Catalysed%252BCyclization%252Bof%252BPyrazol%2525E2%252580%2525905%2525E2%252580%252590amine%252Band%252B1%25252C3%2525E2%252580%252590Diketone%2525E2%252580%2525902%2525E2%252580%252590diazo%252BCompounds%252BUsing%252BN%252B%25252C%252BN%252B%2525E2%252580%252590Dimethylformamide%252Bas%252Ba%252BCarbon%2525E2%252580%252590Hydrogen%252BSource%25253A%252BAccess%252Bto%252BPyrazolo%25255B3%25252C4%2525E2%252580%252590%252Bb%252B%25255Dpyridines%26aulast%3DNing%26aufirst%3DYi%26date%3D2019%26date%3D2019%26volume%3D361%26issue%3D15%26spage%3D3518%26epage%3D3524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sakineh  Dadashpour</span>, <span class="hlFld-ContribAuthor ">Tuba Tüylü  Küçükkılınç</span>, <span class="hlFld-ContribAuthor ">Beyza  Ayazgök</span>, <span class="hlFld-ContribAuthor ">Seyed Jalal  Hosseinimehr</span>, <span class="hlFld-ContribAuthor ">Ann M  Chippindale</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>, <span class="hlFld-ContribAuthor ">Hamid  Irannejad</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 1,2,4-triazolo-1,2,4-triazines with thiomethylpyridine hinge binders as potent c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (10)
                                     , 1119-1136. <a href="https://doi.org/10.4155/fmc-2018-0412" title="DOI URL">https://doi.org/10.4155/fmc-2018-0412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0412%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252B1%25252C2%25252C4-triazolo-1%25252C2%25252C4-triazines%252Bwith%252Bthiomethylpyridine%252Bhinge%252Bbinders%252Bas%252Bpotent%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DDadashpour%26aufirst%3DSakineh%26date%3D2019%26volume%3D11%26issue%3D10%26spage%3D1119%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Gang  Sun</span>, <span class="hlFld-ContribAuthor ">Yong-An  Yang</span>, <span class="hlFld-ContribAuthor ">Zhi-Gang  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization techniques for novel c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (1)
                                     , 59-69. <a href="https://doi.org/10.1080/17460441.2019.1551355" title="DOI URL">https://doi.org/10.1080/17460441.2019.1551355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1551355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1551355%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DOptimization%252Btechniques%252Bfor%252Bnovel%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DSun%26aufirst%3DZhi-Gang%26date%3D2019%26date%3D2018%26volume%3D14%26issue%3D1%26spage%3D59%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandrakant D.  Pawar</span>, <span class="hlFld-ContribAuthor ">Aniket P.  Sarkate</span>, <span class="hlFld-ContribAuthor ">Kshipra S.  Karnik</span>, <span class="hlFld-ContribAuthor ">Devanand B.  Shinde</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium Catalyzed Tricyclohexylphosphine Ligand Associated Synthesis of
              N
              -(2-(pyridine-4-yl)-1
              H
              -pyrrolo[3,2-
              c
              ]-pyridin-6-yl-(substituted)-sulfonamide Derivatives as Antiproliferative Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2018,</strong> <em>55 </em>
                                    (7)
                                     , 1695-1701. <a href="https://doi.org/10.1002/jhet.3206" title="DOI URL">https://doi.org/10.1002/jhet.3206</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3206%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DPalladium%252BCatalyzed%252BTricyclohexylphosphine%252BLigand%252BAssociated%252BSynthesis%252Bof%252BN%252B-%2525282-%252528pyridine-4-yl%252529-1%252BH%252B-pyrrolo%25255B3%25252C2-%252Bc%252B%25255D-pyridin-6-yl-%252528substituted%252529-sulfonamide%252BDerivatives%252Bas%252BAntiproliferative%252BAgents%26aulast%3DPawar%26aufirst%3DChandrakant%2BD.%26date%3D2018%26date%3D2018%26volume%3D55%26issue%3D7%26spage%3D1695%26epage%3D1701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Beichen  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>150 </em>, 809-816. <a href="https://doi.org/10.1016/j.ejmech.2018.03.049" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.049%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B3%25252C4-b%25255D%25255B1%25252C3%25252C4%25255Dthiadiazole%252Bderivatives%252Bas%252Bnovel%25252C%252Bpotent%252Band%252Bselective%252Bc-Met%252Bkinase%252Binhibitors%25253A%252BSynthesis%25252C%252BSAR%252Bstudy%25252C%252Band%252Bbiological%252Bactivity%26aulast%3DZhang%26aufirst%3DLi%26date%3D2018%26volume%3D150%26spage%3D809%26epage%3D816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Yinchun  Ji</span>, <span class="hlFld-ContribAuthor ">Yong  Xi</span>, <span class="hlFld-ContribAuthor ">Yanyan  Shen</span>, <span class="hlFld-ContribAuthor ">Xinying  Yang</span>, <span class="hlFld-ContribAuthor ">Yi  Su</span>, <span class="hlFld-ContribAuthor ">Yiming  Sun</span>, <span class="hlFld-ContribAuthor ">Yinglei  Gao</span>, <span class="hlFld-ContribAuthor ">Yuchi  Ma</span>, <span class="hlFld-ContribAuthor ">Bing  Xiong</span>, <span class="hlFld-ContribAuthor ">Jingkang  Shen</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (4)
                                     , 751-762. <a href="https://doi.org/10.1158/1535-7163.MCT-17-0368" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-17-0368</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-17-0368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-17-0368%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DPreclinical%252BEvaluation%252Bof%252BSCC244%252B%252528Glumetinib%252529%25252C%252Ba%252BNovel%25252C%252BPotent%25252C%252Band%252BHighly%252BSelective%252BInhibitor%252Bof%252Bc-Met%252Bin%252BMET-dependent%252BCancer%252BModels%26aulast%3DAi%26aufirst%3DJing%26date%3D2018%26date%3D2017%26volume%3D17%26issue%3D4%26spage%3D751%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Bicyclic Pyridines Containing Ring-Junction Nitrogen. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 481-535. <a href="https://doi.org/10.1002/9781118686263.ch13" title="DOI URL">https://doi.org/10.1002/9781118686263.ch13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch13%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252BPyridines%252BContaining%252BRing-Junction%252BNitrogen%26date%3D2018%26date%3D2018%26spage%3D481%26epage%3D535%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan  Jiang</span>, <span class="hlFld-ContribAuthor ">Qiufeng  Liu</span>, <span class="hlFld-ContribAuthor ">Ruifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Peng  Wei</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Yechun  Xu</span>, <span class="hlFld-ContribAuthor ">Yuchi  Ma</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Jingkang  Shen</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Bing  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of a Series of 5H-Pyrrolo[2,3-b]pyrazine FGFR Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (3)
                                     , 698. <a href="https://doi.org/10.3390/molecules23030698" title="DOI URL">https://doi.org/10.3390/molecules23030698</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23030698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23030698%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructure-Based%252BDiscovery%252Bof%252Ba%252BSeries%252Bof%252B5H-Pyrrolo%25255B2%25252C3-b%25255Dpyrazine%252BFGFR%252BKinase%252BInhibitors%26aulast%3DJiang%26aufirst%3DAlan%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D3%26spage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frédéric  Buron</span>, <span class="hlFld-ContribAuthor ">Marie-Aude  Hiebel</span>, <span class="hlFld-ContribAuthor ">Jean-Yves  Mérour</span>, <span class="hlFld-ContribAuthor ">Karen  Plé</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">The Chemistry of Sulfur-Containing [5,5]-Fused Ring Systems With a Bridgehead Nitrogen. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 301-356. <a href="https://doi.org/10.1016/bs.aihch.2017.10.003" title="DOI URL">https://doi.org/10.1016/bs.aihch.2017.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2017.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2017.10.003%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BChemistry%252Bof%252BSulfur-Containing%252B%25255B5%25252C5%25255D-Fused%252BRing%252BSystems%252BWith%252Ba%252BBridgehead%252BNitrogen%26aulast%3DBuron%26aufirst%3DFr%25C3%25A9d%25C3%25A9ric%26date%3D2018%26spage%3D301%26epage%3D356%26pub%3DElsevier%26date%3D2018%26volume%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Palak K.  Parikh</span>, <span class="hlFld-ContribAuthor ">Manjunath D.  Ghate</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the discovery of small molecule c-Met Kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 1103-1138. <a href="https://doi.org/10.1016/j.ejmech.2017.08.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bsmall%252Bmolecule%252Bc-Met%252BKinase%252Binhibitors%26aulast%3DParikh%26aufirst%3DPalak%2BK.%26date%3D2018%26volume%3D143%26spage%3D1103%26epage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Beichen  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Yanle  Zhi</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, synthesis, and evaluation of 4,5,6,7-tetrahydro-1 H -pyrazolo[4,3-c]pyridine derivatives as novel c-Met inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>138 </em>, 942-951. <a href="https://doi.org/10.1016/j.ejmech.2017.06.057" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.06.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.06.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.06.057%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252B4%25252C5%25252C6%25252C7-tetrahydro-1%252BH%252B-pyrazolo%25255B4%25252C3-c%25255Dpyridine%252Bderivatives%252Bas%252Bnovel%252Bc-Met%252Binhibitors%26aulast%3DZhang%26aufirst%3DLi%26date%3D2017%26volume%3D138%26spage%3D942%26epage%3D951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weijie  Gu</span>, <span class="hlFld-ContribAuthor ">Yuxuan  Dai</span>, <span class="hlFld-ContribAuthor ">Hao  Qiang</span>, <span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Chen  Liao</span>, <span class="hlFld-ContribAuthor ">Fangnuo  Zhao</span>, <span class="hlFld-ContribAuthor ">Wenlong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 2-substituted-4-(2-fluorophenoxy) pyridine derivatives possessing pyrazolone and triazole moieties as dual c-Met/VEGFR-2 receptor tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2017,</strong> <em>72 </em>, 116-122. <a href="https://doi.org/10.1016/j.bioorg.2017.04.001" title="DOI URL">https://doi.org/10.1016/j.bioorg.2017.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2017.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2017.04.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252B2-substituted-4-%2525282-fluorophenoxy%252529%252Bpyridine%252Bderivatives%252Bpossessing%252Bpyrazolone%252Band%252Btriazole%252Bmoieties%252Bas%252Bdual%252Bc-Met%25252FVEGFR-2%252Breceptor%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DGu%26aufirst%3DWeijie%26date%3D2017%26volume%3D72%26spage%3D116%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongchun  Liu</span>, <span class="hlFld-ContribAuthor ">Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Ruifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Tongchao  Liu</span>, <span class="hlFld-ContribAuthor ">Chaoyun  Wang</span>, <span class="hlFld-ContribAuthor ">Yuchi  Ma</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>, <span class="hlFld-ContribAuthor ">Jingkang  Shen</span>, <span class="hlFld-ContribAuthor ">Bing  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Biological Evaluation of a Series of Pyrrolo[2,3-b]pyrazines as Novel FGFR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (4)
                                     , 583. <a href="https://doi.org/10.3390/molecules22040583" title="DOI URL">https://doi.org/10.3390/molecules22040583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22040583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22040583%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Band%252BBiological%252BEvaluation%252Bof%252Ba%252BSeries%252Bof%252BPyrrolo%25255B2%25252C3-b%25255Dpyrazines%252Bas%252BNovel%252BFGFR%252BInhibitors%26aulast%3DZhang%26aufirst%3DYan%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D4%26spage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irina V.  Rassokhina</span>, <span class="hlFld-ContribAuthor ">Yulia A.  Volkova</span>, <span class="hlFld-ContribAuthor ">Andrey S.  Kozlov</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Scherbakov</span>, <span class="hlFld-ContribAuthor ">Olga E.  Andreeva</span>, <span class="hlFld-ContribAuthor ">Valerik Z.  Shirinian</span>, <span class="hlFld-ContribAuthor ">Igor V.  Zavarzin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiproliferative activity evaluation of steroidal imidazo[1,2-a]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2016,</strong> <em>113 </em>, 29-37. <a href="https://doi.org/10.1016/j.steroids.2016.06.001" title="DOI URL">https://doi.org/10.1016/j.steroids.2016.06.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2016.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2016.06.001%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DSynthesis%252Band%252Bantiproliferative%252Bactivity%252Bevaluation%252Bof%252Bsteroidal%252Bimidazo%25255B1%25252C2-a%25255Dpyridines%26aulast%3DRassokhina%26aufirst%3DIrina%2BV.%26date%3D2016%26volume%3D113%26spage%3D29%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tong-chao  Liu</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Yu-chi  Ma</span>, <span class="hlFld-ContribAuthor ">Yin-chun  Ji</span>, <span class="hlFld-ContribAuthor ">Dan-qi  Chen</span>, <span class="hlFld-ContribAuthor ">Ming-yue  Zheng</span>, <span class="hlFld-ContribAuthor ">Dong-mei  Zhao</span>, <span class="hlFld-ContribAuthor ">Mao-sheng  Cheng</span>, <span class="hlFld-ContribAuthor ">Mei-yu  Geng</span>, <span class="hlFld-ContribAuthor ">Jing-kang  Shen</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Bing  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2016,</strong> <em>37 </em>
                                    (5)
                                     , 698-707. <a href="https://doi.org/10.1038/aps.2016.11" title="DOI URL">https://doi.org/10.1038/aps.2016.11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2016.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2016.11%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DDiscovery%252Bof%252Ba%252Bnew%252Bseries%252Bof%252Bimidazo%25255B1%25252C2-a%25255Dpyridine%252Bcompounds%252Bas%252Bselective%252Bc-Met%252Binhibitors%26aulast%3DLiu%26aufirst%3DTong-chao%26date%3D2016%26date%3D2016%26volume%3D37%26issue%3D5%26spage%3D698%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Yanfen  Wang</span>, <span class="hlFld-ContribAuthor ">Gongchao  Huang</span>, <span class="hlFld-ContribAuthor ">Conghui  Ji</span>, <span class="hlFld-ContribAuthor ">Wei  Fan</span>, <span class="hlFld-ContribAuthor ">Haitao  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Cheng</span>, <span class="hlFld-ContribAuthor ">Hongqi  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2016,</strong> <em>65 </em>, 146-158. <a href="https://doi.org/10.1016/j.bioorg.2016.02.009" title="DOI URL">https://doi.org/10.1016/j.bioorg.2016.02.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2016.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2016.02.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B1H-pyrrolo%25255B2%25252C3-b%25255Dpyridine%252Band%252B1H-pyrazolo%25255B3%25252C4-b%25255Dpyridine%252Bderivatives%252Bas%252Bc-Met%252Binhibitors%26aulast%3DLiu%26aufirst%3DNa%26date%3D2016%26volume%3D65%26spage%3D146%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Shiyu  Jin</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Dong  Lu</span>, <span class="hlFld-ContribAuthor ">Limin  Zeng</span>, <span class="hlFld-ContribAuthor ">Yiming  Sun</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Youhong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridazinone derivatives displaying highly potent and selective inhibitory activities against c-Met tyrosine kinase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>108 </em>, 322-333. <a href="https://doi.org/10.1016/j.ejmech.2015.11.042" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.11.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.11.042%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyridazinone%252Bderivatives%252Bdisplaying%252Bhighly%252Bpotent%252Band%252Bselective%252Binhibitory%252Bactivities%252Bagainst%252Bc-Met%252Btyrosine%252Bkinase%26aulast%3DLiu%26aufirst%3DYang%26date%3D2016%26volume%3D108%26spage%3D322%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0020.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative c-Met inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of new core structures based on the reference HTS hit compound.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>46</b> inhibits c-Met phosphorylation and downstream signaling in cancer cell lines. (A, B) Compound <b>46</b> effectively inhibits the phosphorylation of c-Met and the c-Met pathway downstream effectors Erk1/2 and Akt in MKN45 (A), EBC-1 (B), and BaF3/TPR-Met cells (C). Cells treated for 1 h with compound <b>46</b> at the indicated concentrations were lysed and subjected to Western blot analysis. (D) Compound <b>46</b> inhibited HGF-induced c-Met phosphorylation and its downstream signaling in A549 cells. Cells treated with compound <b>46</b> for 1 h following HGF stimulation for 15 min were then lysed and subjected to Western blot analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>46</b> possesses potent and selective antiproliferation activity in cell lines with c-Met activation by G1/S phase arresting. (A) The antiproliferation activity of compound <b>46</b> against a panel of tumor cell lines originating from different tissue types was determined by a sulforhodamine B (SRB) or an MTT assay. The IC<sub>50</sub> values were plotted as the mean ± SD (μmol/L) from three separate experiments or estimated values from two separate experiments. (B) Induction of G<sub>1</sub> phase arrest by compound <b>46</b>. EBC-1 cells were treated with increasing concentrations of compound <b>46</b> or vehicle for 24 h. The DNA content was measured by FACS analysis. (C) Percentage of EBC-1 cells in different cell cycle phases determined by FACS and analyzed with FCS expression software. The data shown are the mean ± SD from three independent experiments, and representative images are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>46</b> inhibits HGF-induced cell migration, invasion, scattering, and invasive growth. (A) The migratory ability and (B) invasive ability of NCI-H441 cells induced by 100 ng/mL HGF were impaired by compound <b>46</b>. Representative pictures are shown (scale bar, 100 μm). The relative migration (C) and invasion (D) were plotted. The data shown are the mean ± SD from three independent experiments, assuming 100% migration or invasion of cells stimulated with HGF. (E) Cell scattering by MDCK cells induced by HGF were dose-dependently inhibited by compound <b>46</b>. Representative images from three separate experiments are shown (scale bars, 100 μm). (F) Compound <b>46</b> significantly inhibited HGF-stimulated invasive cell growth. The MDCK branching morphogenesis on collagen induced by HGF was inhibited by compound <b>46</b>. Images were obtained 5 days after treatment. Representative images from three separate experiments are shown (scale bars, 100 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo antitumor efficacy of compound <b>46</b> in EBC-1 xenograft model. (A) Compound <b>46</b> was administered orally once daily for 21 days after the tumor volume reached 100–150 mm<sup>3</sup>. Results are expressed as the mean ± SEM (<i>n</i> = 6 per group). The percentage of tumor volume inhibition values (TGI) was measured on the final day of the study for the drug-treated mice compared with the control mice: (∗∗∗) <i>P</i> < 0.001 versus vehicle group, using Student’s <i>t</i> test. Compound <b>46</b> significantly prevented tumor growth. (b) Inhibition of c-Met phosphorylation and downstream signaling pathways in EBC-1 xenografts by compound <b>46</b>. Mice were humanely euthanized on final day at 1 h postadministration of compound <b>46</b>, and the tumors were resected, snap-frozen, and pulverized. The protein lysates were subjected to Western blot analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-nitrobenzene-1-sulfonyl chloride, NaH, THF, rt, 4h, 64% (<b>56a</b>), 61% (<b>56b</b>); (b) 1-methylpyrazole-4-boronic acid pinacol ester, PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 30 min, 76% (<b>7</b>), 74% (<b>9</b>).</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) I<sub>2</sub>, KOH, DMF, rt, 3.5 h, 96%; (b) 2-nitrothiophenol, CuI, ethylene glycol, K<sub>2</sub>CO<sub>3</sub>, isopropanol, 130 °C, 24 h, 57%; (c) mCPBA, CHCl<sub>3</sub>, 50 °C, 3 h, 75%; (d) 1-methylpyrazole-4-boronic acid pinacol ester, PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 20 min, 76%.</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-methylpyrazole-4-boronic acid pinacol ester, PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 30 min, 82%; (b) NaH, DMF, rt, 4h, 46–81%; (c) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h, 68%; (d) R<sup>2</sup>-C(O)-Cl, 4-dimethylaminopyridine, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, 92–97%; (e) iron powder, ammonium chloride, acetic acid, toluene, 70 °C, 5 h, 56%; (f) butyraldehyde, NaBH<sub>3</sub>(CN), acetic acid, MeOH, rt, 14 h, 83%; (g) boronic acid or R<sup>1</sup>-boronic acid pinacol ester, PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 30 min, 37–78%.</p></p></figure><figure data-id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/medium/jm-2014-02018y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm502018y/20150306/images/large/jm-2014-02018y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm502018y&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-methylpyrazole-4-boronic acid pinacol ester, PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 120 °C, 30 min, 87%; (b) phosphorus oxychloride, reflux, 24 h, 25%; (c) <b>55b</b>, NaH, DMF, rt, 4 h, 63%; (d) R-boronic acid or R-boronic acid pinacol ester, PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 30 min, 31–81%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35161" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35161" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Bottaro, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faletto, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kmiecik, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandewoude, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aaronson, S. A.</span><span> </span><span class="NLM_article-title">Identification of the hepatocyte growth-factor receptor as the c-Met protooncogene product</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1991&pages=802-804&author=D.+P.+Bottaroauthor=J.+S.+Rubinauthor=D.+L.+Falettoauthor=A.+M.+L.+Chanauthor=T.+E.+Kmiecikauthor=G.+F.+Vandewoudeauthor=S.+A.+Aaronson&title=Identification+of+the+hepatocyte+growth-factor+receptor+as+the+c-Met+protooncogene+product"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26aulast%3DRubin%26aufirst%3DJ.%2BS.%26aulast%3DFaletto%26aufirst%3DD.%2BL.%26aulast%3DChan%26aufirst%3DA.%2BM.%2BL.%26aulast%3DKmiecik%26aufirst%3DT.%2BE.%26aulast%3DVandewoude%26aufirst%3DG.%2BF.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26atitle%3DIdentification%2520of%2520the%2520hepatocyte%2520growth-factor%2520receptor%2520as%2520the%2520c-Met%2520protooncogene%2520product%26jtitle%3DScience%26date%3D1991%26volume%3D251%26spage%3D802%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebeau, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandewoude, G. F.</span><span> </span><span class="NLM_article-title">The human Met oncogene is related to the tyrosine kinase oncogenes</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=1985&pages=385-388&author=M.+Deanauthor=M.+Parkauthor=M.+M.+Lebeauauthor=T.+S.+Robinsauthor=M.+O.+Diazauthor=J.+D.+Rowleyauthor=D.+G.+Blairauthor=G.+F.+Vandewoude&title=The+human+Met+oncogene+is+related+to+the+tyrosine+kinase+oncogenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DM.%26aulast%3DLebeau%26aufirst%3DM.%2BM.%26aulast%3DRobins%26aufirst%3DT.%2BS.%26aulast%3DDiaz%26aufirst%3DM.%2BO.%26aulast%3DRowley%26aufirst%3DJ.%2BD.%26aulast%3DBlair%26aufirst%3DD.%2BG.%26aulast%3DVandewoude%26aufirst%3DG.%2BF.%26atitle%3DThe%2520human%2520Met%2520oncogene%2520is%2520related%2520to%2520the%2520tyrosine%2520kinase%2520oncogenes%26jtitle%3DNature%26date%3D1985%26volume%3D318%26spage%3D385%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0lhuJKyzlQsChg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Cooper, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tainsky, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huebner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croce, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandewoude, G. F.</span><span> </span><span class="NLM_article-title">Molecular-cloning of a new transforming gene from a chemically transformed human cell-line</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=1984&pages=29-33&author=C.+S.+Cooperauthor=M.+Parkauthor=D.+G.+Blairauthor=M.+A.+Tainskyauthor=K.+Huebnerauthor=C.+M.+Croceauthor=G.+F.+Vandewoude&title=Molecular-cloning+of+a+new+transforming+gene+from+a+chemically+transformed+human+cell-line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DC.%2BS.%26aulast%3DPark%26aufirst%3DM.%26aulast%3DBlair%26aufirst%3DD.%2BG.%26aulast%3DTainsky%26aufirst%3DM.%2BA.%26aulast%3DHuebner%26aufirst%3DK.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26aulast%3DVandewoude%26aufirst%3DG.%2BF.%26atitle%3DMolecular-cloning%2520of%2520a%2520new%2520transforming%2520gene%2520from%2520a%2520chemically%2520transformed%2520human%2520cell-line%26jtitle%3DNature%26date%3D1984%26volume%3D311%26spage%3D29%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hubbard, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickson, W. A.</span><span> </span><span class="NLM_article-title">Crystal-structure of the tyrosine kinase domain of the human insulin-receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1994&pages=746-754&author=S.+R.+Hubbardauthor=L.+Weiauthor=L.+Elisauthor=W.+A.+Hendrickson&title=Crystal-structure+of+the+tyrosine+kinase+domain+of+the+human+insulin-receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DElis%26aufirst%3DL.%26aulast%3DHendrickson%26aufirst%3DW.%2BA.%26atitle%3DCrystal-structure%2520of%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520the%2520human%2520insulin-receptor%26jtitle%3DNature%26date%3D1994%26volume%3D372%26spage%3D746%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Holmes, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillozzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deakin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carafoli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, P. J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, E.</span><span> </span><span class="NLM_article-title">Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2007&pages=395-408&author=O.+Holmesauthor=S.+Pillozziauthor=J.+A.+Deakinauthor=F.+Carafoliauthor=L.+Kempauthor=P.+J.+G.+Butlerauthor=M.+Lyonauthor=E.+Gherardi&title=Insights+into+the+structure%2Ffunction+of+hepatocyte+growth+factor%2Fscatter+factor+from+studies+with+individual+domains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DO.%26aulast%3DPillozzi%26aufirst%3DS.%26aulast%3DDeakin%26aufirst%3DJ.%2BA.%26aulast%3DCarafoli%26aufirst%3DF.%26aulast%3DKemp%26aufirst%3DL.%26aulast%3DButler%26aufirst%3DP.%2BJ.%2BG.%26aulast%3DLyon%26aufirst%3DM.%26aulast%3DGherardi%26aufirst%3DE.%26atitle%3DInsights%2520into%2520the%2520structure%252Ffunction%2520of%2520hepatocyte%2520growth%2520factor%252Fscatter%2520factor%2520from%2520studies%2520with%2520individual%2520domains%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D367%26spage%3D395%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ponzetto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallazonca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panayotou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">A multifunctional docking site mediates signaling and transformation by the hepatocyte growth-factor scatter factor-receptor family</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1994&pages=261-271&author=C.+Ponzettoauthor=A.+Bardelliauthor=Z.+Zhenauthor=F.+Mainaauthor=P.+Dallazoncaauthor=S.+Giordanoauthor=A.+Grazianiauthor=G.+Panayotouauthor=P.+M.+Comoglio&title=A+multifunctional+docking+site+mediates+signaling+and+transformation+by+the+hepatocyte+growth-factor+scatter+factor-receptor+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPonzetto%26aufirst%3DC.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DZhen%26aufirst%3DZ.%26aulast%3DMaina%26aufirst%3DF.%26aulast%3DDallazonca%26aufirst%3DP.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DGraziani%26aufirst%3DA.%26aulast%3DPanayotou%26aufirst%3DG.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DA%2520multifunctional%2520docking%2520site%2520mediates%2520signaling%2520and%2520transformation%2520by%2520the%2520hepatocyte%2520growth-factor%2520scatter%2520factor-receptor%2520family%26jtitle%3DCell%26date%3D1994%26volume%3D77%26spage%3D261%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span> </span><span class="NLM_article-title">Met, metastasis, motility and more</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1038%2Fnrm1261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=14685170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=915-925&author=C.+Birchmeierauthor=W.+Birchmeierauthor=E.+Gherardiauthor=G.+F.+Vande+Woude&title=Met%2C+metastasis%2C+motility+and+more"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Met, metastasis, motility and more</span></div><div class="casAuthors">Birchmeier, Carmen; Birhcmeier, Walter; Gherardi, Ermanno; Vande Woude, George F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">915-925</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocyte growth factor. scatter factor and its receptor, the tyrosine kinase Met, arose late in evolution and are unique to vertebrates.  In spite of this, Met uses mols. such as Gab1 - homologues of which are present in Caenorhabditis elegans and Drosophila melanogaster - for downstream signalling. Pivotal roles for Met in development and cancer have been established: Met controls cell migration and growth in embryogenesis; it also controls growth, invasion and metastasis in cancer cells; and activating Met mutations predispose to human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG_-6XRpZ-sLVg90H21EOLACvtfcHk0liJf2eUhd1kdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D&md5=ff5a02c73415784480c628fe65299a81</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrm1261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1261%26sid%3Dliteratum%253Aachs%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DGherardi%26aufirst%3DE.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26atitle%3DMet%252C%2520metastasis%252C%2520motility%2520and%2520more%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D915%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Weidner, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiCesare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=173-176&author=K.+M.+Weidnerauthor=S.+DiCesareauthor=M.+Sachsauthor=V.+Brinkmannauthor=J.+Behrensauthor=W.+Birchmeier&title=Interaction+between+Gab1+and+the+c-Met+receptor+tyrosine+kinase+is+responsible+for+epithelial+morphogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeidner%26aufirst%3DK.%2BM.%26aulast%3DDiCesare%26aufirst%3DS.%26aulast%3DSachs%26aufirst%3DM.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBehrens%26aufirst%3DJ.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DInteraction%2520between%2520Gab1%2520and%2520the%2520c-Met%2520receptor%2520tyrosine%2520kinase%2520is%2520responsible%2520for%2520epithelial%2520morphogenesis%26jtitle%3DNature%26date%3D1996%26volume%3D384%26spage%3D173%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Trusolino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">MET signalling: principles and functions in development, organ regeneration and cancer</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1038%2Fnrm3012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=21102609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGrurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=834-848&author=L.+Trusolinoauthor=A.+Bertottiauthor=P.+M.+Comoglio&title=MET+signalling%3A+principles+and+functions+in+development%2C+organ+regeneration+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">MET signalling: principles and functions in development, organ regeneration and cancer</span></div><div class="casAuthors">Trusolino, Livio; Bertotti, Andrea; Comoglio, Paolo M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">834-848</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The MET tyrosine kinase receptor (also known as the HGF receptor) promotes tissue remodelling, which underlies developmental morphogenesis, wound repair, organ homeostasis and cancer metastasis, by integrating growth, survival and migration cues in response to environmental stimuli or cell-autonomous perturbations.  The versatility of MET-mediated biol. responses is sustained by qual. and quant. signal modulation.  Qual. mechanisms include the engagement of dedicated signal transducers and the subcellular compartmentalization of MET signalling pathways, whereas quant. regulation involves MET partnering with adaptor amplifiers or being degraded through the shedding of its extracellular domain or through intracellular ubiquitylation.  Controlled activation of MET signalling can be exploited in regenerative medicine, whereas MET inhibition might slow down tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzaWXvEKEpVrVg90H21EOLACvtfcHk0liJf2eUhd1kdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGrurfI&md5=c97f7b6ff2522bc0d20d0371d07c5ea2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrm3012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3012%26sid%3Dliteratum%253Aachs%26aulast%3DTrusolino%26aufirst%3DL.%26aulast%3DBertotti%26aufirst%3DA.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DMET%2520signalling%253A%2520principles%2520and%2520functions%2520in%2520development%252C%2520organ%2520regeneration%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D834%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Chmielowiec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borowiak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stradal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">c-Met is essential for wound healing in the skin</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2007&pages=151-162&author=J.+Chmielowiecauthor=M.+Borowiakauthor=M.+Morkelauthor=T.+Stradalauthor=B.+Munzauthor=S.+Wernerauthor=J.+Wehlandauthor=C.+Birchmeierauthor=W.+Birchmeier&title=c-Met+is+essential+for+wound+healing+in+the+skin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChmielowiec%26aufirst%3DJ.%26aulast%3DBorowiak%26aufirst%3DM.%26aulast%3DMorkel%26aufirst%3DM.%26aulast%3DStradal%26aufirst%3DT.%26aulast%3DMunz%26aufirst%3DB.%26aulast%3DWerner%26aufirst%3DS.%26aulast%3DWehland%26aufirst%3DJ.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3Dc-Met%2520is%2520essential%2520for%2520wound%2520healing%2520in%2520the%2520skin%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2007%26volume%3D177%26spage%3D151%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Michalopoulos, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFrances, M. C.</span><span> </span><span class="NLM_article-title">Liver regeneration</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1126%2Fscience.276.5309.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=9082986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADyaK2sXitlyqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=60-66&author=G.+K.+Michalopoulosauthor=M.+C.+DeFrances&title=Liver+regeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Liver regeneration</span></div><div class="casAuthors">Michalopoulos, George K.; DeFrances, Marie C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">5309</span>),
    <span class="NLM_cas:pages">60-66</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 98 refs.  Liver regeneration after the loss of hepatic tissue is a fundamental parameter of liver response to injury.  Recognized as a phenomenon from mythol. times, it is now defined as an orchestrated response induced by specific external stimuli and involving sequential changes in gene expression, growth factor prodn., and morphol. structure.  Many growth factors and cytokines, most notably hepatocyte growth factor, epidermal growth factor, transforming growth factor-α, interleukin-6, tumor necrosis factor-α, insulin, and norepinephrine, appear to play important roles in this process.  This review attempts to integrate the findings of the last three decades and looks toward clues as to the nature of the causes that trigger this fascinating organ and cellular response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryWZQ48IfGpbVg90H21EOLACvtfcHk0liJf2eUhd1kdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitlyqt78%253D&md5=3961787026f78ecfbd3032e6c6f8fc90</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.276.5309.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.276.5309.60%26sid%3Dliteratum%253Aachs%26aulast%3DMichalopoulos%26aufirst%3DG.%2BK.%26aulast%3DDeFrances%26aufirst%3DM.%2BC.%26atitle%3DLiver%2520regeneration%26jtitle%3DScience%26date%3D1997%26volume%3D276%26spage%3D60%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusolino, L.</span><span> </span><span class="NLM_article-title">Invasive growth: from development to metastasis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=857-862&author=P.+M.+Comoglioauthor=L.+Trusolino&title=Invasive+growth%3A+from+development+to+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DTrusolino%26aufirst%3DL.%26atitle%3DInvasive%2520growth%253A%2520from%2520development%2520to%2520metastasis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D109%26spage%3D857%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Otsuka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRochelle, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottaro, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellmore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anver, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlino, G.</span><span> </span><span class="NLM_article-title">c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5157</span><span class="NLM_x">–</span> <span class="NLM_lpage">5167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=5157-5167&author=T.+Otsukaauthor=H.+Takayamaauthor=R.+Sharpauthor=G.+Celliauthor=W.+J.+LaRochelleauthor=D.+P.+Bottaroauthor=N.+Ellmoreauthor=W.+Vieiraauthor=J.+W.+Owensauthor=M.+Anverauthor=G.+Merlino&title=c-Met+autocrine+activation+induces+development+of+malignant+melanoma+and+acquisition+of+the+metastatic+phenotype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtsuka%26aufirst%3DT.%26aulast%3DTakayama%26aufirst%3DH.%26aulast%3DSharp%26aufirst%3DR.%26aulast%3DCelli%26aufirst%3DG.%26aulast%3DLaRochelle%26aufirst%3DW.%2BJ.%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26aulast%3DEllmore%26aufirst%3DN.%26aulast%3DVieira%26aufirst%3DW.%26aulast%3DOwens%26aufirst%3DJ.%2BW.%26aulast%3DAnver%26aufirst%3DM.%26aulast%3DMerlino%26aufirst%3DG.%26atitle%3Dc-Met%2520autocrine%2520activation%2520induces%2520development%2520of%2520malignant%2520melanoma%2520and%2520acquisition%2520of%2520the%2520metastatic%2520phenotype%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D5157%26epage%3D5167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Schmidt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duh, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choyke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubensky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allikmets, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chidambaram, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergerheim, U. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltis, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamarron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernues, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lips, C. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geil, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orcutt, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stackhouse, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slife, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niehans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storkel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerman, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linehan, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zbar, B.</span><span> </span><span class="NLM_article-title">Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1038%2Fng0597-68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=9140397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADyaK2sXivFKhsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=68-73&author=L.+Schmidtauthor=F.+M.+Duhauthor=F.+Chenauthor=T.+Kishidaauthor=G.+Glennauthor=P.+Choykeauthor=S.+W.+Schererauthor=Z.+P.+Zhuangauthor=I.+Lubenskyauthor=M.+Deanauthor=R.+Allikmetsauthor=A.+Chidambaramauthor=U.+R.+Bergerheimauthor=J.+T.+Feltisauthor=C.+Casadevallauthor=A.+Zamarronauthor=M.+Bernuesauthor=S.+Richardauthor=C.+J.+M.+Lipsauthor=M.+M.+Waltherauthor=L.+C.+Tsuiauthor=L.+Geilauthor=M.+L.+Orcuttauthor=T.+Stackhouseauthor=J.+Lipanauthor=L.+Slifeauthor=H.+Brauchauthor=J.+Deckerauthor=G.+Niehansauthor=M.+D.+Hughsonauthor=H.+Mochauthor=S.+Storkelauthor=M.+I.+Lermanauthor=W.+M.+Linehanauthor=B.+Zbar&title=Germline+and+somatic+mutations+in+the+tyrosine+kinase+domain+of+the+MET+proto-oncogene+in+papillary+renal+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas</span></div><div class="casAuthors">Schmidt, Laura; Duh, Fuh-Mei; Chen, Fan; Kishida, Takeshi; Glenn, Gladys; Choyke, Peter; Scherer, Stephen W.; Zhuang, Zhenping; Lubensky, Irina; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-73</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Hereditary papillary renal carcinoma (HPRC) is a recently recognized form of inherited kidney cancer characterized by a predisposition to develop multiple, bilateral papillary renal tumors.  The pattern of inheritance of HPRC is consistent with autosomal dominant transmission with reduced penetrance.  HPRC is histol. and genetically distinct from two other causes of inherited renal carcinoma, von Hippel-Lindau disease (VHL) and the chromosome translocation (3;8).  Malignant papillary renal carcinomas are characterized by trisomy of chromosomes 7, 16 and 17, and in men, by loss of the Y chromosome.  Inherited and sporadic clear cell renal carcinomas are characterized by inactivation of both copies of the VHL gene by mutation, and/or by hypermethylation.  We found that the HPRC gene was located at chromosome 7q31.1-34 in a 27-centimorgan (cM) interval between D7S496 and D7S1837.  We identified missense mutations located in the tyrosine kinase domain of the MET gene in the germline of affected members of HPRC families and in a subset of sporadic papillary renal carcinomas.  Three mutations in the MET gene are located in codons that are homologous to those in c-kit and RET, proto-oncogenes that are targets of naturally-occurring mutations.  The results suggest that missense mutations located in the MET proto-oncogene lead to constitutive activation of the MET protein and papillary renal carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm-x_dqJPR-7Vg90H21EOLACvtfcHk0lhoPMUC4JqsGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFKhsbw%253D&md5=7209dbbaa538b418defad117830df3c9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fng0597-68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0597-68%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DL.%26aulast%3DDuh%26aufirst%3DF.%2BM.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DKishida%26aufirst%3DT.%26aulast%3DGlenn%26aufirst%3DG.%26aulast%3DChoyke%26aufirst%3DP.%26aulast%3DScherer%26aufirst%3DS.%2BW.%26aulast%3DZhuang%26aufirst%3DZ.%2BP.%26aulast%3DLubensky%26aufirst%3DI.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DAllikmets%26aufirst%3DR.%26aulast%3DChidambaram%26aufirst%3DA.%26aulast%3DBergerheim%26aufirst%3DU.%2BR.%26aulast%3DFeltis%26aufirst%3DJ.%2BT.%26aulast%3DCasadevall%26aufirst%3DC.%26aulast%3DZamarron%26aufirst%3DA.%26aulast%3DBernues%26aufirst%3DM.%26aulast%3DRichard%26aufirst%3DS.%26aulast%3DLips%26aufirst%3DC.%2BJ.%2BM.%26aulast%3DWalther%26aufirst%3DM.%2BM.%26aulast%3DTsui%26aufirst%3DL.%2BC.%26aulast%3DGeil%26aufirst%3DL.%26aulast%3DOrcutt%26aufirst%3DM.%2BL.%26aulast%3DStackhouse%26aufirst%3DT.%26aulast%3DLipan%26aufirst%3DJ.%26aulast%3DSlife%26aufirst%3DL.%26aulast%3DBrauch%26aufirst%3DH.%26aulast%3DDecker%26aufirst%3DJ.%26aulast%3DNiehans%26aufirst%3DG.%26aulast%3DHughson%26aufirst%3DM.%2BD.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DStorkel%26aufirst%3DS.%26aulast%3DLerman%26aufirst%3DM.%2BI.%26aulast%3DLinehan%26aufirst%3DW.%2BM.%26aulast%3DZbar%26aufirst%3DB.%26atitle%3DGermline%2520and%2520somatic%2520mutations%2520in%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520the%2520MET%2520proto-oncogene%2520in%2520papillary%2520renal%2520carcinomas%26jtitle%3DNat.%2520Genet.%26date%3D1997%26volume%3D16%26spage%3D68%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Umeki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, H.</span><span> </span><span class="NLM_article-title">Clinical significance of c-met oncogene alterations in human colorectal cancer</span> <span class="citation_source-journal">Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=314-321&author=K.+Umekiauthor=G.+Shiotaauthor=H.+Kawasaki&title=Clinical+significance+of+c-met+oncogene+alterations+in+human+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUmeki%26aufirst%3DK.%26aulast%3DShiota%26aufirst%3DG.%26aulast%3DKawasaki%26aufirst%3DH.%26atitle%3DClinical%2520significance%2520of%2520c-met%2520oncogene%2520alterations%2520in%2520human%2520colorectal%2520cancer%26jtitle%3DOncology%26date%3D1999%26volume%3D56%26spage%3D314%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zejnullahu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsudomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappuzzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span> </span><span class="NLM_article-title">MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1043</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1126%2Fscience.1141478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=17463250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlOjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=1039-1043&author=J.+A.+Engelmanauthor=K.+Zejnullahuauthor=T.+Mitsudomiauthor=Y.+Songauthor=C.+Hylandauthor=J.+O.+Parkauthor=N.+Lindemanauthor=C.-M.+Galeauthor=X.+Zhaoauthor=J.+Christensenauthor=T.+Kosakaauthor=A.+J.+Holmesauthor=A.+M.+Rogersauthor=F.+Cappuzzoauthor=T.+Mokauthor=C.+Leeauthor=B.+E.+Johnsonauthor=L.+C.+Cantleyauthor=P.+A.+Janne&title=MET+amplification+leads+to+gefitinib+resistance+in+lung+cancer+by+activating+ERBB3+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling</span></div><div class="casAuthors">Engelman, Jeffrey A.; Zejnullahu, Kreshnik; Mitsudomi, Tetsuya; Song, Youngchul; Hyland, Courtney; Park, Joon Oh; Lindeman, Neal; Gale, Christopher-Michael; Zhao, Xiaojun; Christensen, James; Kosaka, Takayuki; Holmes, Alison J.; Rogers, Andrew M.; Cappuzzo, Federico; Mok, Tony; Lee, Charles; Johnson, Bruce E.; Cantley, Lewis C.; Jaenne, Pasi A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5827</span>),
    <span class="NLM_cas:pages">1039-1043</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance.  Here, we describe a gefitinib-sensitive lung cancer cell line that developed resistance to gefitinib as a result of focal amplification of the MET proto-oncogene. inhibition of MET signaling in these cells restored their sensitivity to gefitinib.  MET amplification was detected in 4 of 18 (22%) lung cancer specimens that had developed resistance to gefitinib or erlotinib.  We find that amplification of MET causes gefitinib resistance by driving ERBB3 (HER3)-dependent activation of PI3K, a pathway thought to be specific to EGFR/ERBB family receptors.  Thus, we propose that MET amplification may promote drug resistance in other ERBB-driven cancers as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr430gbvBeIoLVg90H21EOLACvtfcHk0lhA1pUWQozjPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlOjt7g%253D&md5=3da9383b4acb965f57529b095f8f4686</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.1141478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1141478%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DMitsudomi%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DHyland%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DJ.%2BO.%26aulast%3DLindeman%26aufirst%3DN.%26aulast%3DGale%26aufirst%3DC.-M.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DKosaka%26aufirst%3DT.%26aulast%3DHolmes%26aufirst%3DA.%2BJ.%26aulast%3DRogers%26aufirst%3DA.%2BM.%26aulast%3DCappuzzo%26aufirst%3DF.%26aulast%3DMok%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26atitle%3DMET%2520amplification%2520leads%2520to%2520gefitinib%2520resistance%2520in%2520lung%2520cancer%2520by%2520activating%2520ERBB3%2520signaling%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D1039%26epage%3D1043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Michieli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basilico, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavassa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sottile, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">Targeting the tumor and its microenvironment by a dual-function decoy Met receptor</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=61-73&author=P.+Michieliauthor=M.+Mazzoneauthor=C.+Basilicoauthor=S.+Cavassaauthor=A.+Sottileauthor=L.+Naldiniauthor=P.+M.+Comoglio&title=Targeting+the+tumor+and+its+microenvironment+by+a+dual-function+decoy+Met+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMichieli%26aufirst%3DP.%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DBasilico%26aufirst%3DC.%26aulast%3DCavassa%26aufirst%3DS.%26aulast%3DSottile%26aufirst%3DA.%26aulast%3DNaldini%26aufirst%3DL.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DTargeting%2520the%2520tumor%2520and%2520its%2520microenvironment%2520by%2520a%2520dual-function%2520decoy%2520Met%2520receptor%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D61%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusolino, L.</span><span> </span><span class="NLM_article-title">Drug development of MET inhibitors: targeting oncogene addiction and expedience</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=504-516&author=P.+M.+Comoglioauthor=S.+Giordanoauthor=L.+Trusolino&title=Drug+development+of+MET+inhibitors%3A+targeting+oncogene+addiction+and+expedience"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DTrusolino%26aufirst%3DL.%26atitle%3DDrug%2520development%2520of%2520MET%2520inhibitors%253A%2520targeting%2520oncogene%2520addiction%2520and%2520expedience%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D504%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Cui, J. J.</span><span> </span><span class="NLM_article-title">Targeting receptor tyrosine kinase MET in cancer: small molecule inhibitors and clinical progress</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4427</span><span class="NLM_x">–</span> <span class="NLM_lpage">4453</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401427c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4427-4453&author=J.+J.+Cui&title=Targeting+receptor+tyrosine+kinase+MET+in+cancer%3A+small+molecule+inhibitors+and+clinical+progress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress</span></div><div class="casAuthors">Cui, J. Jean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4427-4453</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The HGF/MET signaling pathway is crit. in mediating a wide range of normal physiol. functions including embryol. development, wound healing, and tissue regeneration.  Aberrant activation of the pathway has frequently been found in human cancers via protein overexpression, mutation, gene amplification, and also paracrine or autocrine up-regulation.  In addn., the activation of HGF/MET signaling confers resistance to the effects of cancer treatments.  Therefore, inhibition of the HGF/MET signaling pathway has great potential for therapeutic intervention in cancer.  Currently, there are three approaches toward modulating HGF/MET signaling in human clin. studies of cancer: anti-HGF monoclonal antibodies, MET monoclonal antibodies, and small mol. MET inhibitors.  Preliminary clin. benefit from inhibition of HGF or MET has been reported.  This Perspective will provide an overview of the HGF/MET signaling pathway in cancer and then will review the development of small mol. MET inhibitors and their progress in clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoARAsEnH4X5rVg90H21EOLACvtfcHk0lhA1pUWQozjPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltbvE&md5=534fd1c6fd8b83be41251d0d556903d1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm401427c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401427c%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520receptor%2520tyrosine%2520kinase%2520MET%2520in%2520cancer%253A%2520small%2520molecule%2520inhibitors%2520and%2520clinical%2520progress%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4427%26epage%3D4453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ghiso, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span> </span><span class="NLM_article-title">Targeting MET: why, where and how?</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1016%2Fj.coph.2013.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=23797036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVSmurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=511-518&author=E.+Ghisoauthor=S.+Giordano&title=Targeting+MET%3A+why%2C+where+and+how%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting MET: why, where and how?</span></div><div class="casAuthors">Ghiso, Elena; Giordano, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-518</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite the initial skepticism, targeted therapies represent a new perspective in the treatment of cancer.  Tyrosine kinases, and in particular receptor tyrosine kinases (RTKs), are considered ideal targets for this type of therapy.  MET, the tyrosine kinase receptor for the Hepatocyte Growth Factor (HGF), has recently become a very interesting and studied target in oncol.  In this review we discuss firstly 'why' the MET/HGF pathway can be considered a target in human tumors; secondly 'where' MET/HGF inhibition can be useful in cancer treatment and finally 'how' MET and HGF can be inhibited using either monoclonal antibodies or tyrosine kinase inhibitors.  We also highlight some questions in the anti-MET/HGF targeted therapy field that are still waiting for an answer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq33qI6WAqWJ7Vg90H21EOLACvtfcHk0lgADYy2DA5C9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSmurnL&md5=507f17d762550af451af791c1527d50d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2013.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2013.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DGhiso%26aufirst%3DE.%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DTargeting%2520MET%253A%2520why%252C%2520where%2520and%2520how%253F%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2013%26volume%3D13%26spage%3D511%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Organ, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, M. S.</span><span> </span><span class="NLM_article-title">An overview of the c-MET signaling pathway</span> <span class="citation_source-journal">Ther. Adv. Med. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">S7</span><span class="NLM_x">–</span> <span class="NLM_lpage">S19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1177%2F1758834011422556" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=22128289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=S7-S19&author=S.+L.+Organauthor=M.+S.+Tsao&title=An+overview+of+the+c-MET+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of the c-MET signaling pathway</span></div><div class="casAuthors">Organ, Shawna Leslie; Tsao, Ming-Sound</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Medical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S7-S19</span>CODEN:
                <span class="NLM_cas:coden">TAMOB8</span>;
        ISSN:<span class="NLM_cas:issn">1758-8340</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  C-MET is a receptor tyrosine kinase that, after binding with its ligand, hepatocyte growth factor, activates a wide range of different cellular signaling pathways, including those involved in proliferation, motility, migration and invasion.  Although c-MET is important in the control of tissue homeostasis under normal physiol. conditions, it has also been found to be aberrantly activated in human cancers via mutation, amplification or protein overexpression.  This paper provides an overview of the c-MET signaling pathway, including its role in the development of cancers, and provides a rationale for targeting the pathway as a possible treatment option.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp79uA73SrMTLVg90H21EOLACvtfcHk0lgADYy2DA5C9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSqsg%253D%253D&md5=94f1ef8e31e21a15edc525e2c6325f52</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1177%2F1758834011422556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1758834011422556%26sid%3Dliteratum%253Aachs%26aulast%3DOrgan%26aufirst%3DS.%2BL.%26aulast%3DTsao%26aufirst%3DM.%2BS.%26atitle%3DAn%2520overview%2520of%2520the%2520c-MET%2520signaling%2520pathway%26jtitle%3DTher.%2520Adv.%2520Med.%2520Oncol.%26date%3D2011%26volume%3D3%26spage%3DS7%26epage%3DS19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusolino, L.</span><span> </span><span class="NLM_article-title">Drug development of MET inhibitors: targeting oncogene addiction and expedience</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=504-16&author=P.+M.+Comoglioauthor=S.+Giordanoauthor=L.+Trusolino&title=Drug+development+of+MET+inhibitors%3A+targeting+oncogene+addiction+and+expedience"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DTrusolino%26aufirst%3DL.%26atitle%3DDrug%2520development%2520of%2520MET%2520inhibitors%253A%2520targeting%2520oncogene%2520addiction%2520and%2520expedience%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D504%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Dube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrous, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6342</span><span class="NLM_x">–</span> <span class="NLM_lpage">6363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2007613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6342-6363&author=J.+J.+Cuiauthor=M.+Tran-Dubeauthor=H.+Shenauthor=M.+Nambuauthor=P.+P.+Kungauthor=M.+Pairishauthor=L.+Jiaauthor=J.+Mengauthor=L.+Funkauthor=I.+Botrousauthor=M.+McTigueauthor=N.+Grodskyauthor=K.+Ryanauthor=E.+Padriqueauthor=G.+Altonauthor=S.+Timofeevskiauthor=S.+Yamazakiauthor=Q.+H.+Liauthor=H.+L.+Zouauthor=J.+Christensenauthor=B.+Mroczkowskiauthor=S.+Benderauthor=R.+S.+Kaniaauthor=M.+P.+Edwards&title=Structure+based+drug+design+of+crizotinib+%28PF-02341066%29%2C+a+potent+and+selective+dual+inhibitor+of+mesenchymal-epithelial+transition+factor+%28c-MET%29+kinase+and+anaplastic+lymphoma+kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)</span></div><div class="casAuthors">Cui, J. Jean; Tran-Dube, Michelle; Shen, Hong; Nambu, Mitchell; Kung, Pei-Pei; Pairish, Mason; Jia, Lei; Meng, Jerry; Funk, Lee; Botrous, Iriny; McTigue, Michele; Grodsky, Neil; Ryan, Kevin; Padrique, Ellen; Alton, Gordon; Timofeevski, Sergei; Yamazaki, Shinji; Li, Qiuhua; Zou, Helen; Christensen, James; Mroczkowski, Barbara; Bender, Steve; Kania, Robert S.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6342-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the crit. roles of aberrant signaling in cancer, both c-MET and ALK receptor tyrosine kinases are attractive oncol. targets for therapeutic intervention.  The cocrystal structure of 3 (PHA-665752), bound to c-MET kinase domain, revealed a novel ATP site environment, which served as the target to guide parallel, multiattribute drug design.  A novel 2-amino-5-aryl-3-benzyloxypyridine series was created to more effectively make the key interactions achieved with 3.  In the novel series, the 2-aminopyridine core allowed a 3-benzyloxy group to reach into the same pocket as the 2,6-dichlorophenyl group of 3 via a more direct vector and thus with a better ligand efficiency (LE).  Further optimization of the lead series generated the clin. candidate crizotinib (PF-02341066), which demonstrated potent in vitro and in vivo c-MET kinase and ALK inhibition, effective tumor growth inhibition, and good pharmaceutical properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHs_cKJ-U3t7Vg90H21EOLACvtfcHk0ljVpJef37tBaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN&md5=dbab4c1b3e7c76180dbad04be2b6a474</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm2007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007613%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%2BH.%26aulast%3DZou%26aufirst%3DH.%2BL.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DStructure%2520based%2520drug%2520design%2520of%2520crizotinib%2520%2528PF-02341066%2529%252C%2520a%2520potent%2520and%2520selective%2520dual%2520inhibitor%2520of%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-MET%2529%2520kinase%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6342%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Boezio, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santostefano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimanovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span> </span><span class="NLM_article-title">Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6307</span><span class="NLM_x">–</span> <span class="NLM_lpage">6312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1016%2Fj.bmcl.2009.09.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=19819693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWlsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6307-6312&author=A.+A.+Boezioauthor=L.+Berryauthor=B.+K.+Albrechtauthor=D.+Bauerauthor=S.+F.+Bellonauthor=C.+Bodeauthor=A.+Chenauthor=D.+Choquetteauthor=I.+Dussaultauthor=S.+Hiraiauthor=P.+Kaplan-Lefkoauthor=J.+F.+Larrowauthor=M.+H.+J.+Linauthor=J.+Lohmanauthor=M.+H.+Potashmanauthor=K.+Rexauthor=M.+Santostefanoauthor=K.+Shahauthor=R.+Shimanovichauthor=S.+K.+Springerauthor=Y.+Tefferaauthor=Y.+J.+Yangauthor=Y.+H.+Zhangauthor=J.+C.+Harmange&title=Discovery+and+optimization+of+potent+and+selective+triazolopyridazine+series+of+c-Met+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors</span></div><div class="casAuthors">Boezio, Alessandro A.; Berry, Loren; Albrecht, Brian K.; Bauer, David; Bellon, Steven F.; Bode, Christiane; Chen, April; Choquette, Deborah; Dussault, Isabelle; Hirai, Satoko; Kaplan-Lefko, Paula; Larrow, Jay F.; Lin, Min-Hwa Jasmine; Lohman, Julia; Potashman, Michele H.; Rex, Karen; Santostefano, Michael; Shah, Kavita; Shimanovich, Roman; Springer, Stephanie K.; Teffera, Yohannes; Yang, Yajing; Zhang, Yihong; Harmange, Jean-Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6307-6312</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Deregulation of the receptor tyrosine kinase c-Met has been implicated in several human cancers and is an attractive target for small mol. drug discovery.  We previously showed that O-linked triazolopyridazines can be potent inhibitors of c-Met.  Herein, we report the discovery of a related series of N-linked triazolopyridazines which demonstrate nanomolar inhibition of c-Met kinase activity and display improved pharmacodynamic profiles.  Specifically, the potent time-dependent inhibition of cytochrome P 450 assocd. with the O-linked triazolopyridazines has been eliminated within this novel series of inhibitors.  N-linked triazolopyridazine 24 exhibited favorable pharmacokinetics and displayed potent inhibition of HGF-mediated c-Met phosphorylation in a mouse liver PD model.  Once-daily oral administration of 24 for 22 days showed significant tumor growth inhibition in an NIH-3T3/TPR-Met xenograft mouse efficacy model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiJYhob-fk_bVg90H21EOLACvtfcHk0ljVpJef37tBaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWlsrbF&md5=254e67e6f81b7018b75f73290505e8af</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.09.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.09.096%26sid%3Dliteratum%253Aachs%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DHirai%26aufirst%3DS.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DLarrow%26aufirst%3DJ.%2BF.%26aulast%3DLin%26aufirst%3DM.%2BH.%2BJ.%26aulast%3DLohman%26aufirst%3DJ.%26aulast%3DPotashman%26aufirst%3DM.%2BH.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSantostefano%26aufirst%3DM.%26aulast%3DShah%26aufirst%3DK.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSpringer%26aufirst%3DS.%2BK.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520potent%2520and%2520selective%2520triazolopyridazine%2520series%2520of%2520c-Met%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6307%26epage%3D6312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Liu, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marando, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behshad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span> </span><span class="NLM_article-title">A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7127</span><span class="NLM_x">–</span> <span class="NLM_lpage">7138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1158%2F1078-0432.CCR-11-1157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=21918175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKht7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=7127-7138&author=X.+D.+Liuauthor=Q.+Wangauthor=G.+J.+Yangauthor=C.+Marandoauthor=H.+K.+Koblishauthor=L.+M.+Hallauthor=J.+S.+Fridmanauthor=E.+Behshadauthor=R.+Wynnauthor=Y.+Liauthor=J.+Boerauthor=S.+Diamondauthor=C.+H.+Heauthor=M.+Z.+Xuauthor=J.+C.+Zhuoauthor=W.+Q.+Yaoauthor=R.+C.+Newtonauthor=P.+A.+Scherle&title=A+novel+kinase+inhibitor%2C+INCB28060%2C+blocks+c-MET-dependent+signaling%2C+neoplastic+activities%2C+and+cross-talk+with+EGFR+and+HER-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Kinase Inhibitor, INCB28060, Blocks c-MET-Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3</span></div><div class="casAuthors">Liu, Xiangdong; Wang, Qian; Yang, Gengjie; Marando, Cindy; Koblish, Holly K.; Hall, Leslie M.; Fridman, Jordan S.; Behshad, Elham; Wynn, Richard; Li, Yu; Boer, Jason; Diamond, Sharon; He, Chunhong; Xu, Meizhong; Zhuo, Jincong; Yao, Wenqing; Newton, Robert C.; Scherle, Peggy A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7127-7138</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The c-MET receptor tyrosine kinase plays important roles in the formation, progression, and dissemination of human cancer and presents an attractive therapeutic target.  This study describes the preclin. characterization of INCB28060, a novel inhibitor of c-MET kinase.  Exptl. Design: Studies were conducted using a series of in vitro and in vivo biochem. and biol. expts.  RESULTS: INCB28060 exhibits picomolar enzymic potency and is highly specific for c-MET with more than 10,000-fold selectivity over a large panel of human kinases.  This inhibitor potently blocks c-MET phosphorylation and activation of its key downstream effectors in c-MET-dependent tumor cell lines.  As a result, INCB28060 potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis in vitro.  Oral dosing of INCB28060 results in time- and dose-dependent inhibition of c-MET phosphorylation and tumor growth in c-MET-driven mouse tumor models, and the inhibitor is well tolerated at doses that achieve complete tumor inhibition.  In a further exploration of potential interactions between c-MET and other signaling pathways, we found that activated c-MET pos. regulates the activity of epidermal growth factor receptors (EGFR) and HER-3, as well as expression of their ligands.  These effects are reversed with INCB28060 treatment.  Finally, we confirmed that circulating hepatocyte growth factor levels are significantly elevated in patients with various cancers.  CONCLUSIONS: Activated c-MET has pleiotropic effects on multiple cancer-promoting signaling pathways and may play a crit. role in driving tumor cell growth and survival.  INCB28060 is a potent and selective c-MET kinase inhibitor that may have therapeutic potential in cancer treatment.  Clin Cancer Res; 17(22); 7127-38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqqT6dM1mGprVg90H21EOLACvtfcHk0ljVpJef37tBaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKht7nK&md5=c272514704702cb5cbcc9e405bea3c53</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1157%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%2BD.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DG.%2BJ.%26aulast%3DMarando%26aufirst%3DC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DHall%26aufirst%3DL.%2BM.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DBehshad%26aufirst%3DE.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DDiamond%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DC.%2BH.%26aulast%3DXu%26aufirst%3DM.%2BZ.%26aulast%3DZhuo%26aufirst%3DJ.%2BC.%26aulast%3DYao%26aufirst%3DW.%2BQ.%26aulast%3DNewton%26aufirst%3DR.%2BC.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26atitle%3DA%2520novel%2520kinase%2520inhibitor%252C%2520INCB28060%252C%2520blocks%2520c-MET-dependent%2520signaling%252C%2520neoplastic%2520activities%252C%2520and%2520cross-talk%2520with%2520EGFR%2520and%2520HER-3%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D7127%26epage%3D7138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Atreya, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messersmith, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venook, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arcaroli, J. J.</span><span> </span><span class="NLM_article-title">Potent antitumor activity of XL184 (cabozantinib), a c-MET and VEGFR2 inhibitor, in colorectal cancer patient-derived tumor explant models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=73&author=C.+E.+Atreyaauthor=E.+K.+Songauthor=W.+Messersmithauthor=A.+Purkeyauthor=S.+Bagbyauthor=K.+Quackenbushauthor=R.+K.+Kelleyauthor=E.+Kwakauthor=D.+Ryanauthor=A.+Venookauthor=J.+J.+Arcaroli&title=Potent+antitumor+activity+of+XL184+%28cabozantinib%29%2C+a+c-MET+and+VEGFR2+inhibitor%2C+in+colorectal+cancer+patient-derived+tumor+explant+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtreya%26aufirst%3DC.%2BE.%26aulast%3DSong%26aufirst%3DE.%2BK.%26aulast%3DMessersmith%26aufirst%3DW.%26aulast%3DPurkey%26aufirst%3DA.%26aulast%3DBagby%26aufirst%3DS.%26aulast%3DQuackenbush%26aufirst%3DK.%26aulast%3DKelley%26aufirst%3DR.%2BK.%26aulast%3DKwak%26aufirst%3DE.%26aulast%3DRyan%26aufirst%3DD.%26aulast%3DVenook%26aufirst%3DA.%26aulast%3DArcaroli%26aufirst%3DJ.%2BJ.%26atitle%3DPotent%2520antitumor%2520activity%2520of%2520XL184%2520%2528cabozantinib%2529%252C%2520a%2520c-MET%2520and%2520VEGFR2%2520inhibitor%252C%2520in%2520colorectal%2520cancer%2520patient-derived%2520tumor%2520explant%2520models%26jtitle%3DCancer%2520Res.%26date%3D2013%26spage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Katz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlberg, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabarda, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumb, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutterbach, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathvink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazef, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soisson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q. W.</span><span> </span><span class="NLM_article-title">Discovery of a 5<i>H</i>-benzo[4,5]cyclohepta[1,2-<i>b</i>]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4092</span><span class="NLM_x">–</span> <span class="NLM_lpage">4108</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200112k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4092-4108&author=J.+D.+Katzauthor=J.+P.+Jewellauthor=D.+J.+Guerinauthor=J.+Limauthor=C.+J.+Dinsmoreauthor=S.+V.+Deshmukhauthor=B.+S.+Panauthor=C.+G.+Marshallauthor=W.+Luauthor=M.+D.+Altmanauthor=W.+K.+Dahlbergauthor=L.+Davisauthor=D.+Falconeauthor=A.+E.+Gabardaauthor=G.+Z.+Hangauthor=H.+Hatchauthor=R.+Holmesauthor=K.+Kuniiauthor=K.+J.+Lumbauthor=B.+Lutterbachauthor=R.+Mathvinkauthor=N.+Nazefauthor=S.+B.+Patelauthor=X.+L.+Quauthor=J.+F.+Reillyauthor=K.+W.+Rickertauthor=C.+Rosensteinauthor=S.+M.+Soissonauthor=K.+B.+Spencerauthor=A.+A.+Szewczakauthor=D.+Walkerauthor=W.+X.+Wangauthor=J.+Youngauthor=Q.+W.+Zeng&title=Discovery+of+a+5H-benzo%5B4%2C5%5Dcyclohepta%5B1%2C2-b%5Dpyridin-5-one+%28MK-2461%29+inhibitor+of+c-Met+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm200112k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200112k%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%2BD.%26aulast%3DJewell%26aufirst%3DJ.%2BP.%26aulast%3DGuerin%26aufirst%3DD.%2BJ.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DPan%26aufirst%3DB.%2BS.%26aulast%3DMarshall%26aufirst%3DC.%2BG.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DDahlberg%26aufirst%3DW.%2BK.%26aulast%3DDavis%26aufirst%3DL.%26aulast%3DFalcone%26aufirst%3DD.%26aulast%3DGabarda%26aufirst%3DA.%2BE.%26aulast%3DHang%26aufirst%3DG.%2BZ.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DHolmes%26aufirst%3DR.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DLumb%26aufirst%3DK.%2BJ.%26aulast%3DLutterbach%26aufirst%3DB.%26aulast%3DMathvink%26aufirst%3DR.%26aulast%3DNazef%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DQu%26aufirst%3DX.%2BL.%26aulast%3DReilly%26aufirst%3DJ.%2BF.%26aulast%3DRickert%26aufirst%3DK.%2BW.%26aulast%3DRosenstein%26aufirst%3DC.%26aulast%3DSoisson%26aufirst%3DS.%2BM.%26aulast%3DSpencer%26aufirst%3DK.%2BB.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DW.%2BX.%26aulast%3DYoung%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DQ.%2BW.%26atitle%3DDiscovery%2520of%2520a%25205H-benzo%255B4%252C5%255Dcyclohepta%255B1%252C2-b%255Dpyridin-5-one%2520%2528MK-2461%2529%2520inhibitor%2520of%2520c-Met%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4092%26epage%3D4108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Munshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">France, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leggett, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. J.</span><span> </span><span class="NLM_article-title">ARQ 197, a novel and selective inhibitor of the human c-met receptor tyrosine kinase with antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1544</span><span class="NLM_x">–</span> <span class="NLM_lpage">1553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1158%2F1535-7163.MCT-09-1173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=20484018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFGgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1544-1553&author=N.+Munshiauthor=S.+Jeayauthor=Y.+Z.+Liauthor=C.+R.+Chenauthor=D.+S.+Franceauthor=M.+A.+Ashwellauthor=J.+Hillauthor=M.+M.+Moussaauthor=D.+S.+Leggettauthor=C.+J.+Li&title=ARQ+197%2C+a+novel+and+selective+inhibitor+of+the+human+c-met+receptor+tyrosine+kinase+with+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity</span></div><div class="casAuthors">Munshi, Neru; Jeay, Sebastien; Li, Youzhi; Chen, Chang-Rung; France, Dennis S.; Ashwell, Mark A.; Hill, Jason; Moussa, Magdi M.; Leggett, David S.; Li, Chiang J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1544-1553</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The met proto-oncogene is functionally linked with tumorigenesis and metastatic progression.  Validation of the receptor tyrosine kinase c-Met as a selective anticancer target has awaited the emergence of selective c-Met inhibitors.  Herein, we report ARQ 197 as the first non-ATP-competitive small mol. that selectively targets the c-Met receptor tyrosine kinase.  Exposure to ARQ 197 resulted in the inhibition of proliferation of c-Met-expressing cancer cell lines as well as the induction of caspase-dependent apoptosis in cell lines with constitutive c-Met activity.  These cellular responses to ARQ 197 were phenocopied by RNAi-mediated c-Met depletion and further demonstrated by the growth inhibition of human tumors following oral administration of ARQ 197 in multiple mouse xenograft efficacy studies.  Cumulatively, these data suggest that ARQ 197, currently in phase II clin. trials, is a promising agent for targeting cancers in which c-Met-driven signaling is important for their survival and proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxYa8M1T1wfLVg90H21EOLACvtfcHk0libWv46N3SOWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFGgsL0%253D&md5=2fd9c4ad5be6e1a119f2aa9699bb9519</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1173%26sid%3Dliteratum%253Aachs%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DJeay%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%2BZ.%26aulast%3DChen%26aufirst%3DC.%2BR.%26aulast%3DFrance%26aufirst%3DD.%2BS.%26aulast%3DAshwell%26aufirst%3DM.%2BA.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DMoussa%26aufirst%3DM.%2BM.%26aulast%3DLeggett%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DC.%2BJ.%26atitle%3DARQ%2520197%252C%2520a%2520novel%2520and%2520selective%2520inhibitor%2520of%2520the%2520human%2520c-met%2520receptor%2520tyrosine%2520kinase%2520with%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1544%26epage%3D1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Porter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascon-Simorte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calmiano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Riche, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallemand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyaerts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecomte, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuberson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, M.</span><span> </span><span class="NLM_article-title">Discovery of 4-azaindoles as novel inhibitors of c-Met kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2780</span><span class="NLM_x">–</span> <span class="NLM_lpage">2784</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1016%2Fj.bmcl.2009.03.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=19369077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltl2rsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2780-2784&author=J.+Porterauthor=S.+Lumbauthor=R.+J.+Franklinauthor=J.+M.+Gascon-Simorteauthor=M.+Calmianoauthor=K.+Le+Richeauthor=B.+Lallemandauthor=J.+Keyaertsauthor=H.+Edwardsauthor=A.+Maloneyauthor=J.+Delgadoauthor=L.+Kingauthor=A.+Foleyauthor=F.+Lecomteauthor=J.+Reubersonauthor=C.+Meierauthor=M.+Batchelor&title=Discovery+of+4-azaindoles+as+novel+inhibitors+of+c-Met+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4-azaindoles as novel inhibitors of c-Met kinase</span></div><div class="casAuthors">Porter, John; Lumb, Simon; Franklin, Richard J.; Gascon-Simorte, Jose M.; Calmiano, Mark; Le Riche, Kelly; Lallemand, Benedicte; Keyaerts, Jean; Edwards, Helen; Maloney, Alison; Delgado, Jean; King, Lloyd; Foley, Anne; Lecomte, Fabien; Reuberson, James; Meier, Christoph; Batchelor, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2780-2784</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 4-azaindole inhibitors of c-Met kinase, e.g. I (R1 = H, NH2, CO2H, 1-piperazinyl, etc.; R2 = PhSO2, 2-O2NC6H4SO2, benzofurazan-4-ylsulfonyl, etc.), is described.  The postulated binding mode was confirmed by an X-ray crystal structure of complex of I (R1 = CONH2; R2 = 2-O2NC6H4SO2) with c-Met kinase and series optimization was performed on the basis of this structure.  Future directions for series development are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9V4U2KtkairVg90H21EOLACvtfcHk0lgePxqGZaYQzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltl2rsLY%253D&md5=41dac12c5511c2ca5bb33a72704dfb78</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.110%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DJ.%26aulast%3DLumb%26aufirst%3DS.%26aulast%3DFranklin%26aufirst%3DR.%2BJ.%26aulast%3DGascon-Simorte%26aufirst%3DJ.%2BM.%26aulast%3DCalmiano%26aufirst%3DM.%26aulast%3DLe%2BRiche%26aufirst%3DK.%26aulast%3DLallemand%26aufirst%3DB.%26aulast%3DKeyaerts%26aufirst%3DJ.%26aulast%3DEdwards%26aufirst%3DH.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DDelgado%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DL.%26aulast%3DFoley%26aufirst%3DA.%26aulast%3DLecomte%26aufirst%3DF.%26aulast%3DReuberson%26aufirst%3DJ.%26aulast%3DMeier%26aufirst%3DC.%26aulast%3DBatchelor%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25204-azaindoles%2520as%2520novel%2520inhibitors%2520of%2520c-Met%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2780%26epage%3D2784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span> </span><span class="NLM_article-title">Biotransformation reactions of five-membered aromatic heterocyclic rings</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx015574b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=269-299&author=D.+K.+Dalvieauthor=A.+S.+Kalgutkarauthor=S.+C.+Khojasteh-Bakhtauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnell&title=Biotransformation+reactions+of+five-membered+aromatic+heterocyclic+rings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span></div><div class="casAuthors">Dalvie, Deepak K.; Kalgutkar, Amit S.; Khojasteh-Bakht, S. Cyrus; Obach, R. Scott; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-299</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 278 refs. is given on the biotransformation pathways of most commonly used 5-membered arom. heterocyclic rings.  The effect of physicochem. properties such as the electronic effects of heteroatoms, aromaticity, and acidity/basicity (pKa) of the rings are correlated on their biotransformation.  The generation of reactive metabolites following oxidn. or redn. of these heterocycles and the subsequent toxicol. consequences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNaEz19aehbVg90H21EOLACvtfcHk0lgePxqGZaYQzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D&md5=e8e2dfd12772f9ff2289b173bdefa590</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Ftx015574b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx015574b%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBiotransformation%2520reactions%2520of%2520five-membered%2520aromatic%2520heterocyclic%2520rings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D269%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">He, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M. Y.</span><span> </span><span class="NLM_article-title">Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1038%2Faps.2013.125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=24241352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitlSktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=89-97&author=C.+X.+Heauthor=J.+Aiauthor=W.+Q.+Xingauthor=Y.+Chenauthor=H.+T.+Zhangauthor=M.+Huangauthor=Y.+H.+Huauthor=J.+Dingauthor=M.+Y.+Geng&title=Yhhu3813+is+a+novel+selective+inhibitor+of+c-Met+kinase+that+inhibits+c-Met-dependent+neoplastic+phenotypes+of+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Yhhu3813 is a novel selective inhibitor of c-Met Kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells</span></div><div class="casAuthors">He, Chang-xi; Ai, Jing; Xing, Wei-qiang; Chen, Yi; Zhang, Hao-tian; Huang, Min; Hu, You-hong; Ding, Jian; Geng, Mei-yu</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aim: c-Met kinase deregulation is strongly assocd. with the formation, progression and dissemination of human cancers.  In this study we identified Yhhu3813 as a small-mol. inhibitor of c-Met kinase and characterized its antitumor properties both in vitro and in vivo.  Methods: The activities of different kinases were measured using ELISA assays and signaling proteins in the cells were detected with Western blotting.  Cell proliferation was assessed using SRB or MTT assay in twenty human cell lines and cell cycle distribution was detd. with flow cytometry.  Transwell-based assay was used to evaluate cell migration and invasion.  Cell invasive growth was detected by a morphogenesis assay. c-Met overactivated human NSCLC cell line EBC-1 xenografts were used to evaluate the in vivo anti-tumor efficacy.  Results: Yhhu3813 potently inhibited c-Met kinase activity in vitro with an IC50 value of 2.4±0.3 nmol/L, >400-fold higher than that for a panel of 15 different tyrosine kinases, suggesting a high selectivity of Yhhu3813.  The compd. (20, 100 and 500 nmol/L) dose-dependently inhibited the phosphorylation of c-Met and its key downstream Akt and Erk signal cascades in multiple c-Met aberrant human cancer cell lines, regardless of the mechanistic complexity in c-Met activation across different cellular contexts.  In 20 human cancer cell lines harboring different backgrounds of c-Met expression/activation, Yhhu3813 potently inhibited c-Met-driven cell proliferation via arresting cells at G1/S phase.  Furthermore, Yhhu3813 substantially impaired c-Met-mediated cell migration, invasion, scattering, and invasive growth.  Oral administration of EBC-1 xenograft mice with Yhhu3813 (50 or 100 mg·kg-1·d-1, qd, for 2 wk) dose-dependently suppressed the tumor growth, which was correlated with a redn. in the intratumoral proliferation index and c-Met signaling.  Conclusion: Yhhu3813 is a potent selective inhibitor of c-Met that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlTbQCB6nXg7Vg90H21EOLACvtfcHk0lgePxqGZaYQzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitlSktw%253D%253D&md5=24f843fa996cd92beb20ca8b814fcd77</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Faps.2013.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2013.125%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DC.%2BX.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DXing%26aufirst%3DW.%2BQ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DY.%2BH.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%2BY.%26atitle%3DYhhu3813%2520is%2520a%2520novel%2520selective%2520inhibitor%2520of%2520c-Met%2520kinase%2520that%2520inhibits%2520c-Met-dependent%2520neoplastic%2520phenotypes%2520of%2520human%2520cancer%2520cells%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2014%26volume%3D35%26spage%3D89%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Patil, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macias, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Puebla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Role of Ccclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=253-261&author=M.+A.+Patilauthor=S.+A.+Leeauthor=E.+Maciasauthor=E.+T.+Lamauthor=C.+R.+Xuauthor=K.+D.+Jonesauthor=C.+Hoauthor=M.+Rodriguez-Pueblaauthor=X.+Chen&title=Role+of+Ccclin+D1+as+a+mediator+of+c-Met-+and+beta-catenin-induced+hepatocarcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DM.%2BA.%26aulast%3DLee%26aufirst%3DS.%2BA.%26aulast%3DMacias%26aufirst%3DE.%26aulast%3DLam%26aufirst%3DE.%2BT.%26aulast%3DXu%26aufirst%3DC.%2BR.%26aulast%3DJones%26aufirst%3DK.%2BD.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DRodriguez-Puebla%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DRole%2520of%2520Ccclin%2520D1%2520as%2520a%2520mediator%2520of%2520c-Met-%2520and%2520beta-catenin-induced%2520hepatocarcinogenesis%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D253%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C. H.</span><span> </span><span class="NLM_article-title">Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma</span> <span class="citation_source-journal">Oral Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1114</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1016%2Fj.oraloncology.2012.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=22704061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFCitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=1114-1119&author=Y.+C.+Limauthor=J.+H.+Hanauthor=H.+J.+Kangauthor=Y.+S.+Kimauthor=B.+H.+Leeauthor=E.+C.+Choiauthor=C.+H.+Kim&title=Overexpression+of+c-Met+promotes+invasion+and+metastasis+of+small+oral+tongue+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma</span></div><div class="casAuthors">Lim, Young Chang; Han, Jae Ho; Kang, Hyun Jung; Kim, Young Sook; Lee, Bum Hei; Choi, Eun Chang; Kim, Chul-Ho</div><div class="citationInfo"><span class="NLM_cas:title">Oral Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1114-1119</span>CODEN:
                <span class="NLM_cas:coden">EJCCER</span>;
        ISSN:<span class="NLM_cas:issn">1368-8375</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">C-Met proto-oncogene, which is a receptor of ligand hepatocyte growth factor (HGF), has been assocd. with cancer cell invasion.  There have been no reports on the relationship between the expression of c-Met and tumor invasion and metastasis in small (T1-2) squamous cell carcinoma of the oral tongue (SCCOT).  We analyzed the relationship between c-Met expression and tumor invasion depth and lymph node metastasis in 71 surgically treated patients with small SCCOT using immunohistochem.  Furthermore, we investigated the assocns. between the c-Met expression status and patient survival.  In addn., we explored whether overexpression of c-Met enhances tumor growth and invasion of tongue cancer cells in vitro and in vivo.  Pos. immunohistochem. staining of c-Met was obsd. in 39 (55%) samples.  Presence of neck metastasis, and >4 mm depth of tumor invasion, strongly correlated with c-Met expression in small SCCOT both by the univariate and multivariate anal. (p < .05).  The survival rates with c-Met expression were significantly shorter than for patients without c-Met expression (p < .05).  Constitutive activation of c-Met enhanced migration and invasion of tongue cancer cells in vitro through the expressions of matrix metalloproteinase-1, -2, and -9, and promoted tongue cancer cell growth in vitro and in vivo.  The results support the assocn. of c-Met with the invasiveness and metastasis of small SCCOT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmHuJ5PG_n3LVg90H21EOLACvtfcHk0lhKYbYlANpgHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFCitLg%253D&md5=51d0d79d6e308d6895cce0b8c41615b6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.oraloncology.2012.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.oraloncology.2012.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DY.%2BC.%26aulast%3DHan%26aufirst%3DJ.%2BH.%26aulast%3DKang%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DChoi%26aufirst%3DE.%2BC.%26aulast%3DKim%26aufirst%3DC.%2BH.%26atitle%3DOverexpression%2520of%2520c-Met%2520promotes%2520invasion%2520and%2520metastasis%2520of%2520small%2520oral%2520tongue%2520carcinoma%26jtitle%3DOral%2520Oncol.%26date%3D2012%26volume%3D48%26spage%3D1114%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M. Y.</span><span> </span><span class="NLM_article-title">SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1016%2Fj.canlet.2014.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=24880078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVejtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=143-150&author=L.+Wangauthor=J.+Aiauthor=Y.+Y.+Shenauthor=H.+T.+Zhangauthor=X.+Pengauthor=M.+Huangauthor=A.+Zhangauthor=J.+Dingauthor=M.+Y.+Geng&title=SOMCL-863%2C+a+novel%2C+selective+and+orally+bioavailable+small-molecule+c-Met+inhibitor%2C+exhibits+antitumor+activity+both+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo</span></div><div class="casAuthors">Wang, Lu; Ai, Jing; Shen, Yanyan; Zhang, Haotian; Peng, Xia; Huang, Min; Zhang, Ao; Ding, Jian; Geng, Meiyu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">143-150</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Deregulation of HGF/c-Met signaling and its driven neoplastic phenotype are assocd. with a variety of human malignancies.  We herein reported SOMCL-863 as a novel selective c-Met inhibitor which effectively abrogated c-Met signaling pathways, thereby leading to substantial impairment of c-Met-dependent cell proliferation, migration, invasion, cell scattering and invasive growth.  In EBC-1 and NCI-H1993 xenografts, SOMCL-863 exerted significant anti-tumor efficacy through anti-proliferative effects and antiangiogenic mechanisms, including redn. of tumor cell proliferation and redns. of microvessel d. and secretion of proangiogenic factor IL-8.  Together with the optimal pharmacokinetic properties, SOMCL-863 is a promising candidate worthy for further evaluation as a treatment of c-Met-driven human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSI82XfAkPNLVg90H21EOLACvtfcHk0li8wc8-eKjBHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVejtL0%253D&md5=eb872a6784e3a2c2349feed61195d83c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DY.%2BY.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%2BY.%26atitle%3DSOMCL-863%252C%2520a%2520novel%252C%2520selective%2520and%2520orally%2520bioavailable%2520small-molecule%2520c-Met%2520inhibitor%252C%2520exhibits%2520antitumor%2520activity%2520both%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D351%26spage%3D143%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Horm, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitler, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broka, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louderbough, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, J. A.</span><span> </span><span class="NLM_article-title">MUC1 drives c-Met-dependent migration and scattering</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1544</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1158%2F1541-7786.MCR-12-0296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=23193156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyns7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=1544-1554&author=T.+M.+Hormauthor=B.+G.+Bitlerauthor=D.+M.+Brokaauthor=J.+M.+Louderboughauthor=J.+A.+Schroeder&title=MUC1+drives+c-Met-dependent+migration+and+scattering"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">MUC1 Drives c-Met-Dependent Migration and Scattering</span></div><div class="casAuthors">Horm, Teresa M.; Bitler, Benjamin G.; Broka, Derrick M.; Louderbough, Jeanne M.; Schroeder, Joyce A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1544-1554</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The transmembrane mucin MUC1 is overexpressed in most ductal carcinomas, and its overexpression is frequently assocd. with metastatic progression.  MUC1 can drive tumor initiation and progression via interactions with many oncogenic partners, including β-catenin, the EGF receptor (EGFR) and Src.  The decoy peptide protein transduction domain MUC1 inhibitory peptide (PMIP) has been shown to inhibit the tumor promoting activities of MUC1 in breast and lung cancer, including cell growth and invasion, and its usage suppresses metastatic progression in mouse models of breast cancer.  To further characterize the reduced metastasis obsd. upon PMIP treatment, we conducted motility assays and obsd. that PMIP inhibits cell motility of breast cancer cells.  To det. the mechanism by which PMIP inhibits motility, we evaluated changes in global gene transcription upon PMIP treatment, and identified a no. of genes with altered expression in response to PMIP.  Among these genes is the metastatic mediator, c-Met, a transmembrane tyrosine kinase that can promote cell scattering, migration, and invasion.  To further investigate the role of c-Met in MUC1-dependent metastatic events, we evaluated the effects of MUC1 expression and EGFR activation on breast cancer cell scattering, branching, and migration.  We found that MUC1 strongly promoted all of these events and this effect was further amplified by EGF treatment.  Importantly, the effect of MUC1 and EGF on these phenotypes was dependent upon c-Met activity.  Overall, these results indicate that PMIP can block the expression of a key metastatic mediator, further advancing its potential use as a clin. therapeutic.  Mol Cancer Res; 10(12); 1544-54. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA7km5ZMahs7Vg90H21EOLACvtfcHk0li8wc8-eKjBHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyns7bN&md5=2d9932d3da7601556e6d5e5ae4febb3a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-12-0296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-12-0296%26sid%3Dliteratum%253Aachs%26aulast%3DHorm%26aufirst%3DT.%2BM.%26aulast%3DBitler%26aufirst%3DB.%2BG.%26aulast%3DBroka%26aufirst%3DD.%2BM.%26aulast%3DLouderbough%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DJ.%2BA.%26atitle%3DMUC1%2520drives%2520c-Met-dependent%2520migration%2520and%2520scattering%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2012%26volume%3D10%26spage%3D1544%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Boccaccio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">Invasive growth: a MET-driven genetic programme for cancer and stem cells</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1038%2Fnrc1912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=16862193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFGlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=637-645&author=C.+Boccaccioauthor=P.+M.+Comoglio&title=Invasive+growth%3A+a+MET-driven+genetic+programme+for+cancer+and+stem+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Invasive growth: a MET-driven genetic programme for cancer and stem cells</span></div><div class="casAuthors">Boccaccio, Carla; Comoglio, Paolo M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">637-645</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Metastasis follows the inappropriate activation of a genetic program termed invasive growth, which is a physiol. process that occurs during embryonic development and post-natal organ regeneration.  Burgeoning evidence indicates that invasive growth is also executed by stem and progenitor cells, and is usurped by cancer stem cells.  The MET proto-oncogene, which is expressed in both stem and cancer cells, is a key regulator of invasive growth.  Recent findings indicate that the MET tyrosine-kinase receptor is a sensor of adverse microenvironmental conditions (such as hypoxia) and drives cell invasion and metastasis through the transcriptional activation of a set of genes that control blood coagulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrNb2dfp5v27Vg90H21EOLACvtfcHk0li8wc8-eKjBHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFGlu70%253D&md5=79319c46d57d395726d389e6cd03068f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnrc1912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1912%26sid%3Dliteratum%253Aachs%26aulast%3DBoccaccio%26aufirst%3DC.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DInvasive%2520growth%253A%2520a%2520MET-driven%2520genetic%2520programme%2520for%2520cancer%2520and%2520stem%2520cells%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D637%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Direnzo, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chastre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirossay, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordlinger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plebani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gespach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">Overexpression and amplification of the Met/Hgf receptor gene during the progression of colorectal-cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=9815967" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=147-154&author=M.+F.+Direnzoauthor=M.+Oliveroauthor=A.+Giacominiauthor=H.+Porteauthor=E.+Chastreauthor=L.+Mirossayauthor=B.+Nordlingerauthor=S.+Brettiauthor=S.+Bottardiauthor=S.+Giordanoauthor=M.+Plebaniauthor=C.+Gespachauthor=P.+M.+Comoglio&title=Overexpression+and+amplification+of+the+Met%2FHgf+receptor+gene+during+the+progression+of+colorectal-cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDirenzo%26aufirst%3DM.%2BF.%26aulast%3DOlivero%26aufirst%3DM.%26aulast%3DGiacomini%26aufirst%3DA.%26aulast%3DPorte%26aufirst%3DH.%26aulast%3DChastre%26aufirst%3DE.%26aulast%3DMirossay%26aufirst%3DL.%26aulast%3DNordlinger%26aufirst%3DB.%26aulast%3DBretti%26aufirst%3DS.%26aulast%3DBottardi%26aufirst%3DS.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DPlebani%26aufirst%3DM.%26aulast%3DGespach%26aufirst%3DC.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DOverexpression%2520and%2520amplification%2520of%2520the%2520Met%252FHgf%2520receptor%2520gene%2520during%2520the%2520progression%2520of%2520colorectal-cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1995%26volume%3D1%26spage%3D147%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span> </span><span class="NLM_article-title">An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4408</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm502018y&amp;key=10.1158%2F0008-5472.CAN-06-4443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm502018y&amp;key=17483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm502018y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4408-17&author=H.+Y.+Zouauthor=Q.+Liauthor=J.+H.+Leeauthor=M.+E.+Arangoauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=T.+B.+Koudriakovaauthor=G.+Altonauthor=J.+J.+Cuiauthor=P.+P.+Kungauthor=M.+D.+Nambuauthor=G.+Losauthor=S.+L.+Benderauthor=B.+Mroczkowskiauthor=J.+G.+Christensen&title=An+orally+available+small-molecule+inhibitor+of+c-Met%2C+PF-2341066%2C+exhibits+cytoreductive+antitumor+efficacy+through+antiproliferative+and+antiangiogenic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms</span></div><div class="casAuthors">Zou, Helen Y.; Li, Qiuhua; Lee, Joseph H.; Arango, Maria E.; McDonnell, Scott R.; Yamazaki, Shinji; Koudriakova, Tatiana B.; Alton, Gordon; Cui, Jingrong J.; Kung, Pei-Pei; Nambu, Mitchell D.; Los, Gerrit; Bender, Steven L.; Mroczkowski, Barbara; Christensen, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4408-4417</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), have been implicated in the progression of several human cancers and are attractive therapeutic targets.  PF-2341066 was identified as a potent, orally bioavailable, ATP-competitive small-mol. inhibitor of the catalytic activity of c-Met kinase.  PF-2341066 was selective for c-Met (and anaplastic lymphoma kinase) compared with a panel of >120 diverse tyrosine and serine-threonine kinases.  PF-2341066 potently inhibited c-Met phosphorylation and c-Met-dependent proliferation, migration, or invasion of human tumor cells in vitro (IC50 values, 5-20 nmol/L).  In addn., PF-2341066 potently inhibited HGF-stimulated endothelial cell survival or invasion and serum-stimulated tubulogenesis in vitro, suggesting that this agent also exhibits antiangiogenic properties.  PF-2341066 showed efficacy at well-tolerated doses, including marked cytoreductive antitumor activity, in several tumor models that expressed activated c-Met.  The antitumor efficacy of PF-2341066 was dose dependent and showed a strong correlation to inhibition of c-Met phosphorylation in vivo.  Near-maximal inhibition of c-Met activity for the full dosing interval was necessary to maximize the efficacy of PF-2341066.  Addnl. mechanism-of-action studies showed dose-dependent inhibition of c-Met-dependent signal transduction, tumor cell proliferation (Ki67), induction of apoptosis (caspase-3), and redn. of microvessel d. (CD31).  These results indicated that the antitumor activity of PF-2341066 may be mediated by direct effects on tumor cell growth or survival as well as antiangiogenic mechanisms.  Collectively, these results show the therapeutic potential of targeting c-Met with selective small-mol. inhibitors for the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEAWtGPOBHC7Vg90H21EOLACvtfcHk0lgMA3JlbBxxtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D&md5=798bf93e6cf8d5e9897e27485cba9002</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4443%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DKoudriakova%26aufirst%3DT.%2BB.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%2BL.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DAn%2520orally%2520available%2520small-molecule%2520inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520exhibits%2520cytoreductive%2520antitumor%2520efficacy%2520through%2520antiproliferative%2520and%2520antiangiogenic%2520mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4408%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Zillhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengyel, E.</span><span> </span><span class="NLM_article-title">An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1-10&author=M.+Zillhardtauthor=J.+G.+Christensenauthor=E.+Lengyel&title=An+orally+available+small-molecule+inhibitor+of+c-Met%2C+PF-2341066%2C+reduces+tumor+burden+and+metastasis+in+a+preclinical+model+of+ovarian+cancer+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZillhardt%26aufirst%3DM.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DLengyel%26aufirst%3DE.%26atitle%3DAn%2520orally%2520available%2520small-molecule%2520inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520reduces%2520tumor%2520burden%2520and%2520metastasis%2520in%2520a%2520preclinical%2520model%2520of%2520ovarian%2520cancer%2520metastasis%26jtitle%3DNeoplasia%26date%3D2010%26volume%3D12%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WD1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WD1','PDB','2WD1'); return false;">PDB: 2WD1</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i55"><a href="/doi/suppl/10.1021/jm502018y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_20022"></div></div></div></div></div><hr /></hr><p class="last">Analytical and spectral data for compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm502018y/suppl_file/jm502018y_si_001.pdf">jm502018y_si_001.pdf (88.49 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm502018y&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm502018y%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-5%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm502018y" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679948bfea093c3a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
